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ABSTRACT OF THE DISSERTATION 
Extracellular Matrix and Cytoskeletal Regulation of Cardiac Aging: Insights from 
Drosophila melanogaster 
 
By 
 
Ayla Sessions 
 
Doctor of Philosophy in Biomedical Sciences 
 
University of California, San Diego, 2017 
 
Professor Adam Engler, Chair 
 
The main purpose of this dissertation was to identify and characterize how both internal 
and external remodeling of the cardiomyocyte affects contractility with age. Not only can 
substructures within the cardiomyocyte, i.e. the cytoskeleton, remodel with age affecting 
longitudinal force transduction, but external structures within the basement membrane can 
remodel, affecting lateral force transduction. Both inherently change how cardiomyocytes sense 
and respond to their environment. Specifically, changes to either means of mechanosensing can 
lead to pressure or volume overload induced hypertrophy of cardiomyocytes resulting in heart 
failure. Recent work has been aimed at distinguishing which age-related molecular changes help 
sustain function over time (physiological aging) versus those that directly lead to impairment in 
cardiac function (pathological aging). In terms of many organ structures, aging has typically been 
thought of as the accumulation of damage or insults over time, but in the heart, where 
regeneration is minimal, these age-related changes may help cardiomyocytes compensate for 
loss in numbers as well as increased stress with age. A complete understanding of cardiac 
 xv 
molecular remodeling is imperative if we are to understand the complex nature of age-related 
cardiac decline to design better treatments or utilize inherent beneficial mechanisms to improve 
cardiac function with age. 
For this PhD dissertation, I began searching for conserved components of cardiac aging 
in Drosophila melanogaster, a rapidly aging and genetically homologous organism with a simple 
heart structure. I identified two substructures, basement membrane and cytoskeleton that in flies 
recapitulated age-related remodeling observed in rats and monkeys. First, I examined basement 
membrane remodeling which has experienced very little study outside of development. Using the 
Drosophila genetic toolbox, we employed a UAS-GAL4 system to knockdown basement 
membrane genes Laminin and Collagen IV that experienced upregulation with age in other 
models, and were overexpressed in our wildtype fly line that exhibits diminished cardiac function. 
These studies proved for the first time, the direct link between basement membrane remodeling 
and cardiac function, and showed that downregulating Laminin and Collagen IV in a genetic 
background in which they are overexpressed correlates with an improvement in contractility, 
fractional shortening, and lifespan.  
I also identified age-related Vinculin upregulation and recruitment to intercalated discs 
and costameres in cardiomyocytes as a conserved phenotype between flies, rats, and monkeys. 
By employing Drosophila melanogaster, to further interrogate the mechanical impact this 
upregulation was having in the heart, I overexpressed Vinculin in the fly hearts using the Gal4-
UAS system and performed Myosin Heavy Chain knockdown with Vinculin overexpression rescue 
experiments. These data revealed that Vinculin overexpression correlated with significant 
improvements in contractile velocities, fractional shortening, and relative power produced. By 
performing transmission electron microscopy on these hearts, I showed that the myofibrils in 
hearts overexpressing Vinculin experience improved crystallinity which could explain the 
improved contraction observed. I also examined what effect improved cardiac output in flies 
overexpressing Vinculin had on organismal metabolism and healthspan since these changes 
impacted a highly metabolic organ integral to nutrient delivery. Through whole fly mass 
 xvi 
spectrometry, we found significant age-related accumulation of metabolites in flies 
overexpressing Vinculin in the heart in addition to improved organismal fitness with age. These 
data suggest that a cardiac specific cytoskeletal perturbation can significantly impact systemic 
metabolic homeostasis and alter age-related metabolism improving healthspan as well as 
lifespan. Taken together this research points to the effectiveness of the Drosophila model to study 
the mechanics of cardiac aging and to find conserved mechanisms that either help or hinder 
cardiac function so that we may target these to promote healthier aging. 
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Ayla O. Sessions1 and Adam J. Engler1-3* 
1Biomedical Sciences Program and 2Department of Bioengineering, University of 
California, San Diego, La Jolla, CA 92093, 3Sanford Consortium for Regenerative 
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Preface to Chapter 1 
Chapter 1 in full is a review article published in Circulation Research. The text in Chapter 
1 provides a comprehensive introduction of the cardiac field and how specific model organisms 
have been used to distinguish the different types of cardiac aging: physiological vs. pathological. 
In recent years, much of cardiac aging research has been aimed at identifying inherent molecular 
changes that occur with age deemed “cardiac remodeling” which help cardiomyocytes sustain 
function over time (physiological aging). With the identification of these physiological aging 
processes, we can hope to target and promote healthier aging. This review looks at both internal 
and external cardiac remodeling and specifically highlights how Drosophila melanogaster has 
been uniquely suited for aiding the cardiac aging research field. For example, we indicate that 
age-related vinculin reinforcement of the ID and costamere is beneficial to cardiomyocyte function 
further outlined in Chapters 3 and 4. While extracellular matrix changes often appear associated 
with pathological changes, these changes focus more on fibrillar ECM, and we note the 
underappreciated role that the basement membrane which surrounds cardiomyocytes could have 
on cardiac aging. To that end, we ask the question: how do basement membrane components 
affect lateral signal transduction from the sarcomere to the ECM? This question prefaces the 
work presented in Chapter 2 which discusses how basement membrane ECM regulates cardiac 
function with age. 
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Abstract 
Unlike diet and exercise, which individuals can modulate according to their lifestyle, aging 
is unavoidable. With normal or “healthy” aging, the heart undergoes extensive vascular, cellular, 
and interstitial molecular changes that result in stiffer less compliant hearts that experience a 
general decline in organ function. While these molecular changes deemed “cardiac remodeling” 
were once thought to be concomitant with advanced cardiovascular disease, they can be found in 
patients without manifestation of clinical disease. It is now mostly acknowledged that these age-
related mechanical changes confer vulnerability of the heart to cardiovascular stresses 
associated with disease such as hypertension and atherosclerosis. However, recent studies have 
aimed at differentiating the initial compensatory changes that occur within the heart with age to 
maintain contractile function from the maladaptive responses associated with disease. This work 
has identified new targets to improve cardiac function during aging. Spanning invertebrate to 
vertebrate models, we use this review to delineate some hallmarks of physiological vs. 
pathological remodeling that occur in the cardiomyocyte and its microenvironment, focusing 
especially on the mechanical changes that occur within the sarcomere, intercalated disc, 
costamere, and extracellular matrix (ECM). 
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Introduction 
The majority of people afflicted by cardiovascular disease and heart failure (HF) are of 
advanced age. While aging specifically is not thought to be the cause, it is an independent risk 
factor for cardiovascular disease (CVD) as both the incidence and prevalence of CVD increases 
dramatically after the age of 50 for men and women (1). The heart undergoes extensive structural 
changes with aging independent of disease; this is marked by an asymmetric increase in septum 
thickness and overall decrease in ventricular tissue compliance (2). However when changes are 
superimposed with cardiac stresses associated with disease, the occurrence and severity of 
disease increases. Regardless of pathology, however, these global age-related, organ-level 
structural changes are all rooted in intra- and extra-cellular remodeling, leading to hypertrophied 
cardiomyocytes regardless of sex or disease state. This remodeling is thought at least in part to 
reinforce organ structure under increased systolic pressure and afterload experienced with age 
(3, 4). Cardiomyocytes must maintain function with increasing loads via compensatory molecular 
mechanisms that span the sarcomere, intercalated disc, and the sarcolemma. Proteins within 
these units remodel with increased stress and strain associated with aging to maintain function, 
but the accumulation of remodeling events may lead to a pathological response resulting to HF. 
Recent studies have focused on differentiating which specific molecular changes that accumulate 
with age help maintain cardiomyocyte function, and can be deemed hallmarks of “physiological 
aging,” versus those that aid in disease progression during advanced age, and can be deemed 
“pathological aging.” 
The past few decades have seen the emergence of many likely and unlikely animal 
models utilized for their unique ability to study certain aspects of physiological and pathological 
cardiac aging, disease, or both. Recent aging studies have used large mammalian models such 
as simians, pigs, and dogs since they may more closely model functional decline and respond 
similarly to treatments. However, these models are costly and slow to age. Smaller, cheaper, and 
easier to use models are ideal to elucidate cellular and molecular mechanisms of aging. For that 
reason, the bulk of cardiac aging and disease research has focused on rat and mouse models 
  
5 
rather than larger mammalian counterparts. Yet, mice and rats have significantly increased heart 
rates over humans, and still require 2 years to age from young to old. The need for a rapidly 
aging, genetically tractable, and genetically homologous model has led to the recent popularity of 
the fruit fly, Drosophila melanogaster, as a model for age-related cardiovascular disease. The fruit 
fly is uniquely suited to study cardiovascular aging and disease due to its relatively short lifespan 
~5-7 weeks, conservation of cardiac disease genes (5), the breadth of transgenic systems (6-8), 
and ease of in situ measurement of cardiac parameters (9-12). With all of these models and tools, 
the scientific community can use multivariate approaches to explore how the age-related 
mechanical changes that occur in cardiomyocytes progress from maintenance of physiological 
function to those that induce pathological disease.  
Using the model systems introduced above, this review highlights a range of protein 
complexes implicated in regulating the mechanical sensing and transmitting of forces necessary 
for physiological cellular remodeling under increased load and stress (13-15), which with age may 
become increasingly dysregulated. We will first focus on the intracellular cytoskeletal and 
sarcomeric remodeling that leads to age-related cardiac hypertrophy. In this context, we will pay 
close attention to separate physiological and pathological cardiac aging to highlight differences, 
which to date have been less appreciated. 
 
Intracellular Remodeling as a Result of Stress, Age, or Disease 
Cardiomyocytes undergo extensive morphological changes during development, stress, 
and aging due in large part to “outside-in” transduction of mechanical signals to the sarcomeres, 
cytoskeleton, and junctions e.g. intercalated discs (ID) and costameres. Internal remodeling gives 
cardiomyocytes plasticity to adjust to increased mechanical loads, especially when cells must 
compensate to preserve function. Here we detail each structure and outline its pathological 
remodeling with disease and/or its physiological remodeling with age. For reference, Figure 1.1 
contains many of the proteins referenced in this section and is color-coded based on whether 
expression changes have been shown to change with physiological aging prior to disease 
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progression or still only associated with pathological cardiac aging; proteins in black are 
mentioned in the text without indicating conclusively if they contribute to either, whereas those in 
gray are shown to indicate overall structure. 
 
Sarcomeric Remodeling and Maintenance 
The sarcomere is a complex assembly of thick (myosin) and thin (actin) filaments 
responsible for force generation within the cardiomyocyte. Sarcomeres generate the contractile 
force within myocytes together with regulatory proteins, e.g. troponins and tropomyosin, and 
cytoskeletal components, e.g. titin and myosin binding protein C. Sarcomere function is spatially 
and temporally regulated by post-translational modifications and alternative splice isoforms. 
Therefore, aberrant expression of certain isoforms with age may result in reduced contraction, 
reduced mechanical response, and disease.  
In mammalian hearts, two myosin heavy chain (MHC) isoforms, a and b, exist. a-MHC is 
associated with higher ATPase activity, greater contractile velocity (16), and is the dominant form 
of MHC in rodent LV, i.e. >90% (17). In adult humans, b-MHC comprises ~95% of MHC found in 
ventricles (18) and produces more force per power stroke (16). Failing human myocardium 
experiences a further decrease in a-MHC expression (Figure 1.1, blue) (19, 20). Rat hearts 
experience a similar decrease in a-MHC with aortic banding (21), suggesting that cardiomyocyte 
regulation of MHC isoforms during pressure overload is not retarded by age and is more closely 
associated with pathology. Since MHC isoforms have unique effects on contractility, decreasing 
a-MHC could negatively impact contractile velocity and impair adaptation to increased cardiac 
demand. Unfortunately, age-related MHC expression data outside of disease are lacking, which 
could further clarify if this is a response to pressure changes or downstream activator of 
pathological remodeling. Similarly, essential myosin light chain (MLC) undergoes isoform shifts 
during disease, with an increase in the ratio of atrial to ventricular isoforms expressed with 
hypertrophic cardiomyopathy (HCM) (22). In addition to isoform switches, phosphorylation of 
ventricular MLC-2 regulates cross-bridge cycling; when ventricular MLC-2 is phosphorylated, 
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hearts exhibit greater force production per myosin power stroke by slowing down cycling kinetics 
and prolonging the duty cycle, allowing more myosin heads to come into contact with actin (23, 
24). Conversely, reduced phosphorylation in mice exhibit dilated cardiomyopathy (DCM)-like 
remodeling (24, 25). Humans also shift to more dephosphorylated MLC-2 in diseased and failing 
myocardium (26-28), suggesting that cross-bridge cycling becomes increasingly dysregulated 
with disease (Figure 1.1, blue). Yet much of how both MHC and MLC isoforms change with 
physiological aging have yet to be discovered, owing largely to a focus on how mutations cause 
familial HCM. Due to the strong correlation of HF and the decline of a-MHC and phosphorylated 
MLC-2 across species, these data suggest that a threshold of a-MHC expression and MLC-2 
phosphorylation is needed for proper cardiomyocyte contraction; thus declining levels of either 
protein may be a marker for pathology.  
In addition to thick filaments, some thin filament proteins change with aging and disease. 
For example, cardiac tropomyosin-binding protein troponin T (cTnT) undergoes alternative 
splicing to confer increased myofilament Ca2+sensitivity in failing human hearts (29, 30). 
However, a cTnT3 to cTnT4 isoform switch does not enhance disease progression (Figure 1.1, 
red) (31), suggesting that the switch to more Ca2+ sensitive isoform might compensate for 
increased hemodynamic stress. In Drosophila mutations adjacent to a highly conserved TnT1 
tropomyosin-binding domain result in excessive cross-bridge formation at rest even under low 
Ca2+, prolonged muscle activation, and restrictive cardiomyopathy (32). Since these cTnT 
changes result in diastolic dysfunction for fly hearts, this model could explain why aging hearts 
experience increased resting tension and stiffness and ultimately impaired function. However, a 
cTnT isoform expression profile with age is needed to confirm that the isoform switch is part of 
physiological compensation under increased stress since prolonged stress could have adverse 
consequences.  
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Figure 1.1. Physiological vs. Pathological Age-Related Changes of the Sarcomere and 
Intercalated Disc. Schematic of sarcomere and intercalated disc (ID) components in the 
cardiomyocyte implicated in physiological aging [red, up-regulated; green, down-regulated], 
pathological aging [yellow, upregulated; blue, down-regulated], or yet undetermined [black]. F-
actin indicates filamentous actin; P-MLC-2, phosphorylated myosin light chain-2, a-MHC, a-
myosin heavy chain; c-TnT4, cardiac tropomyosin binding protein 4; MLP, muscle binding limb 
protein; Vinc, vinculin; a-CAT, a-catenin; b-CAT, b-catenin; ACTN1, a-actinin-1; N-CAD, N-
cadherin. Arrows to nucleus indicate translocation of protein into the nucleus with age. 
Maintaining myofilament structure and function with age and increased load is a 
combinatory process across the sarcomere. Major mechanical regulators of sarcomere structure, 
e.g. titin (14)–a giant sarcomeric protein that spans from Z-disc to M-band (33), appear to 
contribute to this balance between physiological compensation and pathological remodeling. Titin 
acts as a sarcomeric ruler (33, 34), generates resting stiffness, and transduces signals in times of 
mechanical overload (35). The role of titin in mechanically regulating the switch from physiological 
aging to pathological remodeling and heart failure has been extensively reviewed (Figure 1.1, 
yellow) (36). Recent work studying titin-associated proteins demonstrated that only patients with 
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heart failure with preserved ejection fraction exhibited a significant increase in titin-dependent 
stiffness (37), reinforcing the importance of this protein and proteins in complex with it in 
regulating the switch from normal to pathological function. As another example, the Z-disc protein 
a-actinin anchors actin filaments at the Z-disc (14, 38, 39). Mutations in a-actinin are associated 
with familial HCM and arrhythmias, suggesting that it is integral for proper sarcomeric growth and 
force propagation (40). Patients who recover enough LV function to warrant explantation of their 
Left Ventricular Assist Device (LVAD) often experience a significant increase in a-actinin (41), 
implying that a-actinin could scale with sarcomeric function. In addition to concentration, a-actinin 
lattice organization has been implicated in disease severity; canine HF models show partial 
rescue of a-actinin lattice structure post cardiac resynchronization therapy (Figure 1.1, blue) (42). 
However, it remains undetermined if these changes precede pathology since aging or stress-
induced studies involving a-actinin are lacking (Figure 1.1, black). However, non-sarcomeric a-
actinin, which aids costameric and ID adhesion complexes, does experience an increase in aged 
diseased hearts (Figure 1 and 2, yellow) (43), but how these levels change with physiological 
aging have not yet been studied. Beyond these most commonly discussed proteins, a variety of 
other models and proteins have been studied but to a lesser extent, e.g. Drosophila and muscle 
LIM protein (MLP) expression and localization changes (Figure 1.1, yellow). Common MLP 
polymorphisms result in DCM (44), creating cardiomyocytes unable to sense load (45). MLP is 
also shuttled to the nucleus upon hypertrophic response (46, 47), suggesting that mislocalization 
results in impaired mechanosensing (Figure 1.1, arrow) (48). These data clearly imply that MLP 
and a-actinin are tied to mechanical sensing, but future work needs to explore their changes with 
age outside of disease. 
 
ID Reinforcement and Gap Junction (GJ) Remodeling with Age  
The intercalated disc forms a specialized junction between adjacent cardiomyocytes to 
propagate longitudinal forces from sarcomeres to adjacent cells. Coupling is achieved through 
actin cytoskeleton bridges that occur specifically within the fascia adherens and reinforced by the 
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desmosome; electrical coupling is achieved through gap junctions (13). In recent years the ID has 
emerged as a key mechanical component, permitting the cell to sense and respond to stress and 
load via ultrastructural changes as in volume overloaded rabbit (49) and mouse hearts (50) as 
well as human DCM patients (50). These correlations imply that IDs may have a more regulatory 
role in cardiomyocyte hypertrophy, which is evident when examining key components of ID and 
GJ substructures. Both are regulated with age across animal models (51-53), suggesting that 
cardiomyocytes transition from adaptive remodeling to pathological loss of sarcomere regulation. 
Within these junctions, N-cadherins (N-CAD), vinculin, and the catenins form Ca2+ 
dependent cell-cell adhesions that are linked to the cortical actin cytoskeleton (54). By forming a 
mechanical link to adjacent cardiomyocytes (36), they may help induce pathological remodeling in 
the heart. For example, N-CAD knockout mice lose ID and GJ structures but exhibit growth in the 
LV long axis (55), suggesting that N-CAD could regulate eccentric or concentric sarcomeric 
growth. Yet mouse aging studies show that while other junction components change expression 
with age, e.g. connexin 43 and b-catenin (b-CAT), N-CAD expression remains unchanged (52). 
These data imply that while N-CAD may mechanically regulate differential cell growth (Figure 1.1, 
black), other junctional proteins may regulate disease. The catenins, for example, link N-CAD’s 
cytoplasmic tail to actin via vinculin, and b-CAT in particular changes its localization to the 
nucleus with age (Figure 1.1, arrow) (56), mediating fetal gene reactivation through novel 
transcriptional activity (Figure 1.1, yellow) (57). Recent work showed that while b-CAT 
overexpression has no measurable effects, its knockdown induces significant dysfunction (58). 
While b-CAT could have a role in pathological disease, we have recently demonstrated that its 
counterpart–a-catenin–was upregulated in aged, non-diseased simian and fly hearts using 
proteomic and genetic analyses. Data suggest that a-CAT appears upregulated with 
physiological aging (51) and may precede pathological remodeling (Figure 1.1, red). Indeed 
mechanical stimulation of a-CAT via N-CAD triggers vinculin recruitment to junctions, 
demonstrating that a-CAT is necessary for force-mediated remodeling (59, 60). Although 
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consensus is building for force-dependent regulation of the junctions (61, 62), further work is 
needed to explore how a-CAT combines with other signals to impact function with age. 
Finally vinculin, which is another critical linker protein within the ID, binds to a-CAT to 
translate sarcomeric contraction into cell shortening. In aging patients with heart failure, vinculin 
undergoes remodeling (53, 63), which can be reversed with LVADs (64, 65). In a recent 
comprehensive study across simian, rat, and fly, we demonstrated that upregulation of vinculin 
with age is conserved from invertebrates to mammals and that its role is compensatory rather 
than deleterious in aging (Figure 1.1, red) (51). Vinculin overexpression resulted in increased 
cortical stiffness most significantly at the ID where it increased longitudinal myofibril anchoring 
between adjacent cells and increased force transmission. Increased cardiac vinculin correlated 
with better force production and fractional shortening in fly hearts (51), further supporting the idea 
that vinculin upregulation and localization to the ID with age aids the cardiomyocyte in preserving 
contraction, even under mechanical load. Metavinculin, a muscle specific alternative splicing, is 
more associated to actin bundling (66) and involved in DCM versus aging (66, 67). Metavinculin 
expression levels have not be examined as a function of age, but these molecular interactions 
could play a large role in the mechanical regulation of vinculin-mediated cytoskeletal 
reinforcement mentioned above, ultimately adding another potential switch from normal to 
maladaptive remodeling. 
Whether considering cardiomyocyte hypertrophy or subcellular remodeling, it is important 
to keep in mind that such mechanisms are often interrelated and complex, especially since 
multiple proteins within a single complex, e.g. ID, can act in opposing directions with age and 
disease (Figure 1.1). Thus we believe that while it is difficult to dissect and identify, it is critical to 
recognize the existence of intracellular mechanisms that counterbalance aging without 
necessarily contributing to disease.  
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Costamere and Extracellular Matrix Remodeling in Response to Age, Stress, and 
Disease 
In addition to internal remodeling, cardiomyocytes experience changes in their 
surrounding extracellular environment with age. Under physiological conditions cardiac ECM 
provides structural support for cardiomyocytes and facilitates force transduction. However, 
increased ECM deposition and crosslinking along with decreased ECM degradation have all been 
implicated in aged patients (68-70). These changes impact cardiomyocyte function (71), not only 
by changing the mechanical properties of the tissue, but also by altering transmembrane 
receptors (72-74). Cardiac ECM has been recently reviewed (75-77), so we will focus on 
compositional changes that have been implicated in switching from adaptive to maladaptive 
remodeling (Figure 1.2, top). On the opposing side of the sarcolemma (Figure 1.2, bottom), 
costameres aid in cell-ECM adhesion by adhering Z-discs to ECM (78, 79). Given their changes 
with age, we will begin our discussion with costamere complexes, specifically the 
vinculin/talin/integrin structure given its known changes with age (80), and transition to ECM 
utilizing Figure 1.2 to illustrate our conclusions on physiological and pathological changes.  
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Figure 1.2. Physiological vs. Pathological Age-Related Changes of Costamere and ECM. 
Schematic of Costamere and ECM of the cardiomyocyte implicated in physiological aging [red, 
up-regulated; green, down-regulated], pathological aging [yellow, upregulated; blue, down-
regulated], or yet undetermined [black]. Stripes of two colors indicate lack of consensus on 
expression levels across species or involvement in physiological vs. pathological aging. F-actin 
indicates filamentous actin; ID, intercalated disc, ECM, extracellular matrix; ACTN1, a-actinin-1; 
Vinc, vinculin; ILK, integrin linked kinase; b1, b1-integrin; a7, a7-integrin; Col IV, collagen type IV; 
AGE’s, advanced glycosylation endproducts; MMP2, matrix mettaloproteinase-2; MMP9, matrix 
mettaloproteinase-9; MMP14, matrix mettaloproteinase-14; Col I, collagen type 1. 
 
Costamere Complex Reinforcement 
Costameres are periodic vinculin-containing structures on the lateral surface of 
cardiomyocytes (81) that link Z-discs to integrins via talin. Vinculin is integral in responding to 
mechanical stimulus, and patients with DCM and HCM often have vinculin mutations (66). In 
addition to disease, we have shown that as in humans (53, 63), age-related increases in cardiac 
vinculin are observed in simians and flies. Vinculin overexpression in Drosophila increased 
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cortical stiffness at both the ID and the costameres. Improved assembly maintained myofilament 
lattice spacing but significantly improved lattice order (Figure 1.2, red) (51). These findings 
confirmed data in mice, which showed that cardiac vinculin knockout resulted in significantly more 
compliant cardiomyocytes and greater myofilament spacing prior to dysfunction (82). Improved 
myofilament spacing may enhance cross-bridge cycling, which increases force production. Future 
work examining aged, non-diseased human myocardium will be necessary to corroborate vinculin 
upregulation with age in simian and Drosophila models, but these data establish a link between 
vinculin and compensatory non-maladaptive response within aged tissue.  
Together with vinculin, talin links the actin cytoskeleton to integrins and regulates their 
binding affinity across species (83-85). Talin has 2 genes in vertebrates, with talin-2 largely 
expressed in adult myocardium (86). Until recently, their role in the heart was unknown, but 
pharmachalogical and mechanical stress of mouse hearts revealed an upregulation of talin-1, 
which may be a compensatory response to stress (87). However in pressure overloaded hearts, 
talin-1 ablation reduced hypertrophy and improved function (87), suggesting that pressure-
induced upregulation of talin-1 may be deleterious and thus a pathological marker (Figure 1.2, 
yellow). Conversely talin-2 is elevated in aged mice (Figure 1.2, red) (88), specifically between 
middle aged (10-16 month) and aged (20-24 month) mice (88). When hearts are unloaded, e.g. 
via LVAD, talin-2 is down-regulated (41). While these data suggest that talin is involved in 
remodeling, aged non-diseased patient samples are needed to better explore if regulation is age-
associated or merely a response to external load. Invertebrate studies may prove useful for future 
work since they only have one talin gene and age rapidly. 
A final major component in this complex is integrin, which occurs as a heterodimer of a 
and b subunits (89, 90) and directly transduces signals to and from ECM and costameres. The 
range of integrin dimer pairs confer ECM ligand specificity (91), so their modulation with age 
could impact costamere function. a7b1 heterodimer is the most prevalent pair in adult 
cardiomyocytes (92), but additional a and b subunits have been detected after pressure overload, 
post MI, and with age (93-95). In Drosophila, b1-integrin increases with age, but moderate 
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attenuation correlates with improved cardiac function and significantly increased organismal 
lifespan (73). Ventricular expression of b1-integrin is also increased in aged monkeys (51); 
however, cardiac ablation of b1-integrin results in DCM during pressure overload (74), suggesting 
that integrins are an integral regulator of stretch and load sensing. Knockdown of integrin-linked 
kinase (ILK), a b1-integrin binding protein, also correlated with improved cardiac function and 
lifespan (73). These results confirmed the correlation of ILK inhibition and extended lifespan in C. 
elegans (96, 97). While increased expression of b1-integrin and ILK with age correlate with 
impaired function, a moderate reduction in their expression can be cardioprotective, which 
suggests that tightly controlling b1-integrin (Figure 1.2, red and yellow stripes) and ILK (Figure 
1.2, yellow) expression could have beneficial effects on function of aged hearts. 
 
ECM Protein Composition and Remodeling Changes with Age 
Cardiac ECM consists of a complex arrangement of interacting structural proteins, which 
include a basement membrane (BM) lattice of laminin and collagen IV linked together with 
fibronectin mediating attachment to collagen I and III (98). Accumulation of collagen I and 
collagen III with age has been documented across mammals (52, 53, 99, 100) and including aged 
healthy human myocardium, suggesting it occurs with physiological aging (101). While these 
changes are thought to increase LV tissue stiffness (37) and impair ventricular relaxation, the 
propensity of data in patients with no known cardiovascular disease suggests that an increase 
per se is not indicative of pathology. Additionally, accumulation with age can occur in the absence 
of excessive mRNA (102) unlike in cardiovascular disease (103), suggesting that genetic 
regulation correlates with pathological conditions, but not necessary in physiological aging (Figure 
1.2, yellow). However, an increase of collagen III relative to collagen I has been implicated in 
disease, but it is not clear how collagen III changes with age (104, 105). If anything, an increase 
in collagen III has been linked to increased tissue plasticity and not rigidity as with collagen I 
(106). Classically though, interstitial ECM accumulation is implicated in less compliant 
myocardium, and excessive collagen I can induce diastolic dysfunction making its role appear 
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more context specific (Figure 1.2, red and yellow stripes). In addition to accumulation with age, 
the degree of crosslinking can have a significant effect on tissue stiffness and function (107). 
Collagen crosslinking, measured by changes in hydroxylated lysine and proline levels, increases 
significantly with age in sedentary rats (108). Collagen crosslinking via advanced glycosylation 
endproducts also increases with age in canine and human myocardium (Figure 1.2, yellow) (109, 
110), which when inhibited, improved tissue compliance (110). Such pathological crosslinking is 
at least partly reversible with exercise as well (107, 108).  
Fibronectin, an adhesion molecule that links collagen fibers to BM, changes its 
expression with collagen, increasing in mice from 12 to 20 months (Figure 1.2, yellow) (95). When 
fibronectin is knocked out, mice experience less cardiac remodeling and hypertrophy with 
transaortic constriction (111), which together suggest that fibronectin is associated pathological 
remodeling with age. In addition to fibronectin, cardiac BM has an important role in transducing 
mechanical signals between cells. For example, laminin a2 decreases as a function of age in 
both human and rat myocardium, but only in rats is it associated with pathological remodeling due 
to a decrease in myocyte number (Figure 1.2, black) (112). Conversely, BM collagen IV increases 
with age in mice, suggesting an overall age-related BM thickening (113), though it is not clear if 
age-related changes contribute to pathological remodeling since their response to stress is not 
clear (Figure 1.2, black). However, collagen IV is down-regulated after LVAD unloading, providing 
evidence that collagen IV expression is responding to pressure-overload (64). Regardless, 
extensive studies are necessary to explore how reinforcement of the BM with age affects signal 
transduction across the sarcolemma. 
Finally all of these age-associated ECM changes–especially collagen remodeling–occur 
in part because matrix metalloproteinases (MMPs), a large family of endopeptidases, degrade 
ECM (114). MMP expression changes with age, e.g. up-regulation of MMPs, e.g. MMP-2, MMP-
9, and MMP-14 (Figure 1.2, yellow), modulate collagen persistence, turnover, and fibrotic 
remodeling, but there is not yet consensus on whether the remodeling is maladaptive. Aged rats 
have significant interstitial fibrosis and depressed MMP-2 levels, which suggested that decreased 
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MMP-2-mediated proteolysis led to ECM accumulation (115). However in pressure overload, 
MMP-2 loss improved diastolic dysfunction and suppressed fibrosis (116). These studies highlight 
the different actions by which MMP-2 mediates ECM remodeling with age: MMP-2 decrease 
eventually leads to ECM accumulation, but acute upregulation and chronic pressure overload 
initiates pathological activation of matrix degradation (Figure 1.2, blue and yellow stripes). Indeed 
mice with impaired MMP expression experience reduced age-related fibrosis but total loss results 
in DCM (100). More specifically, MMP-14 is an important regulator of ECM degradation with age 
via its sensitivity to mechanical load and its ability to activate MMP-2. Increased myocardial MMP-
14 has been noted in patients with LV pressure overload (117), and in vitro studies have shown 
MMP-14 upregulation with increased wall tension (118). Induction of pressure overload in mice 
also leads to increased MMP-14 activation, which correlates with increased ECM accumulation 
(119). Thus it would appear that MMP-14, and subsequent MMP-2 activation, in part regulate 
adverse cardiac remodeling under stress conditions that mimic aging (Figure 1.2, yellow). MMP-9 
also increases with age in conjunction with diastolic dysfunction (Figure 1.2, yellow) (120), 
whereas its deletion prevents age-related myocardial stiffening (88). Yet in the larger discussion 
of whether MMPs contribute to pathological or physiological ECM remodeling, it is critical to note 
that MMPs degrade matrix, preventing accumulation, which is physiological for collagen I but 
pathological for collagen III. Thus the context of all of these changes matter significantly to their 
effect(s) on aging. 
 
Conclusions 
Cardiac aging is a complex process that involves many molecular changes both inside 
and outside of the cardiomyocyte. In this review we have highlighted some of the age-related 
structural changes that occur within the sarcomere and cytoskeletal complexes that longitudinally 
transmit forces between adjacent cardiomyocytes. For example, we have indicated that age-
related vinculin reinforcement of the ID and costamere is beneficial to cardiomyocyte function 
whereas decreasing proportion of a-MHC and phosphorylated MLC-2 correlates strongly with 
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disease progression. However due to the overlap in function of multiple complexes and proteins 
within the sarcomere and fascia adherens junction, conclusive age-related data for other 
cytoskeletal components has been lacking. While matrix changes often appear associated with 
pathological changes, we also noted the underappreciated role it has during normal aging, e.g. 
the increase in interstitial collagens that can precede heart disease. To that end, we have 
provided evidence that while collagen accumulation can lead to pathological fibrosis, genetic 
upregulation of collagen mRNA is clearly implicated in disease progression. Despite the evidence 
we presented, question remains about what constitutes causal evidence of physiological 
responses such as: how much fibrillar collagen is too much, or is it the extent of crosslinking that 
determines pathology? How do basement membrane components affect lateral signal 
transduction from the sarcomere to the ECM? As aging studies increase, phenotypes that were 
once thought to be solely maladaptive have become increasingly complex due to some instances 
in which they are actually mechanisms of physiological adaptation of cardiomyocytes with age. 
We will need more multi-model approaches to stratify some of these molecular changes that have 
been previously noted with aging in the context of advance disease into hallmarks of 
physiological reinforcement vs. pathological progression in order to provide causal evidence for 
our hypotheses.  
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Preface to Chapter 2 
Chapter 2, in full, is an article published in Matrix Biology. The work in Chapter 2 
addresses a subset of the cardiovascular extracellular matrix [ECM], the basement membrane, 
that has been unappreciated in recent research. We investigate how basement membrane [BM] 
components affect lateral signal transduction from the sarcomere to the ECM and how regulates 
cardiac function with age. This work utilized the model Drosophila melanogaster, uniquely suited 
for this work since BM proteins are the only ECM present in its heart tube. Furthermore, the 
simpler cardiovascular geometry, a heart tube, allowed for in situ measurement of cardiac and 
basement membrane tissue mechanics via atomic force microscopy. Using a heart specific 
genetic perturbation experiment, we showed, for the first time, that moderate downregulation of 
BM afforded better preservation of cardiac dimensions and contraction with age, ultimately 
increasing lifespan significantly in these flies, linking BM regulation to function.  
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Abstract 
Aging is associated with extensive remodeling of the heart, including basement 
membrane (BM) components that surround cardiomyocytes. Remodeling is thought to impair 
cardiac mechanotransduction, but the contribution of specific BM components to age-related 
lateral communication between cardiomyocytes is unclear. Using a genetically tractable, rapidly 
aging model with sufficient cardiac genetic homology and morphology, e.g. Drosophila 
melanogaster, we observed differential regulation of BM collagens between laboratory strains, 
correlating with changes in muscle physiology leading to cardiac dysfunction. Therefore, we 
sought to understand the extent to which BM proteins modulate contractile function during aging. 
Cardiac-restricted knockdown of ECM genes Pericardin, Laminin A, and Viking in Drosophila 
prevented age-associated heart tube restriction and increased contractility, even under viscous 
load. Most notably, reduction of Laminin A expression correlated with an overall preservation of 
contractile velocity with age and extension of organismal lifespan. Global heterozygous 
knockdown confirmed these data, which provides new evidence of a direct link between BM 
homeostasis, contractility, and maintenance of lifespan.
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Introduction 
Aging is associated with the progressive decline of cardiac performance (1). Reduced 
cardiac output is observed in species ranging from complex vertebrates down to simple 
invertebrates because of conserved cellular and molecular alterations (2, 3). Aging has also been 
associated with aberrant interstitial extracellular matrix (ECM) expression and assembly, leading 
to stiffer, less contractile muscle (4, 5). The basement membrane (BM) is a thin layer of ECM that 
surrounds the lateral surfaces of cardiomyocytes; while mutations in BM components, e.g. 
Collagen IV, result in cardiovascular disease (6, 7), the role of specific components has remained 
largely unstudied, especially during aging. From what is known, Collagen IV expression increases 
with age in mice and is correlated with a thickening of cardiac BM (8). Humans of advanced age 
in heart failure also experience an increase in Laminin and Collagen IV protein content within the 
heart relative to their age-matched counterparts (9). Taken together these data suggest that 
cardiac BM remodeling in response to pressure and load could be conserved with age. 
Conserved ECM alterations may compensate for age-associated damage similar to cytoskeletal 
proteins, e.g. Vinculin (10), but it is not yet clear whether certain BM protein changes are 
beneficial or deleterious to cardiac function with physiological aging. So to build consensus on 
ECM-based mechanisms of age-associated but non-pathological remodeling, we used a rapidly 
aging system where cardiac BM proteins could be controllably expressed and myocyte function 
assessed in situ. 
Model organisms like Drosophila melanogaster can be extremely useful to understand 
the cell biology of cardiac aging given their genetic tractability, rapid aging, and conserved 
cardiac proteome, which has >80% protein domain homology with mice (11). Its heart consists of 
bilateral rows of contractile cardiomyocytes (CM) that form a 40-120 µm wide linear tube in the fly 
abdomen (Figure S2.1, A and B). Though the heart tube morphology differs from mammals, its 
simplicity allows for rapid measurement of cardiac parameters (12) and permits in situ mechanical 
measurement (10, 13, 14). CMs are anchored to the cuticle by a non-contractile, skeletal muscle-
derived, and longitudinally-oriented layer of 10-12 ventral muscle fibers (VM; Figure S2.1, B-D) 
(14-16). Separating these muscle layers is a densely packed, thin BM that adheres the lateral 
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surfaces of CMs to the VM and surrounds the VM fibers (Figure S2.1, B and D) (16). Manipulation 
of BM proteins can result in partial to complete loss of heart tube structure. For example, global 
loss of the cardiac specific subunit of the laminin trimer, Laminin A, prevents tube formation (17, 
18). Additionally, global mutations or knockdown in either of two Collagen IV genes, Cg25C or 
Viking, weaken cardiac ECM assembly (19) by perturbing Perlecan, a BM proteoglycan, 
assembly (20). In addition to typical BM components, the fly heart tube also has an outer “fibrillar-
like” matrix largely composed of Pericardin, which is has domains homologous to mammalian 
Collagen IV (21, 22). Pericardin is also essential for tube formation (22, 23) and colocalizes with 
other BM components on the outer BM surfaces of the heart tube. While BM and integrin 
expression help polarize cells during development (17, 24), their function in adult Drosophila may 
be to mechanically couple CMs and VM.  
Despite our limited knowledge of ECM regulation of adult Drosophila heart tube 
morphology and function, the heart tube’s advantages as an aging system suggests that we can 
use it to rapidly screen BM-dependent cardiac aging phenotypes relevant to mammals. The 
reduced number of collagen and laminin genes versus higher organisms also simplifies genetic 
perturbations and can ensure cardiac specificity. Thus, we sought to characterize BM in the adult 
Drosophila heart and hypothesized that BM components directly affect age-related myocyte 
extracellular interactions and cardiac function. As with advanced aged humans with heart 
disease, we found that some BM proteins are increased in the adult hearts for some wild-type 
Drosophila melanogaster strains (i.e. w1118 versus yw strains), as with macaca mulatta and to a 
lesser extent with rattus norvegicus, and this correlated with increased BM thickness and 
decreased contraction. Restricting cardiac expression of Pericardin, Laminin A, and Viking in 
w1118 flies resulted in thinner BM, increased contractile capacity with age, and significantly 
increased lifespan, which suggests a closer relationship between BM expression and CM 
function. 
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Results 
Genotype-dependent BM expression correlates with altered muscle morphology, 
impaired contractility, and decreased lifespan. 
Age-related differences in heart function occur between the common Drosophila wildtype 
lab strains yw and w1118 (10, 14)  and include decreased fractional shortening and significantly 
shortened lifespan for w1118 flies (Figure 2.1, A and B). By adapting our biphasic analysis method 
for atomic force microscopy (AFM) (13, 14) to fit three layers, we were able to determine the 
mechanics of the BM between muscle layers (Figure 2.1C-E). We found that the BM layer 
between VM and CMs layers was thicker in w1118 flies–determined by the change in probe 
indentation depth–but independent of age. However, BM layer stiffness was unaffected by 
genotype or age and remained relatively soft (Figure 2.1F). 
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Figure 2.1. Decreased Fractional Shortening in w1118 Correlates with Decreased Longevity 
and Increased BM Thickness. (A) Fractional shortening was calculated for each genotype and 
age (mean ± s.e.m., n=20) and is plotted at 1 and 5 weeks. * p<0.05 (B) Survival curves for 
indicated wildtypes show median survival indicated by the dashed black line for each genotype, 
55 and 35 days for yw (n=215) and w1118 (n=223), respectively. ***p<0.001. (C) Brightfield image 
of AFM cantilever (open triangular shape) positioned over midline (center) of the Drosophila heart 
tube during nanoindentation analysis of Drosophila tri-layered myocardium. Scale bar is 100 µm. 
(D) Schematic of 3 layered AFM nanoindentation (black circle) into Drosophila heart tube 
depicting: (i) the 1st layer indentation of the VM, (ii) the complete compaction of the VM layer and 
2nd layer indentation of the BM, and (iii) the final compaction of the first 2 layers and 3rd layer 
indentation of the CM layer. (E) A representative force vs. indentation depth plot in black showing 
the respective Linearized-Hertz fits for both the shallow (green) VM and deep (red) CM with a BM 
layer indicated by a linear region shown in blue starting and ending within the brackets. (F) BM 
stiffness and BM thickness reported as the length over which the BM linear region was fit were 
measured by AFM at the ventral midline and plotted at indicated ages. All data represented as 
mean ± s.e.m of >15 flies. *p<0.05 and **p<0.01 for indicated comparisons. 
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Due to correlations between BM thickness, cardiac compliance, and lifespan, we then 
characterized proteomic changes that could drive genotype-specific cardiac BM differences. 
Cardiac protein expression patterns were assessed by orbitrap mass spectrometry (MS) to 
quantify protein accumulation differences that may not be reflected in genetic analyses; only 1-
week-old adults were analyzed since BM phenotype seemed age-independent for w1118. 1872 
nonredundant proteins were quantified (Table S2.1 and S2.2) via MS for each genotype. We 
used STRAP (Software Tool for Rapid Annotation of Proteins) analysis (25) to identify the most 
enriched ontologies on a median normalized scatter plot of MS1 intensities. Cytoskeleton and 
ECM ontologies were among the most abundant proteins regardless of genotype, i.e. 67% of 
ECM and 56% of cytoskeletal proteins were found in the first quadrant (Figure 2.2A; Table S2.3) 
(26). We calculated the differential expression of proteins between genotypes as the absolute 
distance of MS1 intensity values from identical expression, i.e. x=y (Table S2.3). Pericardin and 3 
distinct Laminin subunits (Laminin A, Laminin B1, and Laminin B2) were among the most 
differentially expressed proteins (Figure 2.2B). In addition to candidate proteins, we explored 
other BM components based on an unbiased screen via immunoflourescent staining. We 
quantified protein abundance via calculation of mean pixel intensity for each protein normalized to 
F-actin within a region of interest selected over the heart tube. These data confirmed that 
Pericardin and to a lesser extent Viking were more robustly expressed in w1118 flies at 1 and 5 
weeks relative to their yw counterparts (Figure 2.2, C and D, and Supplemental Figure S2.2). 
Laminin A (the cardiac specific subunit of the laminin trimer) did not exhibit any conclusive 
differences between genotypes or with age as measured by average flourescent intensity. These 
data suggest that increased accumulation of some BM proteins could be responsible for BM 
thickening in w1118. 
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Figure 2.2. Cardiac Basement Membrane Protein Regulation Differences in wildtype 
Drosophila. (A) Scatter plot of the MS1 intensity values for each protein. MS1 intensity values 
(protein abundance) are plotted for w1118 value on the x-axis and yw value on the y-axis. Colors of 
points indicate biological function as determined by Software Tool for Rapid Annotation of 
Proteins (STRAP) analysis and relative percentages in each quadrant are given (ECM - green, 
Cytoskeleton - blue). Red arrow indicates Pericardin [Prc]. Data represents a mean value of 4 
biological replicates of 50 pooled fly hearts for protein analysis. (B) Absolute distance of MS1 
intensity values from a zero log2 fold change or x=y were plotted for each protein in decreasing 
fashion. 25 proteins with highest calculated distance values are shown in subpanel (grey dashed 
box) color coded by STRAP analysis (ECM - green, Cytoskeleton - blue) with ECM proteins of 
interest listed on the x-axis and Laminin A (the cardiac specific laminin subunit within trimer) 
highlighted with green arrow and Pericardin in red arrow. (C) Representative immunofluorescent 
images for the indicated genotypes at 1 week for proteins Laminin A (green), Viking (purple), 
Pericardin (red), and F-actin (white). All fluorescent intensities were normalized to F-actin within 
region of interest (ROI) selected over bulk of heart tube (top left, white dashed box). Scale bar is 
50 µm. (D) Mean pixel intensity for each indicated protein as measured within ROI, normalized to 
F-actin intensity within ROI, and shown as w1118 normalized to yw. Mean F-actin intensity varied 
<10% sample to sample between each genotype or with age. n=4 hearts per comparison. 
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ECM Knockdown Decreases BM Thickness, Preserves Contractile Function with Age, 
and Extends Lifespan 
The role of BM collagen and laminin in modulating cardiac function with age has not been 
well documented. In aged, non-diseased rhesus macaque and to a lesser extent in rat 
myocardium, ECM proteins including BM laminin subunits and collagen chains were upregulated 
(Table S2.4) (10). These genes exhibit significant homology across mammalian models verified 
by BLAST (Tables S2.5-7) (27) and provide BM structure and stability (6, 17-19, 28). Given their 
conservation across animal models and the up-regulation of some in w1118 ECM, we determined 
what affect modulating cardiac BM production might have on function in a fly with thick cardiac 
BM, i.e. w1118. Because homozygous mutations in either Laminin A  or Viking result in embryonic 
lethality (18), RNA interference was instead performed for Pericardin, LamininA, and Viking and 
knockdown (KD) restricted to the fly heart using a Hand-Gal4 driver (29, 30) and the UAS 
expression system (Figure S2.3A). Hand-Gal4 flies were crossed into a blank w1118 background 
as a control. 30-40% cardiac specific KD was verified by qPCR for each strain (LanAKD, VkgKD, 
and PrcKD), although LanAKD, which affects the entire laminin trimer, also resulted in decreased 
BM expression overall (Figure S2.3B). Fluorescent intensity of each BM protein from 
immunofluorescence decreased by 30-47% compared to controls when normalized first to F-
actin, indicating fidelity between qPCR and protein assays (Figure S2.3C). 
ECM expression and organization can influence organ size and function (20, 31, 32), so 
changes to cardiac tube physiology as a function of RNA interference were determined by 
diastolic and systolic diameter measurements (Figure 2.3A) (33). Hand-w1118 control flies 
exhibited a significant reduction in diastolic and systolic dimensions with age (10, 34, 35) whereas 
PrcKD, LanAKD, or VkgKD flies did not (Figure 2.3, B and C). Combined with a basal increase in 
fly heart dimensions, PrcKD, LanAKD, and VkgKD flies exhibited improved fractional shortening 
with age while control flies did not (Figure 2.3D). Cardiac specific RNAi phenotypes were 
confirmed with using w1118 lines with global heterozygous deletion of genomic regions 
encompassing one allele for each gene, i.e. LanA +/-, Vkg +/-, and Prc +/- (36). These lines have 
well documented down-regulation of the corresponding ECM protein (37, 38). We found up to a 
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70% decrease in the corresponding ECM protein when normalized to F-actin via 
immunofluorescent imaging in these heterozygous lines compared to w1118 controls (Figure 
S2.4A). Despite overlap with other genes in the deficient region, we observed that LanA +/- line 
had increased diastolic diameter (Figure S2.4B) and all heterozygous lines had increased 
fractional shortening (Figure S2.4C). Thus regardless of how BM expression is perturbed, we 
found that it regulates cardiac function with a similar hierarchy of phenotype changes. 
 
Figure 2.3. High Speed Image Analysis Reveals Dilated Heart Tube in ECM KD Flies and 
Prevention of Age-Related Tube Restriction. High Speed Image Analysis Reveals Dilated 
Heart Tube in ECM KD Flies and Prevention of Age-Related Tube Restriction (A) Still ventral 
images of fly heart from 120 fps video capture used to create motion-mode kymographs. Lines 
depict where measurements for dimensions (diastole, red, and systole, green) are taken in 
segment a2. (B) Diastolic heart diameters were quantified at 1 and 5 weeks for indicated 
genotypes. (C) Systolic heart diameters were quantified at 1 and 5 weeks for indicated 
genotypes. (D) Fractional Shortening were quantified for indicated genotypes and ages. All data 
represented as mean ± s.e.m. n>20. All data were analyzed via 2-way-ANOVA with post hoc 
Bonferroni test. Non-parametric student’s two-tailed t-test was used to assess significance within 
each genotype with age. *p< 0.05, **p< 0.01, ***p<0.001. 
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Figure 2.4. Knockdown of ECM genes Decreases BM Thickness and Decreases LanAKD 
Cardiac Stiffness. (A) BM thickness reported at midline by AFM for indicated genotypes at 1 
week. All KD flies were not statistically different from each other, but ***p<0.001 for comparisons 
between KD flies and their control. (B) BM stiffness reported in kiloPascals by AFM for indicated 
genotypes at 1 week. All data reported as mean ± s.e.m of >15 flies. All data analyzed with non-
parametric Student’s two-tailed t-test with unequal variances assumption. 
The goal of RNAi mediated reduction in BM expression was to reduce BM thickness in 
w1118. Using the tri-layered AFM analysis method, BM thickness and stiffness was measured; all 
KD flies experienced significant reduction BM thickness compared to control (Figure 2.4A) while 
all remaining exceedingly soft (Figure 2.4B). To measure the contractile capacity for both KD and 
heterozygous flies, we observed hearts beating against a viscous load in situ (12). High-speed 
movies from sequentially loaded hearts were converted into m-modes (Figure 2.5A) so that 
shortening and lengthening velocities could be assessed. While genotype differences were 
absent for shortening velocity as a function of load at 1 week, LanAKD exhibited increased 
lengthening velocities compared to other genotypes at all loads at 1 week and demonstrated the 
most significant preservation in force production at all loads compared to Hand-w1118 controls at 5 
weeks (Figure 2.5B and Table S2.8). Shortening velocities were also improved in LanA+/- flies at 
1 week without viscous load (Figure S2.4D), while all heterozygous flies experienced significant 
increase in lengthening velocities at 1 week compared to controls (Figure S2.4E). Similarly, KD 
flies exhibited increased fractional shortening compared to controls (Figure 2.5C). Attenuation of 
other matrix-related pathways and presence of transgenic drivers has correlated with organismal 
lifespan extension (34, 39), and similarly we found that all maximum lifespans exceeded Hand-
w1118 controls with LanAKD flies living the longest at 39% longer (Table S2.9, Figure 2.5D). 
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Figure 2.5. ECM KD Leads to Preserved Cardiac Mechanics with Age. (A) To the left, motion-
mode images of a heart sequentially loaded by increasing relative viscosity, u, by increasing 
Ficoll w/v% in the hemolymph in which the fly hearts are bathed. Arrows indicate where systole 
and diastole are located in the motion-mode images. To the right, m-mode image expanded to 
show contraction length (CL) in blue, shortening interval (SI) in green, and lengthening interval 
(LI) in red used for velocity measurements below. (B) Heart wall shortening (contraction) and 
lengthening (relaxation) velocities were assessed under viscous load and fit by Hill’s model for 
each genotype and age. (C) Fractional shortening were measured under viscous load for each 
indicated genotype and age. Data represented as mean ±s.e.m. n>20. All viscous load data were 
analyzed with 2-way-ANOVA with post hoc Bonferroni test. Significance indicates load/genotype 
as source of variance. *p<0.05, **p<0.01, ***p<0.001 (D) Survival curves for indicated genotypes 
show median survival indicated by the dashed black line for each genotype. ***p<0.0001 
 
Discussion 
Increased ECM deposition has been noted in heart disease (40) and aged myocardium 
(41), but these changes focus on fibrillar collagens and not BM proteins. We identified increased 
BM protein expression in non-diseased, aged rhesus macaque and rat myocardium (10), but 
since clarifying cardiac specific BM effects in human or mammalian models is less practical, we 
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employed a rapidly aging model with simple cardiac physiology, i.e. Drosophila melanogaster. 
Fruit flies are well suited for a multitude of in situ mechanistic analyses not easily adapted to more 
complex mammalian models (10, 12-14, 42, 43) where age (10) or ECM preference (44) may 
impair accurate assessment. Moreover, flies can be exceedingly sensitive; here we have 
demonstrated that through direct measurement of transgenic flies where Laminin A, Viking, or 
Pericardin expression was moderately reduced we observed obvious improvements in age-
related heart function. Similar sensitively is found throughout the fly heart; as β1-integrin signaling 
is reduced via heterozygous mutations to ILK or Mys (β1-integrin), cardiac tissue stiffening 
attenuates and lifespan is extended (34). Conversely when cell-ECM signaling is excessive, it can 
alter myocyte coupling and stiffness, leading to functional deficits (45). Yet it is important to note 
that stiffness itself is not a direct indicator of dysfunction regardless of sensitivity as cytoskeleton-
mediated stiffening is associated with improved function (10, 31). Despite this challenge, our data 
suggest that fly is a system that can precisely and accurately monitor the effects of ECM changes 
with age.  
 
BM Thickening is Associated with Impaired Cardiac Function 
Phenotypes can vary significantly with genetic diversity, especially within laboratory-
controlled lines. We found that two wildtype Drosophila strains–w1118 and yw–exhibited vastly 
different fractional shortening and lifespan. Correlated with these changes was the observation 
that w1118 flies had significantly increased BM thickness compared to yw flies, reminiscent of 
aging phenotypes observed in mice (8) and disease phenotypes observed in humans (9). 
Pericardin and Viking were upregulated in w1118 flies, leading us to hypothesize that thicker or 
more disorganized BM could disrupt mechanical crosstalk or previously hypothesized tension (16) 
that occurs between the two muscle layers. Without such signals, outside-in signaling between 
muscle layers mediated by BM could be absent (46); internal CM remodeling with age also may 
not occur. This could explain the decreased fractional shortening for w1118 flies that we have 
observed. Taken together, these data could present cardiac-based reasons for the severely 
decreased lifespan of w1118 flies relative to yw; specifically, that increased accumulation of BM 
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proteins Pericardin, Viking, or Laminin A could be responsible for the increased BM thickness and 
organization leading to dysfunction in w1118. 
 
Physiological Reduction in BM Components Correlates with Increased Cardiac Function 
and Improved Lifespan 
BM is a complex and hierarchical assembly of matrix proteins (18). Based on our 
mechanical and protein expression analyses, we hypothesized that decreasing BM expression in 
w1118 may improve cardiac function. We applied cardiac restricted knockdown of Pericardin and 
Viking, as well as Laminin A due to its importance in regulating Drosophila heart tube 
morphogenesis (17, 18), known upregulation in disease (9), and conserved upregulation in aged 
monkey and rat myocardium (10). Reducing BM protein production decreased BM thickness in 
the Drosophila heart, but the modulation of specific matrix proteins correlated with improvement 
in heart tube function with age and enhanced longevity to varying degrees. For example, cardiac 
restricted LanAKD increased wall velocities at 1 week, and correlated with the greatest 
preservation of function with age. These data were validated using Drosophila lines heterozygous 
deficient in portions of a single chromosome spanning an ECM gene of interest. LanA+/- hearts 
experienced similar increases in diastolic dimensions as well as increased fractional shortening 
and heart tube wall velocities. While consistent with RNAi, these global heterozygous KO models 
are not as precise due to excision over a multi-gene span of the chromosome, e.g. Vkg+/- 
deficiency spans the neighboring gene Cg25c, which is the other collagen type IV subunit 
exacerbating the phenotype. Together though, these data suggest that BM proteins are more 
than just structural entities; rather, they are capable of regulating cardiac function with age as 
they change how heart tube and adjacent muscle layers interact. With considerable homology of 
fly BM proteins to mammals, our data suggests that targeting cardiac BM expression and 
resultant thickening with age or disease in mammals could improve long-term cardiac function 
and positively affect lifespan. 
Here we have examined the effect of attenuating BM production within non-pathological 
levels in the Drosophila heart where aging occurs rapidly and interrogation of the effect of 
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decreased ECM between muscle layers can be measured. The beneficial effects that we 
observed should be further examined in larger mammalian models more similar to humans where 
3D microenvironments and a multitude of various fibrillar ECM and BM proteins could be explored 
for their effect on heart function and aging. Additionally, future work exploiting Drosophila’s 
genetic tools could allow further exploration into the cell-ECM crosstalk mediated by β1-integrin 
and matrix. 
 
Materials and Methods 
Drosophila Lines, Husbandry, and Culture Conditions 
yellow-white (yw) and white-1118 (w1118) served as wildtype controls. The following RNAi 
lines were obtained from Vienna Drosophila Center (VDRC): UAS-PrcRNAi (#41320), UAS-
LanARNAi (#18873), and UAS-VkgRNAi (#16858). The cardiac specific driver hand-Gal4 line(47) 
and Vkg-GFP flytrap line (48) were used for RNAi silencing of genes and visualization, 
respectively. Briefly, UAS-transgenic males were crossed with virgin female hand-Gal4 flies using 
the GAL4-UAS system as previously described (49, 50). Female progeny of hand-Gal4 and w1118 
served as control labeled Hand-w1118. The following w1118 deficiency stocks from Bloomington 
were used for genetic KD validation: Df(3L)BSC373/TM6C (#24397) for deficiency of Laminin A 
referred to as LanA+/-, Df (2L)BSC172/CyO (#9605) for deficiency of both collagen IV alleles 
Viking and Cg25c referred to as Vkg+/-, and Df(3L)BSC840/TM6C (#29024) for deficiency of 
Pericardin referred to as Prc+/- (36). w1118 flies served as controls for deficiency comparisons. All 
stocks were raised on standard agar-containing food at 25o through all life stages. Food was 
changed every fourth day.  
 
Drosophila Microsurgeries 
Preparation of the Drosophila heart for ventral imaging, AFM, and tissue collection was 
performed as previously described (43), and did not affect heart function as previously shown 
(10). Adult female flies were briefly exposed to 5psi CO2 (< 1 min), then anesthetized with Fly 
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Nap (Carolina Biological) for 5 minutes, and secured dorsal side down onto a 35 mm petri dish. 
The beating heart was exposed by incisions to remove heart, thorax, and the ventral abdominal 
cuticle. Flies were then submerged in an artificial oxygenated hemolymph at 25oC (33). Internal 
organs and debris above the beating heart were all carefully aspirated away with a micropipette 
so as to not perturb the heart, which could result in a hypercontractile state. The beating heart 
can be sustained for hours with regular oxygenation and hemolymph changes, but all 
experiments were performed within 1 hour of microsurgery. 
 
Immunostaining and Imaging 
Fluorescent labeling was performed using a modified protocol as previously described for 
Figures 2, S1, S2, S3, and S4 (51). Briefly, ventrally-exposed beating hearts were relaxed with 10 
mM EGTA, then fixed with 3.7% paraformaldehyde in hemolymph, and then permeabalized in 
0.1% Triton X in PBS (PBST). Samples were blocked with 1% Seablock in PBST before being 
incubated in primary antibody overnight at 4°C. Samples were then washed and submersed in 
secondary antibodies in PBST for 60 min, washed with PBST and then PBS before mounting 
dorsal side down on 25 mm coverslips with Fluoromount (Southern Biotech). Fluorescence 
microscopy was performed on a Zeiss LSM 710 laser scanning confocal microscope at either 20 
or 40x magnification. Quantification of relative fluorescent intensity for ECM proteins was 
performed in ImageJ via measurement of mean pixel intensity within a region of interest (ROI) 
selected over the heart tube (Figure 2.2C) and normalized to F-actin average intensity. The 
following antibodies were used: mouse anti-Pericardin (1:40, EC11-s, DSHB), guinea pig anti-
Laminin A (1:500) (52), rabbit anti-GFP (1:500, ab6556, Abcam), rabbit anti-Collagen IV (1:500, 
ab6586, Abcam), and Rhodamin Phalloidin (1:1000, Invitrogen). 
 
Atomic Force Microscopy (AFM)-based Nanoindentation 
All indentation was performed on MFP-3D Bio Atomic Force Microscope (Asylum 
Research) mounted in a Ti-U fluorescent inverted scope (Nikon Instruments, Melville, NY) with 2 
µm radius borosilicate glass beads mounted on a 120 pN/nm silicon nitride cantilevers (Novascan 
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Technologies). All probes were calibrated for precise spring constant via the thermal noise 
method. Adult female flies with exposed beating hearts were immobilized on 25 mm glass cover 
slip, which is mounted on a Fluid Cell Lite coverslip holder (Asylum Research) with 1 mL of 
hemolymph. Hearts were checked for regular contractions and arrested with 10 mM EGTA just 
prior to indentation. 1 µm2 area was probed with a 4 x 4 grid of indentations and an indentation 
velocity of 1 µm/s resulting in 16 force curves per replicate.  All indentation curves were analyzed 
to by an automated software custom written in MATLAB (Mathworks) as previously described in 
(13, 14) to calculate the elastic modulus (Pa, Pascal), or stiffness, of the myocardium. This 
software was further adapted to analyze the elastic modulus (Pa) of the ECM between the VM 
and myocardium and the thickness of this layer in µm. This analysis method can detect the 
presence of a third material not fit by either the ventral or cardiac fits. A third region is found if R2 
> 0.95 and stiffness is 25% less than the VM layer. 
 
Proteomic Analysis of Drosophila Cardiac Tissue 
50 heart tubes per biological replicate were prepared and analyzed by reverse phase 
liquid chromatography tandem mass spectrometry (LC-MS/MS) on a Dionex Ultimate 3000 
NanoLC (Thermo Scientific) connected to an Orbitrap Elite mass spectrometer (Thermo 
Scientific). 4 biological replicates were measured for each genotype. The analysis was operated 
in a data dependent acquisition (DDA) with MS1 scans acquired in the Orbitrap Elite at a 
resolution of 60,000, followed by tandem mass spectra acquired for the top 15 most abundant 
ions in the ion trap after peptide fragmentation by collision-induced dissociation. Specifically, 50 
whole beating heart tubes corresponding to 80 μg of protein were cleaned, extracted and pooled 
into deionized water for each genotype at one week of age. Samples were washed 3 times in 
deionized water and then lyophilized. Lyophilized Drosophila hearts were solubilized in 25 μL of 9 
M urea for 30 minutes at room temperature with agitation. Samples were diluted 1:5 (125 μL) with 
50mM Ammonium Bicarbonate, reduced with 10 mM TCEP for 30 min in the dark, and then 
alkylated with 15 mM Iodoacetamide for 20 min. A Trypsin/LysC solution was used to digest the 
samples at 60:1 ratio (protein:trypsin/lysC) overnight at 37oC at pH 8 with constant agitation in the 
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presence of 10% acetronitrile (ACN). After digestion, the peptide mixture was acidified with 10% 
Formic Acid FA to pH 2, partly dried on a speedvac to evaporate any acetonitrile, and desalted 
using a 30 μg  microelution plate (Waters). 2 µg of peptides were resuspended in 0.1% FA and 
analyzed by liquid chromatography tandem mass spectrometry (LC-MS/MS) on a Dionex Ultimate 
3000 NanoLC (mobile phase A: 0.1% FA in water, mobile phase B: 0.1 % FA in ACN) connected 
to an Orbitrap Elite mass spectrometer (Thermo) equipped with a EasySpray ion source. 
Peptides were directly loaded onto the analytical column (PepMap RSLC C18 2 µm, 100Å, 50 µm 
i.d. x 15 cm) at a flow rate of 300 nL/min using a linear gradient of 2-25% B for 120 minutes, 25-
90% B for 5 minutes, then holding at 90% for 5 minutes and re-equilibrating at 2% B for 9 
minutes. Temperature was set to 40 °C for both columns. The nano-source capillary temperature 
was set to 275 °C and the spray voltage was set to 2 kV. MS1 scans were acquired in the 
Orbitrap Elite at a resolution of 60,000 full-width, half max (FWHM) with a target of 1x106 ions 
over a maximum of 500 ms. MS2 spectra were acquired for the top 15 ions from each MS1 scan 
in normal scan mode in the ion trap with a target setting of 1x104 ions, an accumulation time of 
100 ms, and an isolation width of 2 Da. The normalized collision energy was set to 35% and one 
microscan was acquired for each spectra. All raw data from the orbitrap elite were converted to 
centroided mzXML format for peaklist generation using proteowizard (Version 3.0.8990). The 
mzXML files were then searched using the Comet search algorithm running through the Trans 
Proteomic Pipeline (TPP; Version 4.8.0) against Swiss-prot database of reviewed Drosophila 
protein FASTA sequences with randomized decoys appended. Carbamidomethylation of cysteine 
was set as a fixed modification and oxidization of methionine set as a variable modification. 
Tolerance for mass error was set to 20 ppm for precursors and 1 da for fragments. Trypsin was 
set as the digestion enzyme with up to two missed cleavages allowed. Peptide spectral match 
confidence was determined using the Peptide Prophet algorithm built into the xinteract tool on the 
TPP, using high accurate mass binning, retention time information, and non-parametric modeling 
settings. Peptides with >95% probability were uploaded into Skyline Software to perform MS1 
extraction and quantification as previously described (26). We required all peptides to fit a 
retention time alignment with an r2< 0.95 and to demonstrate an isotope dot product correlation 
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scores >0.8. Only proteotypic peptides were used for quantitative analysis. Results of the MS1 
filtering were exported for input to msstats an R-based tool for proteomic data analysis (53). 
Precursor intensities were median normalized and protein level inference computed using the 
linear mixed model. Median normalized MS1 intensity values are provided for each peptide with 
its corresponding protein ID obtained from Unitprot of the 4 biological replicates of each genotype 
w1118 and yw in Table S2.1 and S2.2 respectively. STRAP analysis for ECM and cytoskeletal 
related proteins are provided in Table S2.3 and plotted with MS1 intensity values in Figure 2.2A. 
Differential expression of proteins is provided by distance calculations provided in Table S2.3 and 
plotted in Figure 2.2B. Additional proteomic methods and analysis related to rhesus macaque and 
rattus norvegicus mass spectrometry used to measure protein expression in Table S2.4 are 
described elsewhere (10). 
 
Quantitative PCR Analysis 
RNA was extracted from 15 whole, beating heart tubes cleaned of any excess fat or 
debris with a fine micropipette by Zymo Research Quick RNA MicroPrep kit. This collection of 15 
hearts constituted one biological replicate. RNA concentration and purity was verified via 
Nanodrop. Reverse transcription to synthesize first strand cDNA was performed on equal 
quantities of RNA per sample. For quantitative PCR each reaction was run with 1 μL template 
cDNA, 2.5 μL each forward and reverse primer, 6.5 μL DEPC water, and 12.5 μL SYBR-green 
intercalating dye (Applied Biosystems). Each gene was analyzed for at least 4 biological 
replicates per genotype and age and absolute quantity was calculated by comparison to a 
standard curve for data in Figure S2.3. For wildtype values were reported normalized aged/adult 
and for the transgenics they were first normalized to housekeeper GapDH2 and then displayed as 
a ratio of given genotype/control quantity. The primers used were presented in 5’ to 3’: Pericardin 
Fwd (CGGAGGACAGGCTACAATAA) Rev (CCAATACCAGGCTGACCTATAA), LamininA Fwd 
(GTTCTTCTACGGCAGGGATAAG) Rev (CTCCACCTTCACCCAAACTAA), Viking Fwd 
(GATCTACGACAACACTGGTGAG) Rev (TTCGCCACGAAGTCCAATAG), Myospheriod (b1-
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integrin) Fwd (AAACACTGCGAGTGCGACAAC) Rev (ACATGTATCGTTGGACTCCTG), 
GapDH2 Fwd (TTCTTCAGCGACACCCATTC) Rev (CGTTGTCGTACCACGAGATTAG). 
 
Heartbeat Analysis and Viscous Loading Assay 
Fly hearts were ventrally exposed and 20 second movies were taken at a rate of 120-150 
frames per second (FPS) using a Hamamatsu EM-CCD digital camera mounted on a Leica DM 
LFSA microscope with a 10X water-immersion lens and HCI imaging software in regular 
hemolymph. Viscous loading assay was then performed as previously described (10, 12). Briefly, 
the hearts after being imaged in regular hemolymph were then washed with 10% w/v Ficoll 
(relative viscosity 5) in oxygenated hemolymph, allowed to equilibrate for 20 min, and then 
imaged again. Hearts were then washed with 20% w/v Ficoll (relative viscosity 20), equilibrated 
for 20 min, and imaged again. Over 20 biological replicates were imaged per genotype and age. 
Images were analyzed and motion-mode kymographs, or m-modes, were generated using the 
Semi-automated Optical Heart Beat Analysis software as previously published (12, 54), and 
calculation of systolic and diastolic lengths, fractional shortening, heart period, heart period 
variance, incomplete relaxation events, and shortening (contraction) and lengthening (relaxation) 
velocities were obtained by the modified software allowing for phase analysis (12). Shortening 
and lengthening velocities were calculated by dividing the contraction length by either the 
contraction and lengthening intervals, i.e. the time between the start of contraction and the start of 
isovolumic systole and the time between the end of isovolumic systole and start of isovolumic 
diastole, respectively. Based on the Hill’s equation (55) a least square’s fit was performed on the 
average shortening velocities for each genotype as a function of relative viscosity using a 
MATLAB script as previously published and plotted in Figure 2.5 (10). Fits are displayed over the 
relative viscosity ranges tested. Coefficients are provided in Table S2.8. A least squares fit was 
also performed for the average lengthening velocities and are displayed over relative viscosity 
ranges tested.  
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Longevity Assay 
For survival experiments in Figures 2.1 and 2.5, virgin females were collected for 10 days 
after which they were briefly anaesthetized by CO2 and separated into groups of 25 flies in each 
vial. The flies were kept at 25o. Dead flies were counted every 2 days after transfer onto new 
standard agar-containing food. Each experiment consisted of 200-250 flies. Data were analyzed 
using Prism 5.0a (Graphpad Software, Inc.). Further details are provided in Table S2.9. 
 
Statistical Methods 
All data were checked for Gaussian distribution prior to analysis using D’agnostino-
Pearson omnibus normality test. Data such as heart-period variance that did not exhibit Gaussian 
distribution were first normalized prior to analysis. Non-parametric Student’s two-tailed t-test with 
unequal variances assumption was used for analyzing AFM measurements when comparing 
more than one genotype at a specific age. Two-way analysis of variance (ANOVA) was used 
when comparing 2 or more groups at more than one condition such as relative viscosity in the 
ficoll assay followed by a Bonferroni multiple comparisons post hoc test of significances. 
Significances are displayed on the graph indicating load/genotype as source of variance with 
Bonferroni post hoc test results denoted over specific point comparisons. Deficiency line data for 
physiological analyses of high-speed movies were analyzed via one-way-ANOVA with post hoc 
dunnetts’s multiple comparisons test. Lifespan analyses were performed using a log-rank 
analysis (Mantel-Cox test). In all cases p < 0.05 were taken as significant. All statistical analyses 
were performed using Prism 5.0a (Graphpad Software, Inc) except for the use of MSstats: an R 
package for statistical analysis for quantitative mass spectrometry–based proteomic experiments 
(53). Specific analyses used are indicated in figure legends. All in situ experiments were 
performed with biological replicates of 15-30 flies unless otherwise indicated while genetic or 
protein expression experiments represent <4 biological replicates of 15-50 pooled fly hearts as 
indicated in the legends. 
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Supplementary Materials  
 
Figure S2.1. Drosophila melanogaster adult heart structure and ECM localization.  (A) 
Schematic of Drosophila heart tube ventral view showing cardiomyocytes CMs arranged in 
bilateral rows forming a tube. Longitudinal and lateral CM junctions between adjacent cells are 
shown in black with the intercalated discs (IDs) located at the ventral junctions down the length of 
the tube. (B) Transverse heart tube schematic indicating the multiple layers of the fly heart: the 
supportive non-contractile skeletal muscle-derived ventral muscle (VM) layer organized 
longitudinally (green), the layer of basement membrane extracellular matrix (ECM) separating the 
two muscle layers and covering the individual VM fibers (blue), and the single layer of CMs for the 
heart tube (red), with IDs (yellow) located at the ventral and dorsal side of the tube, and nuclei 
(purple) on the side. (C) Ventral view of F-actin (white) labeled heart tube showing longitudinally 
oriented ventral muscle (VM) fibers and circumferential CM fibers underneath. The conical 
chamber (CC) is indicated in the yellow box. Scale bar is 50 µm. (D) Fluorescent image of a 
Viking-GFP flytrap yw fly heart stained for Laminin A (green), Viking (purple), and F-Actin (white) 
which depicts ECM localization both it between the VM and CM layers and around the whole 
tube. Scale bar is 25 μm. 
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Figure S2.2. Cardiac Basement Membrane Protein Expression Differences in Aged 
Wildtype Drosophila. (A) Representative immunofluorescent images for w1118 hearts at 5 weeks 
for proteins Laminin A (green), Viking (purple), Pericardin (red), and F-actin (white) used for mean 
pixel intensity measurements in Figure 2.2D. (B) Representative immunofluorescent images for 
the yw hearts at 5 weeks for proteins Laminin A (green), Viking (purple), Pericardin (red), and F-
actin (white) used for mean pixel intensity measurements in Figure 2.2D. All fluorescent 
intensities were normalized to F-actin within region of interest (ROI) selected over bulk of heart 
tube (top left, white dashed box). Scale bar is 50 µm. 
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Figure S2.3. Knockdown of ECM Genes Laminin A, Viking, and Pericardin shows that 
LanAKD exhibits decreased expression of other BM components. (A) Schematic of 
Drosophila genetics in which virgin Hand-Gal4 promoter females were crossed to either wildtype 
w1118 males for control or w1118 -UAS males for desired genetic perturbation. (B) Gene expression 
of BM components for adult LanAKD, VkgKD, and PrcKD flies at 1 week were quantified by 
normalizing each gene to GapDH2 transcript levels and then to corresponding Control transcript 
amount (mean± s.e.m., n=5). *p<0.05 (C) Immunofluorescent ventral maximum intensity 
projections of Control, LanAKD, VkgKD, and PrcKD hearts at 1wk stained for actin (white) and 
corresponding ECM protein KD in the indicated color. The percentage of ECM KD was quantified 
by calculating the mean pixel  intensity ratios of corresponding ECM protein within a ROI selected 
over the heart tube normalized to control F-actin for each genotype and comparing to control ratio 
for the immunofluorescent images shown above. Percentage KD relative to control image above 
is shown bottom right of each ECM KD image in white. Scale Bar is 50 µm. n=5. 
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Figure S2.4. LanA+/- w1118 flies recapitulate LanAKD physiological and functional 
phenotypes. (A) Representative immunofluorescent images from indicated genotypes comparing 
relative amounts of indicated protein in adult 1 week fly hearts between controls and 
heterozygous deficient flies. (B) Diastolic heart diameters were quantified for indicated genotypes 
at 1 week under no viscous load. (C) Fractional Shortening were quantified for indicated 
genotypes at 1 week under no load. (D) Heart wall shortening (contraction) velocities were 
quantified under no load for each genotype at 1 week. (E) Heart wall lengthening (relaxation) 
velocities were quantified under no load each genotype at 1 week. All data represents mean ± 
s.e.m and analyzed via one-way-anova with post hoc dunnetts’s multiple comparisons test. n>15. 
*p<0.05, **p<0.01, ***p<0.0001. 
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Table S2.1. Proteins detected by Mass Spectroscopy for Adult 1 week w1118 Drosophila 
hearts. MS1 intensity values were assessed as described in the Extended Methods for adult 
w1118 flies, and are listed here. Data reported include 4 values (biological replicates) for each 
protein as median normalized for each replicate to control for protein concentration differences. 
Data also include Protein IDs to which the peptides were mapped as well as description of that 
protein obtained by Uniprot. Scatter plot of data shown in Figure 2.3A.  Proteomic data are 
available via the PRoteomics IDEntifications (PRIDE) database at accession number 
PXD006120. 
 
Table S2.2. Proteins detected by Mass Spectroscopy for Adult 1 week w1118 Drosophila 
hearts.  MS1 intensity values were assessed as described in the Extended Methods for adult yw 
flies, and are listed here. Data reported include 4 values (biological replicates) for each protein as 
median normalized for each replicate to control for protein concentration differences. Data also 
include Protein IDs to which the peptides were mapped as well as description of that protein 
obtained by Uniprot. Scatter plot of data shown in Figure 3A. Proteomic data are available via the 
PRoteomics IDEntifications (PRIDE) database at accession number PXD006120. 
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Table S2.9. ECM KD Survival Data. Total subjects (N), median survival, maximum lifespan, 
percent life extension compared to controls, and statistical analyses are given for each genotype 
indicated in Figure 2.6D. 
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One Sentence Summary: Cardiac vinculin-overexpression is a conserved aging 
response that is associated with enhanced myocardial performance and extended 
organismal lifespan, and may be modulated therapeutically. 
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Preface to Chapter 3 
Chapter 3, in full, is an article published in Science Translation Medicine. The work in 
Chapter 3 determines that cardiac vinculin overexpression is a conserved aging response that is 
associated with enhanced myocardial performance and extended organismal lifespan, which with 
future work may be modulated therapeutically. 
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Abstract 
The human heart is capable of functioning for decades despite minimal cell turnover or 
regeneration, suggesting that molecular alterations help sustain heart function with age. However, 
identification of compensatory remodeling events in the aging heart remains elusive. Here we 
present the cardiac proteomes of rhesus monkeys and rats, from which we show that certain age-
associated remodeling events within the cardiomyocyte cytoskeleton are highly conserved and 
beneficial rather than deleterious. Targeted transcriptomic analysis in Drosophila confirmed 
conservation and implicated vinculin as a unique molecular regulator of cardiac function during 
aging. Cardiac-restricted vinculin-overexpression reinforced the cortical cytoskeleton and 
enhanced myofilament organization, leading to improved contractility and hemodynamic stress 
tolerance in healthy and myosin-deficient fly hearts. Moreover, cardiac-specific vinculin-
overexpression increased median lifespan by more than 150% in flies. A broader array of 
potential therapeutic targets and regulators of age-associated modifications, specifically for 
vinculin, are also shown. These findings suggest that the heart has molecular mechanisms to 
sustain function and longevity, which may be assisted by therapeutic intervention for rejuvenation 
of patient hearts or delaying age-related dysfunction. 
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Introduction 
The average age worldwide is projected to increase dramatically in the coming decades. 
Advanced age is a primary risk factor for cardiac dysfunction and subsequent morbidity and 
mortality (1). Treating age-related heart failure (HF) is complicated due to its heterogeneous 
etiologies. A multitude of remodeling events associated with cardiac aging are thought to impair 
myocardial performance (1, 2). Remodeling fundamentally begins with molecular changes, such 
as altered cell growth regulation (3) and protein expression (4). Because cardiomyocyte renewal 
in the heart is limited (5), functional maintenance may depend on molecular remodeling over time 
or age-related compensatory responses to minimize damage. Identifying compensatory aging 
events is difficult because of diverse aging processes within and between organisms and an 
abundance of maladaptive events. However, integrated approaches that identify conserved 
hallmarks of cardiac aging and verify their positive or negative functional consequences can 
assist in distinguishing therapeutic targets for treating age-related HF or improving outcomes 
during aging.  
The cortical cytoskeleton in cardiomyocytes couples sarcomeres to the membrane at cell-
matrix (costameric) and cell-cell junctions (intercalated disc, ID), translates sarcomeric 
contraction into cell shortening, and undergoes remodeling in aging patients (6, 7) and during HF 
(8, 9). Aging may therefore affect mechanotransduction, the signaling induced by changing 
physical forces, through cytoskeletal proteins. Vinculin, for example, is force-sensitive (10), 
regulates cell shape (11) and intracellular signaling (12, 13), and is overexpressed in aging 
patient myocardium (7). Mechanical loading of cardiomyocytes results in reinforcement of cell 
junctions (11, 14, 15) and increased vinculin-mediated crosslinking of transmembrane proteins to 
the cortical actin superstructure (15, 16). Conversely, mechanical unloading via left-ventricular 
assist devices can restore baseline vinculin and cytoskeletal gene expression in HF patients (8, 
9) and, moreover, vinculin mutation alone can result in HF (17). These data suggest relationships 
between the cytoskeleton, ventricular contractility, and ventricular load. Therefore, we 
hypothesized that vinculin may additionally influence cardiac performance with age. However, 
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conservation of vinculin-overexpression in aging model systems and its structural and functional 
consequences have never been investigated. Therefore, we examined these with complementary 
techniques in multiple aging systems of varying complexity. 
We assessed conservation of known human aging hallmarks and identified novel 
molecular alterations by analyzing the left ventricular proteomes of adult and aged simians 
(Macacca mulatta) and rats (Rattus norvegicus) using mass spectrometry (MS). Subsequent 
investigations suggested that the vinculin network has a central, conserved role in cardiac aging. 
Using Drosophila melanogaster, a rapidly aging and genetically tractable model system, we 
observed that cardiac vinculin-overexpression induced extensive cytoskeletal and cellular 
remodeling and correlated with enhanced cardiac contractility and lifespan extension. In contrast 
to a perception that remodeling is predominantly maladaptive, these data strongly suggest a 
beneficial role for vinculin-overexpression in the aging heart. We demonstrate vinculin-mediated 
cytoskeletal remodeling as a compensatory mechanism in which tensional homeostasis is altered 
in order to preserve cardiac function during aging. Vinculin network proteins may thus serve as 
potent therapeutic targets for improving HF patient outcome.  
 
Results 
Simian and murine ventricles exhibit age-related cytoskeletal remodeling 
Proteomic quantification of left ventricular free wall myocardial samples from adult and 
aged rhesus monkeys (11 and 22 years, respectively) and rats (6 and 24 months, respectively) 
was performed using mass spectrometry (Figure 3.1A). Tryptic peptides (Tables S3.1-2) and a 
total of 1206 (simian) and 1086 (rat) non-redundant proteins were quantified (Tables S3.3-4). Of 
these proteins, 602 were common between species. Based on STRAP annotation (18) of the 
cellular compartments in both proteomes, cytoskeletal proteins were among the most plentiful 
groups in monkeys and rats, regardless of gender and age ratios (Figure S3.1; Table S3.5). The 
most abundant biological functions in both species involved molecules with a role in subcellular 
organization, or formation and maintenance of intracellular and/or organelle structure (Figure 
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S3.1; Table S3.6). Based on label-free quantification via normalized spectral counts, proteins 
involved in the cytoskeleton and cell organization increased in quantity with age, especially in 
monkeys (Figure 3.1B). These proteins were associated with cardiac biological functions, 
including cardiovascular disease (Table S3.7), and numerous cardiac toxicological functions, 
such as arrhythmia, hypertrophy, and failure (Table S3.8).  
Given increased expression of peptides with cytoskeletal ontologies, IPA was employed 
to determine interaction networks. We observed age-associated upregulation of vinculin as well 
as components within the vinculin interaction network in rhesus monkeys (Figure 3.1C) and in 
rats (Figure 3.2A). Figure 3.1D additionally depicts a vinculin-centric network of cardiac aging 
biomarkers whose deletion or mutation are also associated with cardiomyopathy and thus may 
serve as therapeutic targets (additional information provided in table S9 for human interactions 
with more than 20 upregulated cytoskeletal proteins). Comparative analysis with IPA and Online 
Mendelian Inheritance in Man (OMIM) (19), a human genetic phenotype database, also identified 
interventional or therapeutic regulators of all age-upregulated proteins from Figure 3.1B (Table 
S3.10) and of vinculin, specifically (Figure S3.2).  
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Figure 3.1. Comparison of cardiac proteomes of ventricles from adult and aged simians 
and rats to identify cardiac aging biomarkers.  (A) Experimental design to analyze LV free wall 
(dashed white box) from intact hearts from aged and adult simians and rats. (B) Scatter plot of the 
ratio of aged to adult spectral counts. Each point represents the ratio for a single protein and 
colors indicate cell component category (left) or biological function (right) into which each protein 
falls, as determined by Software Tool for Rapid Annotation of Proteins (STRAP) analysis. (C) 
Ingenuity Pathway Analysis (IPA) for sarcomeric and cytoskeletal proteins yielded network 
interactions. Protein expression determined by spectral counting for rats are denoted by filled 
symbols, while simian protein expression is an outlined symbol. Color coding of expression is 
shown below with a legend for shapes and interactions. Vinculin (VCL) and vinculin-specific 
interactions are highlighted by bold, blue lines within the network. (D) Network of cardiomyopathy-
associated proteins that are upregulated with age in monkeys. Annotations obtained using IPA 
and Online Mendelian Inheritance in Man (OMIM) are available in table S9. Note that uncolored 
nodes represent protein groups or complexes, not individual or redundant molecules.
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Vinculin localization changes in aged rat ventricles 
Relative to young (6 mo) rats, aged (24 mo) rats exhibited increased body weight, heart 
weight, and total cardiac output. However, heart weight and cardiac output normalized to body 
weight did not differ significantly (Figure S3.3), suggesting that they were undergoing 
physiological aging and non-pathological hypertrophy at this age. Echocardiograms revealed 
significant changes in diastolic and systolic left ventricular internal dimension and resulted in a 
modest decrease in fractional shortening with rat age (Figure 3.2, B and C) as observed 
previously (20).  
 
Figure 3.2. Cytoskeletal remodeling in adult and aged rats with ventricular hypertrophy but 
preserved fractional shortening.  (A) Western blot for vinculin from LV free wall and 
quantification of normalized blot intensity (vinculin/GAPDH) for each age cohort. Shown are three 
technical replicates of six pooled samples at the indicated ages. P-value determined from 
unpaired, non-parametric t-test. (B) LV echocardiograms displaying diastolic (Dia) and Systolic 
(Sys) chamber widths for the indicated ages. (C) LV end diastolic and systolic diameters (LVIDd, 
LVIDs) and fractional shortening were measured from kymographs in (B) for the indicated ages. 
(D) Staining for vinculin, connexin 43 (Cnx43), actin, and nuclei (DAPI) in the rat ventricular 
myocardium. Dashed boxes indicate the magnified areas below. Filled arrowheads indicate 
intercalated discs (IDs); open arrowheads indicate transverse junctions. Scale bars, 10 μm. (E) 
Vinculin expression with age at both IDs (Cnx43+ pixels) and lateral junctions (Cnx43– pixels) as 
quantified using a method outlined in fig. S4. In (C and E), P-values determined from Wilcoxon 
rank sum test
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Age-related morphological differences in vinculin expression were characterized by 
histology. Vinculin accumulated at intercalated discs (IDs) [connexin 43 (Cnx43)+ pixels] and 
lateral borders [Cnx43– pixels] in aged rat myocardium, with an apparent preference at IDs 
(Figure 3.2, D and E; Figure S3.4), similar to observations in elderly human hearts (7). Vinculin 
binds to transmembrane proteins with its head domain and bundles or crosslinks cortical 
filamentous-actin with its tail domain (16, 21) (Figure S3.5). Increased vinculin expression may 
reinforce the cortical actin superstructure, leading to measurable changes in cortical stiffness. 
Therefore, atomic force microscopy (AFM)-based nanoindentation was performed on isolated rat 
cardiomyocytes to probe cortical stiffness, which reflects cytoskeletal integrity or actin 
superstructure abundance and the degree of cross-linking by actin-binding proteins. There were 
no significant differences in stiffness between age groups (Figure S3.6A-C). However, isolated 
cells at these ages were poorly spread and minimally adherent, suggesting that isolation 
compromised cytoskeletal integrity. Thus, mechanical assessments reflecting in vivo physiology 
would benefit from use of an in situ model system that is characterized by preserved cytoskeletal 
structure and protein homology. It has been shown that the Drosophila melanogaster heart fits 
these criteria (22-24) thus would allow for examination of cytoskeletal remodeling during aging 
without disruption of cytoskeletal integrity (Figure 3.3 and Figure S3.5). 
  
Drosophila heart remodeling is genotype-dependent  
The Drosophila heart consists of a bilateral row of cardiomyocytes that form a contractile 
tubular structure with a prominent anterior region called the conical chamber (Figure 3.3A). To 
investigate age-associated cardiac remodeling, we first quantified changes in heart diameter in 
two laboratory fly genotypes (Figure 3.3B). Altered diastolic diameters are characteristic of 
cardiac remodeling. Diastolic diameter was significantly diminished at 5 weeks of age (aged) as 
compared to 1 week (adult) for both yellow-white (yw) and white (w1118) Drosophila genotypes 
(Figure 3.3C), consistent with previous results which have suggested that diastolic restriction is a 
hallmark of cardiac aging in Drosophila (25).  
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Figure 3.3. Age- and genotype-associated structural remodeling in the Drosophila heart.  
(A) Ventral cartoon and confocal microscopy view of the Drosophila head (Hd), thorax (Thrx), and 
abdomen (Abd). Abdomen contains the heart (Hrt; red) whose major contractile compartment is 
the conical chamber (CC). Image modified from (30). Filled arrowheads indicate the cell-cell 
junctions or IDs along the middle axis of the heart. Illustration of heart during diastole versus 
systole. Arrowheads indicate the region of the heart measured in (B). Inset illustration shows an 
orthogonal view through the heart indicating the bilateral myocytes with compartments of interest 
highlighted. (B) Images of hearts captured from a 120 fps movie used for physiological 
assessments. Lines indicate where diastolic and systolic dimensions and phases were measured 
unless otherwise indicated. (C) Heart diameters for the indicated Drosophila genotypes and ages 
(yw, yellow-white; w1118, white) normalized to the genotype-specific 1-wk diameter. *P < 0.05, 
***P < 0.001, unpaired, non-parametric t-tests. 
A correlation between decreased diastolic diameters and increased cortical stiffness has 
been previously demonstrated in aging Drosophila and cardiomyopathy models (22, 24). Thus, 
we examined whether genotype-dependent changes in diastolic diameters with age correlated 
with stiffening. The conical chambers (Figure 3.4A) of relaxed hearts were indented in situ at the 
ventral midline, proximal to IDs (Figure 3.4B, 0 µm), and at distal positions, upon the costameres 
(Figure 3.4B, 15 and 30 µm). Cardiomyocytes from 1-wk flies had relatively homogeneous 
stiffness independent of genotype (Figure 3.4C). However, yw exhibited cardiac stiffening, with 
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preference to the ventral midline (Figure 3.4C, green overlay), suggesting that excessive diastolic 
chamber remodeling correlates with increased cortical stiffness. A correlation between diastolic 
remodeling and cortical stiffening was observed in a third Drosophila genotype, white-Canton S 
(wCS) (Figure S3.7). In sum, wCS has an aging phenotype that resembles yw. 
To examine the underlying contributors to cardiac stiffness in our system, Drosophila 
hearts were incubated in either blebbistatin, which inhibits actomyosin cross-bridge cycling, or 
cytochalasin D, which impairs cardiac contractility and depolymerizes cortical actin (25). Five-wk 
yw exhibited a significant reduction in stiffness at the midline following blebbistatin treatment but 
reduction was more pronounced in cytochalasin D-treated hearts (Figure 3.4D and Figure S3.6D). 
These data suggest that increased resting tone in the relaxed heart does not exclusively account 
for the measured stiffness increase and that the state of the actin cytoskeleton may be a major 
component of age-related stiffening. 
Expression changes in candidate actin-binding molecules were investigated from excised 
fly hearts using qPCR to determine the molecular underpinnings of these changes. A majority of 
cytoskeletal gene transcripts were upregulated with age in yw, including Innexin-3 (152%), 
Vinculin (103%), αCatenin-related (99%), and αCatenin (58%). However, in w1118, most of these 
gene transcripts did not change significantly (Figure 3.4E; Table S3.11). Furthermore, vinculin 
preference at the ID was diminished in 5-wk w1118 flies (Figure 3.4F). This is in contrast to ID-
preference at all ages in yw flies and rats (Figure 3.2E; Figure 3.4F).  These data, in conjunction 
with an observed lack of cortical stiffening, indicate that minimal cytoskeletal reinforcement 
occurs in w1118 with age as compared to yw. 
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Figure 3.4. Age-associated heart stiffening correlates with cortical actin cytoskeletal 
remodeling in flies. (A) AFM cantilever positioned above the Drosophila heart. Insets are 
illustrations of cantilever over the heart (top) and spherical-indenter (bottom). (B) βPS1 localizes 
within hearts at IDs (filled arrowheads) and lateral junctions along the length of the fly heart (open 
arrowheads). AFM indentation locations are indicated by red dots and their distance from ventral 
midline (0, 15, or 30 µm). (C) Cardiac stiffness as a function of distance from ventral midline in yw 
and w1118 flies (average ± SEM, n > 20).*P < 0.05, **P < 0.01 for 5-wk versus 1-wk at respective 
distance, using non-parametric t-tests. Green overlay indicates ventral midline data. (D) Change 
in cardiac stiffness for 5-wk yw following indicated pharmacological treatment. Data are individual 
flies with mean change in stiffness from EGTA ± SD (n = 10 per treatment). *P < 0.05, **P < 0.01, 
versus mean stiffness in EGTA using a repeated measures one-way ANOVA. (E) Ratio of aged 
(5-wk) to adult (1-wk) gene expression in the heart (n = 3 biological replicates of 10 pooled hearts 
per age and genotype). (F) Immunohistochemistry of hearts from 1- and 5-wk flies showing 
vinculin or β1-integrin expression. Plots indicate fluorescent intensity from a line drawn within the 
box in each image for vinculin (green) or β1-integrin (red). Filled arrowheads indicate ID; open 
arrowheads, costameres. 
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Mechanical function is preserved in aging Drosophila hearts that undergo cytoskeletal 
remodeling 
To determine if increased passive stiffness is accompanied by altered active mechanics, 
we assessed the contractile dynamics of hearts beating against acute hemodynamic loads in situ. 
Precise measurements of shortening and lengthening intervals were made from high speed 
videos (Figure 3.5A) and the effect of load on heart wall velocities was assessed (Figure 3.5B) 
(26). Shortening velocity is an index of relative force production. One-wk w1118 flies had 
indistinguishable shortening velocities relative to age-matched yw flies (P = 0.923 for genotype, 
repeated-measures two-way ANOVA). However, w1118 velocities declined with age at all loads 
(Figure 3.5C) whereas yw had preserved baseline shortening and lengthening velocities with age 
(P = 0.96; one-way ANOVA) (Figure 3.5D). Relative cardiac power output during shortening, as 
calculated from Hill’s equation (27) fit over the loads tested, was diminished to a greater degree 
with age in w1118 compared with yw Drosophila (Figure S3.8 and Table S3.12).  
 
Figure 3.5. Cytoskeletal remodeling correlates with the preservation of genotype-specific 
basal shortening during aging. (A) Motion-mode kymographs of fly hearts indicating where time 
of shortening phase (TS, green), lengthening phase (TL, red), and heart width change (ΔL) are 
measured. Purple lines indicate the half-ΔL or movement of one heart wall. (B) M-mode images 
of a heart sequentially placed under hemodynamic or viscous loading with relative viscosities (ν) 
indicated. (C) Shortening and (D) lengthening velocities were calculated from the difference in 
heart width between systole and diastole and time interval (shortening = 2ΔL/TS; lengthening = 
2ΔL/TL). Average velocities ± SEM are plotted for the indicated genotypes and ages as a function 
of hemolymph viscosity (n > 30 for each age, genotype, and load). Shortening velocity is fit with 
Hill’s equation for muscle whereas lengthening velocity is fit with a general log-function for 
illustrative purposes. *P < 0.05 and ***P < 0.001 using two-way ANOVA where asterisks indicate 
P-values for difference in velocity as a function of viscosity and age, respectively (viscosity/age).
Figure 5
ν = 1 (0% w/v)
ν = 5 (10% w/v)
ν = 20 (20% w/v)
B
C
D
A
Sh
or
te
ni
ng
 V
el
oc
ity
 
(µ
m
/s
)
Le
ng
th
en
in
g 
Ve
lo
cit
y 
(µ
m
/s
)
Relative Viscosity (ν)
w1118
1 wk
5 wk
yw1 wk5 wk
0
100
200
300
400
500
0 5 10 15 200 5 10 15 20
0
50
100
150
200
250
300
Time (Shortening)
Time (Lengthening) 
Length Change
TS∆L TL
Time
M-mode
D
ist
an
ce
∆L
***/*
***/***
***/N.S.
***/***
  
85 
These data indicate that mechanical performance is impaired in aged w1118 but is only 
evident under significant load for yw. Therefore, exaggerated diastolic restriction and cortical 
stiffening was not accompanied by contractile dysfunction; rather, restriction and stiffening 
correlated with preservation of baseline shortening and lengthening velocities. Correlation 
between vinculin expression and contractility was also observed in white-CantonS flies (Figure 
S3.7). 
 
Vinculin-overexpression recapitulates age-related cortical stiffening phenotype 
Our data suggest that cardiac vinculin-overexpression is a conserved aging event, 
although its relationship to cardiac performance and organismal longevity remain unclear. 
Therefore, we examined its functional consequences in Drosophila. Transgenes were 
strategically expressed in w1118 hearts, which did not stiffen with age, via the cardiac-specific 
tinHE-Gal4 driver (tinman heart-expresser) in conjunction with UAS-inducible Vinculin (Vinculin 
heart-expressed, VincHE) or UAS-interfering RNA (RNAi) against Vinculin (Vinculin knockdown, 
VincKD) (Figure 3.6A). Because decreased myosin and increased vinculin expression were both 
observed in our proteomic screen of rats and monkeys (Figure 3.1C) and in HF patients (4), we 
also made a line in which hearts co-express UAS-RNAi against Myosin Heavy Chain (MhcKD) 
and UAS-inducible Vinculin, dubbed MhcKD+VincHE (Figure S3.9), to determine if vinculin-
overexpression could rescue dysfunction resulting from impaired myosin motor expression. 
MhcKD+VincHE was compared to both control and a line expressing only UAS-RNAi against 
Myosin Heavy Chain (MhcKD). Cardiac-specific qPCR verified knockdown and/or overexpression 
for each respective gene (fig. S10).  
Structural and functional cardiac metrics were assessed in 1-wk flies (Figure 3.6A). 
Vinculin preferentially localized to IDs in all lines except VincKD (Fig. 6B). VincHE resulted in 
increased cardiac stiffness compared to controls, with preference at IDs, similar to 5-wk yw 
(Figure 3.6C). MhcKD exhibited reduced cardiac stiffness across the heart, consistent with results 
obtained using other transgene drivers (24). However, MhcKD+VincHE was indistinguishable 
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from control, suggesting that vinculin-overexpression could restore basal cardiac stiffness in 
hearts with myosin deficiency. Cytochalasin D treatment reversed the stiffening phenotype in 
VincHE (Figure 3.6D) in a pattern matching 5-wk yw (Figure S3.11), suggesting remodeling of the 
cardiac actin superstructure by increased vinculin. Increased vinculin expression and costameric 
localization, cortical stiffening, and similar response to drug treatments occurred in both w1118 
hearts overexpressing vinculin (VincHE) and 5-wk yw. These data indicate a causative role for 
vinculin in inducing age-related changes in yw and correlate with age-associated cytoskeletal 
changes observed in rodents, monkeys, and humans. 
 
Vinculin expression improves function, myofilament organization, and lifespan 
Heart dimensions and contractility were evaluated to examine the effects of vinculin-
overexpression on cell structure and function. VincHE had restricted cardiac diameters though 
fractional shortening did not differ significantly from control (Figure 3.6E). MhcKD hearts were 
significantly dilated and had impaired fractional shortening relative to control. Compensation for 
myosin knockdown with vinculin-overexpression in MhcKD+VincHE renormalized heart 
dimensions and partially rescued fractional shortening. With regard to relative force production, 
VincHE myocardial shortening velocity was significantly higher at all loads and displayed a less-
severe load-dependent decline in fractional shortening versus all other genotypes (Figure 3.6F). 
MhcKD heart wall velocities were diminished at all loads and resembled 5-wk w1118 (p=0.19, two-
way ANOVA). However, MhcKD+VincHE hearts demonstrated substantially improved shortening 
velocity and relative cardiac power output increased compared to MhcKD and resembled controls 
(Figure S3.8 and Table S3.12). Heart rate and period did not differ between VincHE and control 
and were depressed in MhcKD but renormalized in MhcKD+VincHE (Figure S3.12). Interestingly, 
cardiac-specific vinculin-overexpression was sufficient in prolonging median organismal lifespan 
by as much as 150% (Figure 3.6G). These data suggest that VincHE hearts produce greater 
contractile forces, that vinculin-overexpression can rescue diminished force production, and that 
cardiac-specific vinculin overexpression can increase longevity.  
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Figure 3.6. Cardiac-specific cytoskeletal reinforcement results in increased cardiac 
contractile function and extends Drosophila lifespan. (A) Illustration of crosses used to 
generate control and transgenic lines. (B) Immunohistochemistry of βPS1 and vinculin in 1-wk old 
genotypes. Plots indicate fluorescent intensity from line drawn within box in each image for 
vinculin (green) or βPS1 (red). Filled arrowheads indicate ID; open arrowheads, costameres. (C) 
Average cardiac stiffness ± SEM, n > 20. (D) Change in cardiac stiffness from EGTA following 
indicated pharmacologic treatment (mean change from EGTA ± SD, n = 10). Ventral midline 
indicated by green overlay.  (E) At the indicated position, genotypes in (A) were assessed for 
heart diameters and fractional shortening. Data are individual flies with mean indicated. *P < 0.05, 
**P < 0.01 compared to control by one-way ANOVA in (C-E). (F) Heart wall velocities and 
fractional shortening assessed under viscous load and fit by Hill’s model (shortening velocity) or a 
general log fit (lengthening velocity, fractional shortening, for illustration purposes). Data are 
mean ± SEM, n > 30, *P < 0.05, **P < 0.01, *** P < 0.001, N.S. (not significant), using two-way 
ANOVA, comparing indicated genotype and control (black). (G) Survival curves for indicated 
genotypes (n > 100). Grey lines indicate time in days to which 50% of starting population 
survived. **P < 0.01, ***P < 10-6 using two-way ANOVA for population over time between 
indicated genotype and control (black). P = 0.025 for MhcKD+VincHE versus MhcKD. 
Computational studies have suggested a role for vinculin in regulating sarcomere lattice 
spacing and contractility (28). Therefore, electron micrographs of cross-sections through VincHE 
and control cardiac myofibrils were examined to investigate alterations in ultrastructure (Figure 
3.7A and Figure S3.13). Thick-thick filament lattice spacing was similar in control and VincHE 
(average spacing of 45.74 and 45.79 nm, respectively) (Figure 3.7B); however, a significant 
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reduction in lattice spacing variance was observed for VincHE flies (3.11 nm for control vs. 0.89 
nm for VincHE; P < 10-48, F-test). A similar reduction in variance was observed for thick-to-thin 
filament spacing. These data suggest that improved myofilament order contributes to the 
enhanced contractility observed in VincHE flies. 
 
Figure 3.7. A proposed role for cytoskeletal regulation of myofilament order and 
contractility in the aging myocyte.  (A) Representative TEM micrographs of myofibril cross-
sections of 1-wk control (black) and VincHE (green) flies. (B) Interfilament spacing analysis as 
outlined in fig. S13. Inset image illustrates how distances were measured. Data are histograms 
indicating distribution of interfilament spacing, n = 480 (control) and 670 (VincHE) thick filaments. 
(C) Top: Adult cardiac myocytes (fly, rodent, monkey, human) have defined cell-cell and cell-
matrix junctions, referred to as intercalated discs and costameres, respectively. Costameres 
couple Z-discs to the membrane and cross-link the cortical actin cytoskeleton. The terminal 
sarcomere ends at the ID, rather than a Z-disc, which is populated by actin-based adherens 
junctions as well as desmosomal and gap junctions. Middle: Vinculin binds to integrin and 
cadherin complexes and can facilitate remodeling of the actin superstructure by nucleating and 
bundling F-actin via its tail domain. Bottom: Vinculin is overexpressed with age. We propose that 
this results in reinforcement of the cortical cytoskeleton via cell junctions, which in turn may have 
propagating mechanical effects through the myofilament lattice that support or enhance its 
crystalline order. Thus, the cortical cytoskeleton can act as an extra sarcomeric regulator of 
myocyte structure and contractile function. Simplified schematic shown. Proteins indicated by 
gene name.
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Discussion  
Age-related heart failure results from chronic stressors that induce a heterogeneous array 
of physiological changes associated with overall negative outcome. However, individual events 
may be compensatory and required for maintaining function with age. Such events could be 
further promoted to treat failure or delay age-associated negative outcomes by therapeutic 
intervention in aging patients. A role for cytoskeletal regulation of contractility has been presented 
recently (13) and post-mortem analysis of age-associated HF corroborated altered expression of 
cytoskeletal proteins (7, 8). Though it is known that cytoskeletal molecules are crucial for cardiac 
function, a link between cytoskeletal remodeling and mechanical function has only been inferred 
(29) and not thoroughly vetted in aging cardiac systems. Our goal was to examine the 
contribution of cytoskeletal remodeling to function in aged organisms with varying myocardial 
complexity. Therefore, we integrated expansive proteomic analyses of mammals (rats, monkeys) 
with in-depth mechanistic analyses in a permissive invertebrate system (Drosophila). These data 
establish vinculin-mediated cytoskeletal remodeling as a regulator of myocardial structure and 
contractility during aging. Furthermore, therapeutic targets for age-related HF are proposed 
based on their expression changes and known importance to cardiac function (Figure 3.1D and 
Figure S3.2). In sum, these findings clarify the role of the cortical cytoskeleton in cardiac aging 
and indicate vinculin and other mechanosensitive molecules as biomarkers of healthy or 
beneficial aging and as potential targets for therapeutic intervention in aging patients. 
A primary aim was to assess conservation of age-related cytoskeletal remodeling and its 
impact on myocardial performance across species (simian, rat, and fly) during normal aging (as 
opposed to pathological conditions). The unique but complementary utility of each chosen model 
allows for cooperative approaches to study aging networks or cellular functions of interest. 
Monkeys have a relatively long lifespan and cardiac physiology similar to humans and rats are 
widely-used as a human cardiac pathophysiology model. However, neither is optimally suited for 
mechanistic dissection of candidate proteins. In contrast, Drosophila melanogaster is a rapidly 
aging organism, has extensive proteomic and cellular homology to murine models (30), and 
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allows for tissue-specific genetic manipulation and experiments in which myocytes can be 
interrogated in situ with tools that directly visualize heart structure (24, 31, 32) or probe 
mechanics (22-24) without incurring damage to the heart (Figure S3.14). Cultured neonatal or 
stem-cell derived myocytes are often used to correlate mechanical and functional metrics (33, 
34). However, such systems can lack adult morphology or mature cell junctions owing to 
remodeling of their intracellular structure (35) and contractility (36) in response to extracellular 
cues, such as super-physiological substrate stiffness. Conversely, the Drosophila heart model 
allows us to examine the intersection of tensional and physiological homeostasis as a function of 
age and genetic manipulation with intact structures. It is important to note that genotype-
dependent differences exist within Drosophila (22), similar to what has been observed between 
mouse strains (37) and thus we selected two genotypes with diverse age-associated metrics (yw 
and w1118) for comparison. Conservation of age-related cytoskeletal remodeling and negative 
correlation with contractile dysfunction was observed in a third genotype. 
Vinculin was a promising candidate for investigation as it formed a central hub within the 
network of changes identified by proteomics as well as its known overexpression in aging human 
myocardium (6, 7). Additionally, vinculin has been implicated in integrin- (10) and cadherin-
mediated (15) mechanotransduction and actin cytoskeletal interactions (21). Cardiac-specific 
vinculin deletion disrupts junctions and results in sudden-death or cardiomyopathy in mice (38). 
Thus, vinculin is an appropriate first candidate to induce cytoskeletal remodeling, examine its 
effects on myocardial performance, and investigate a functional role in aging. Increased cardiac 
vinculin expression correlated with greater localization at the cortical cytoskeleton, subsequent 
cytoskeletal reinforcement, and increased contractility. Partial rescue of impaired contractility and 
fractional shortening in MhcKD+VincHE also supports a role for vinculin-mediated compensation 
for myofilament dysfunction, as proposed previously (6). Although it has been suggested that 
cardiac cytoskeletal remodeling would result in stiffening and subsequent dysfunction (29), these 
data suggest that vinculin-mediated cytoskeletal reinforcement positively influences contractility 
and lifespan, as evidenced by the >150% increase in median lifespan in VincHE over control flies. 
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Vinculin-overexpression may therefore be a conserved hallmark of cardiac aging. 
Although the intrinsic molecular causes of vinculin-overexpression in the aging heart remain 
unclear, upstream regulators and activating reagents have been identified which could be used 
for therapeutic vinculin-overexpression. For example, growth differentiation factor 11 (GDF-11), a 
TGF-β family protein, positively regulates vinculin expression in the brain (39) and its 
overexpression can reverse pathophysiological hypertrophy in aged mice (3). However, GDF-11 
declines with age in mice and humans have lower concentrations of GDF-11 than mice at all ages 
(3), implying that reduced GDF-11 is not the underlying cause of vinculin-overexpression in aging 
patients. Antagonism of miR-34, a negative transcriptional regulator of vinculin, led to improved 
outcome in mice experiencing pressure overload or myocardial infarction and correlated with 
vinculin-overexpression (40), although vinculin was not specifically implicated as an active 
component of protection. Post-translational modification of vinculin may also play a role in the 
aging process; vinculin localization is regulated by phosphorylation by the kinase Abelson (41), 
whose chronic inhibition by imatinib is associated with contractile dysfunction (42).  
Vinculin is localized to costameres and IDs and plays separate but complementary roles 
for cell-matrix and cell-cell adhesion. Our data indicate that vinculin-overexpression leads to 
cytoskeletal reinforcement, indicated by elevated cortical stiffness and increased myofilament 
lattice order. Because costameres directly couple Z-discs to the membrane, increased vinculin 
could improve their integrity and ability to anchor myofilaments sufficiently and in correct 
orientation. These data are consistent with in vitro assessment of vinculin-null mouse myocytes, 
which had reduced cortical stiffness and increased interfilament spacing (28). Improved 
interfilament order is predicted to enhance the probability of actin-myosin cross-bridge formation, 
and thus the number of actively cycling motors (43). Because the number of myosin heads 
engaged with thin filaments determines muscle performance (44), increased order predicts 
elevated force production. Vinculin’s role at cell-cell junctions, where it was preferentially localized 
in rats and flies, and where stiffness increased most significantly with age, is less clear. We 
hypothesize that ID-vinculin may help anchor myofibrils and facilitate longitudinal force 
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transmission between myocytes, though additional studies are necessary to confirm this. Finally, 
cross-talk between the cortex and the Z-disk, which is itself mechanosensitive (45), may also 
occur during remodeling and impact force production. 
This study is limited to examination of vinculin-mediated cytoskeletal remodeling in 
Drosophila myocardium, where aging could be observed in a relatively short time. However, in 
order to more directly inform clinical outcomes, the contribution of vinculin-overexpression to 
cardiac function should be further examined in larger mammalian models with physiology and 
lifespans more similar to humans. In such models, a relationship between cardiac vinculin 
expression and clinically-relevant functional metrics (pressure-volume relationship, ejection 
fraction, or electrocardiogram) and organismal lifespan may be demonstrated. Additionally, these 
studies can directly elucidate how vinculin affects diastolic and systolic performance in a four-
chambered heart. With regards to clinical application, our data suggest that vinculin-
overexpression alone may be sufficient to improve cardiac outcome during aging, indicating that 
intervention with vinculin mRNA may be a viable therapy. Application of vinculin-based gene 
therapies in preclinical models should be explored for their potential to prevent or delay age-
related dysfunction. Future studies may also examine the efficacy of clinical treatment with 
previously identified vinculin regulators (enzymes, kinases, miRNAs, and small molecules) with 
emphasis on improving contractility while minimizing off-target effects to maximize cardiac 
protection. Such studies would set the stage for clinical trials. Currently, no trials exist to directly 
upregulate vinculin in patient hearts. In broader studies or trials concerning age-related HF 
without direct focus on vinculin, relative changes in vinculin expression may serve as a biomarker 
or predictor of outcome. Finally, although vinculin was the primary focus of this study, our 
proteomic analysis reveals a wide array of biomarkers that warrant further investigation of their 
possible role in indicating outcome in HF patients or as therapeutic targets.  
Here we have outlined a cytoskeleton-based compensatory mechanism in the aging 
heart that is conserved across species. In presenting aging cardiac proteomes and providing a 
proof-of-concept study of vinculin in cardiac aging, we aimed to establish a resource that will 
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facilitate a broader examination of cardiac aging so that additional therapeutic targets and 
regulators of aging heart function can be identified and validated. Our findings highlight the 
interplay of the molecular, cellular, and ultrastructural state of the cytoskeleton in maintenance of 
function in the aging heart and that studies of mechanotransduction can directly inform clinical 
outcomes. Furthermore, they can assist in developing integrated therapies to promote beneficial 
aging processes while preventing or suppressing maladaptive events to improve cardiac function 
in elderly patients. 
 
Materials and Methods 
Study design 
The aim of this study was to investigate the contribution of cytoskeletal remodeling to 
maintenance of function in aging myocardium and the broader hypothesis that aging is 
accompanied by conserved, compensatory events. Heart function is dependent upon hierarchical 
organization of molecular and cellular components across multiple length scales. Therefore, we 
chose to perform an analysis that integrated complementary information across these scales. 
Recognizing a need for a comprehensive library of myocardial proteins with altered expression 
with age, we performed broad spectrum proteomic analyses of the LV free wall in monkeys and in 
rats. Monkeys were chosen due to their physiological similarity to humans and rats were selected 
due to their demonstrated utility as a model of human cardiac aging. We employed MS methods 
that enriched specifically for cellular/cytoskeletal constituents and not extracellular matrix 
components, given that age- (6, 7) and mutation-associated (17) cytoskeletal alterations have 
been associated with HF. Validation of MS data was performed in flies, a model organism which 
ages rapidly and in which genetic tools allow for examination of the contribution of specific 
network hits to cardiac function. Because this work used the fly heart as a model to study the 
mechanobiology of cardiac aging, we assessed the extent to which the model recapitulates 
mammalian cytoskeletal changes of interest by examining changes in cytoskeletal gene 
expression associated with age in humans. Subsequent data examine changes in form and 
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function following vinculin-mediated cytoskeletal remodeling. For all animals, ages were chosen 
based on conventions for what constitutes post-developmental or adult and aged. One-week old 
transgenic flies (Figure 3.6-7) were examined at 1 week to study the effects of cytoskeletal 
perturbations independent of aging. Sample sizes were chosen to achieve a statistical power of at 
least 0.70 in mammals (Figure 3.1-2) and at least 0.90 in flies (Figure 3.3-7) given α of 0.05. Data 
was not blinded. Flies of the appropriate age were selected randomly from larger populations for 
all experiments. No data were excluded from this study. 
  
Vertebrate Animals 
Six adult (6 mo) and six aged (24 mo) female F344xBN F1 rats were obtained from the 
National Institutes on Aging (NIA). Colony maintenance and experiments were performed in 
accordance with UC San Diego IACUC protocol S11032. Four adult (average: 11.63 years old, 
range: 8.75-14.12) and five aged (average: 22.4 years old, range: 18.81-25.48) male rhesus 
monkeys were maintained at the NIA in in accordance with NIA IACUC protocol AG000238-07 
(Effects of Aging on Experimental Atherosclerosis in Nonhuman Primates). Freshly isolated 
sections of left ventricular rat myocardium were embedded in OCT and then flash-frozen in liquid 
nitrogen for subsequent histological analysis. Alternatively, rat and rhesus monkey samples 
where flash-frozen for subsequent proteomic analysis. Further details regarding 
echocardiography, cardiomyocyte isolation, and other mammalian experimental protocols 
available in Supplemental Materials. 
 
Drosophila melanogaster lines, husbandry, and culture conditions 
Fly lines were obtained from the Bloomington Drosophila Stock Center at Indiana 
University or the Vienna Drosophila RNAi Center (VDRC). Flies were raised on standard agar-
containing food at 25oC. Cardiac-specific perturbation of gene expression was achieved via the 
Gal4-UAS system as described previously (46). The UAS-Vinculin/UAS-MHC-RNAi line 
(MhcKD+VincHE) was generated through a series of crosses between the individual UAS lines 
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and the balancer line Cdc42/FM6;Sco/CyO (fig. S9). Female progeny of tinHE-Gal4 and w1118 
served as control. Proper insertion of both constructs was validated using heart-specific gene 
expression analysis (Figure S3.10; Table S3.11). Details regarding Drosophila stock information 
and cardiac analyses can be found in Supplemental Materials. Fly microsurgery, as detailed in 
the Supplemental Materials, did not influence passive or active measures of heart function 
(Figure S3.14). 
 
Statistical Analyses  
Data comparison was subjected to either a non-parametric Student’s t-test with unequal 
variance assumption, Wilcoxon rank sum test, repeated measures one-way ANOVA, one-way 
ANOVA with post-hoc Tukey correction, or two-way ANOVA with post-hoc Tukey correction, as 
indicated in respective captions. Significance was assigned for P < 0.05. Scatter plots reflect the 
average measurement of individual animals with black bars indicating the mean. Pooled data are 
represented as mean ± SEM unless otherwise indicated. All Drosophila experiments were 
performed with biological replicates of 15-31 flies unless otherwise indicated. All other 
experiments were performed with biological replicates of indicated sample size. (47) 
 
Supplemental Materials and Methods 
Proteomic analysis of ventricular tissue 
Heart tissues were solubilized in 8 M urea, 2 M thiourea, 4% CHAPS, and 1% 
dithiothreitol, and centrifuged at 16,000 rpm for 20 min. Protein concentration of the supernatant 
was determined by CB-X assay kit (G-Biosciences). One-hundred μg of protein was reduced, 
alkylated, and digested with trypsin using FASP protein digest kit (Expedeon). Peptides were 
desalted using Oasis HLB 96-well Plate (Waters). Two μg of peptides were analyzed using label-
free quantification on a reversed-phase liquid chromatography tandem mass spectrometry 
(RPLC–MS/MS) online with an Orbitrap Elite mass spectrometer (Thermo Scientific) coupled to 
an Easy-nLC 1000 system (Thermo Scientific). Peptides were concentrated on a C18 trap column 
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(Acclaim PepMap 100, 300 μm × 5 mm, C18, 5 μm, 100 Å; maximum pressure 800 bar) in 0.1% 
aqueous trifluoroacetic acid, then subsequently separated on a C18 analytical column (Acclaim 
PepMap RSLC, 75 μm × 15 cm, nano Viper, C18, 2 μm, 100 Å) using a linear gradient from 5% 
to 35% solvent B over 155 min (solvent A: 0.1% aqueous formic acid and solvent B: 0.1% formic 
acid in acetonitrile; flow rate 350 nl/min; column oven temperature 45°C). The analysis was 
operated in a data-dependent mode with full scan MS spectra acquired at a resolution of 60,000 
in the Orbitrap analyzer, followed by tandem mass spectra of the 20 most abundant peaks in the 
linear ion trap after peptide fragmentation by collision-induced dissociation (CID).  
  
Database searching and processing  
Tandem mass spectrometry analysis was performed as published previously (47). All raw 
MS/MS data obtained from the Orbitrap Elite were converted to mzXML and mgf format using 
Msconvert version 3.0.3858 from ProteoWizard for peaklist generation.  All data were searched 
using two search engines: X!Tandem algorithm version 2009.10.01.1 and OMSSA algorithm 
version 2.1.9. Rat Heart dataset was searched against the concatenated target/decoy Rat Uniprot 
database as of May 16, 2013, and the Monkey Heart dataset was searched against the 
concatenated target/decoy Human Uniprot database as of April 22, 2013. The search parameters 
were as follows: fixed modification of Carbamidomethyl (C) and variable modifications of 
Oxidation (M), Phosphorylation (STY); Enzyme: Trypsin with two maximum missed cleavages; 
Parent Tolerance: 0.01 Da for Rat Heart dataset and 0.08 Da for Monkey Heart dataset; 
Fragment tolerance: 1.00 Da.  Post-search analysis was performed using Trans Proteomic 
Pipeline version 4.6, rev 1 with protein group and peptide probability thresholds set to 90% and 
90%, respectively, and one peptide required for identification. PeptideProphet was used for 
peptide validation and iProphet was used to further refine the identification probabilities. Lastly, 
ProteinProphet was then used to infer protein identifications from the resulting combined peptide 
list and perform grouping of ambiguous hits.  
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Protein isoforms were only used if a peptide comprising an amino acid sequence that 
was unique to the isoform was identified. Uncharacterized or unknown proteins were blasted 
again “all” mammalian database to infer a common protein name if the amino acid sequence 
matched 100%. Spectra of proteins identified based on a single peptide were manually validated. 
Protein Group and Peptide False Discovery Rates were calculated automatically using a target-
decoy method for the above probability thresholds (1.28 and 0.18%, respectively, for Rat Heart 
dataset, and 1.64 and 0.27%, respectively, for Monkey Heart dataset). The final non-redundant 
protein lists were analyzed through the use of IPA (Ingenuity Systems), when isoforms were 
observed, peptides comprising amino acid sequence unique to each isoform were noted. 
Networks and functional and pathway analyses were performed with IPA, Software Tool for Rapid 
Annotation of Proteins (STRAP), and/or Online Mendelian Inheritance in Man (OMIM) as 
indicated. 
 
Adult rat echocardiography 
Each rat was placed on an IACCUC-approved heating pad and anesthetized with 1.5% 
isofluorane in 100% O2 by facemask. Echocardiographic images were obtained using a GE vivid/I 
imaging system. Echocardiography was performed to measure systolic and diastolic left 
ventricular (LV) dimensions, mass, and percent fractional shortening from motion-mode 
kymographs. The entire procedure was approximately 30 min in length per animal. Animals 
regained full consciousness at the end of procedure and are transferred to cages. 
Echocardiography was performed within 1 week of sacrifice and heart tissue isolation. 
 
Histology and immunofluorescence of rat myocardium 
Each heart was sectioned using a Cryocut 1800 (Leica) in 10-μm slices and stored at -
80oC until staining. Each slice was fixed with 3.7% formaldehyde in PBS and then blocked with 
staining buffer (0.3% Triton-100X, 2% w/v ovalbumin in PBS). Samples were incubated in primary 
antibody (1:1000 Sigma Aldrich mouse anti-vinculin, 1:1000 Sigma Aldrich rabbit anti-Cnx43) in 
staining buffer, washed, incubated in secondary antibody (1:1000 CY5 goat anti-mouse, 1:1000 
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FITC donkey anti-rabbit, 1:1000 phalloidin) in staining buffer, washed, incubated in Hoechst 
(1:10,000) in staining buffer, washed, and finally mounted with fluoromount and a plastic 
coverslip. Imaging was performed using a Zeiss LSM 780 Laser Scanning Confocal Microscope.  
To analyze vinculin localization within the cell, Cnx43-positive pixels were used a region 
of interest (ROI) mask to mark the intercalated discs, since Cnx43 is only expressed at this 
location. In this way, we can associate vinculin-indicating fluorophores with the intercalated disc 
(via Cnx43). Vinculin-colocalized pixels were identified using the Pearson’s colocalization 
analysis (in which a value of -1 indicates no colocalization between fluorophores and +1 indicates 
perfect colocalization) (48) using ImageJ-based FIJI software. The calculated thresholding value 
for vinculin/Cnx43 colocalization fluorescence was then used to separate the vinculin channel into 
Cnx43 co-localized (intercalated disc) and non-Cnx43 co-localized pixels (interpreted as cortical) 
in a custom-built Matlab code (see below). Integrated density was measured as total grey value 
per frame divided by the number of vinculin-positive pixels. The DAPI channel was used as an 
internal normalization control, where DNA was labeled using 1:10,000 Hoechst (fig. S4). 
 
function [Result] = Colocalize_CM(cnx,vinc,dapi,thresh) 
 
% cnx is an image of cnx fluorescence 
% vinc is an image of vinculin fluorescence 
% dapi is an image of dapi/nucleui fluorescence 
cnx = double(cnx); 
vinc = double(vinc); 
dapi = double(dapi); 
 
dims = size(vinc); 
rows = dims(1); 
cols = dims(2); 
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% Set min to zero 
minput_v = min(min(vinc)); 
minput_c = min(min(cnx)); 
minput_d = min(min(dapi)); 
 
for r = 1:rows 
    for c = 1:cols 
        vinc(r,c) = vinc(r,c) - minput_v; 
        cnx(r,c) = cnx(r,c) - minput_c; 
        dapi(r,c) = dapi(r,c) - minput_d; 
    end 
end 
 
% NORMALIZATION 
% Normalize so matrices run from 0 to 1 
max_cnx = max(max(cnx)); 
max_vinc = max(max(vinc)); 
max_dapi = max(max(dapi)); 
cnx = cnx./max_cnx; 
vinc = vinc./max_vinc; 
dapi = dapi./max_dapi; 
max_cnx = max(max(cnx)); 
max_vinc = max(max(vinc)); 
max_dapi = max(max(dapi)); 
 
Result.cnx = cnx; 
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Result.vinc = vinc; 
Result.dapi = dapi; 
 
% These counters count up the number of pixels in which Vinculin and 
% Connexin colocalize above a given threshold (thresh) which is a 
% fraction of the maximal Connexin intensity 
coloc_counter = 0; 
nocoloc_counter = 0; 
coloc_intensity = 0; 
nocoloc_intensity = 0; 
 
% Will threshold for colocalization above a certain amoutn 
thresh_cnx = thresh*max_cnx; 
thresh_vinc = thresh*max_vinc; 
thresh_dapi = thresh*max_dapi; 
 
% Will populate with pixels for colocalization 
coloc_matrix = zeros(rows,cols); 
coloc_histo = []; 
% Will populate with pixels where Vinc does not colocalize 
nocoloc_matrix = zeros(rows,cols); 
nocoloc_histo = []; 
 
for r = 1:rows 
    for c = 1:cols 
        % Check that the pixel is above threshold 
        if cnx(r,c) >= thresh_cnx 
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            % If cnx is above threshold 
            coloc_counter = coloc_counter + 1; 
            coloc_intensity = coloc_intensity + vinc(r,c); 
            coloc_matrix(r,c) = vinc(r,c); 
            coloc_histo(end+1) = vinc(r,c); 
        % If connexin is not at threshold but vinculin is, add to 
        % non-colocalization threshold 
%         elseif vinc(r,c) >= thresh_vinc 
        else 
            nocoloc_counter = nocoloc_counter + 1; 
            nocoloc_intensity = nocoloc_intensity + vinc(r,c); 
            nocoloc_matrix(r,c) = vinc(r,c); 
            nocoloc_histo(end+1) = vinc(r,c); 
        end 
    end 
end 
 
dapi_counter = 0; 
dapi_intensity = 0; 
for r = 1:rows 
    for c = 1:cols 
        % Check that the pixel is above threshold 
        if dapi(r,c) >= thresh_dapi 
            % If cnx is above threshold 
            dapi_counter = dapi_counter + 1; 
            dapi_intensity = dapi_intensity + dapi(r,c); 
        end 
  
102 
    end 
end 
 
Result.coloc_pxl = coloc_counter; 
Result.coloc_total = coloc_intensity; 
Result.nocoloc_pxl = nocoloc_counter; 
Result.nocoloc_total = nocoloc_intensity; 
Result.avg_coloc = coloc_intensity/coloc_counter; 
Result.avg_nocoloc = nocoloc_intensity/nocoloc_counter; 
Result.coloc = coloc_matrix; 
Result.nocoloc = nocoloc_matrix; 
Result.vinccoloc = Result.avg_coloc/dapi_intensity; 
Result.vincnocoloc = Result.avg_nocoloc/dapi_intensity; 
 
 
Ventricular rat cardiomyocyte isolation 
Prior to isolation, rats were euthanized by carbon dioxide asphyxiation. The heart was 
excised and washed in sterile Buffer I (118 mM NaCl, 4.7 mM KCl, 1.3 mM KH2PO4, 1.25 mM 
MgSO4, 1.2 mM CaCl2, 15 mM HEPES, 16 mM glucose, pH 7.35) (49) at 37°C. The atria, right 
ventricle, and septal wall were removed and the left ventricle was washed 3X in sterile Buffer II 
(49 mM NaCl, 69 mM LiCl, 1.2 mM KH2PO4, 3.2 mM MgSO4, 0.1 mM CaCl2, 15 mM HEPES, 16 
mM glucose, 60 mM taurine) for 1 min at 37°C. LV tissue was then minced and washed 3X in 
Buffer II for 5 min. Separated whole LV tissue was placed in either Trizol, mRIPA, or liquid 
nitrogen and transferred to -80oC. Approximately 0.1 g of tissue was reserved and incubated at 
37°C in 1 ml digestion buffer (Buffer II + 0.05% w/v collagenase + 1.5% w/v bovine serum 
albumin). After 15 min, the supernatant was discarded and the tissue, placed again in fresh 
digestion buffer, and incubated. After each 15 min interval, supernatant was reserved and 1 ml 
cardiomyocyte media (20% fetal bovine serum, 1% antibiotic/antimycotic in αMEM) was added to 
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inhibit collagenase. Cardiomyocytes were then allowed to settle by gravity in 37oC incubator for 1 
h. Finally, the supernatant was discarded and the pellet was washed in 4oC PBS and flash-frozen 
in liquid nitrogen.  
 
Western blot analysis 
Cell and tissue specimens were lysed with mRIPA buffer (50 mM HEPES pH 7.5, 150 
mM NaCl, 1.5 mM MgCl2, 1% Triton X-100, 1% Na-DOC, and 0.1% SDS) with 1 mM ethylene 
glycol tetraacetic acid (EGTA), 1 mM Na3VO4, 10 mM Na4P2O7, and 1 mM 
phenylmethanesulfonylﬂuoride for Western blots. Concentration of ventricular cardiomyocyte 
proteins was measured via spectrophotometry. Each sample was then diluted to equal 
concentrations in mRIPA. Equal mass from each animal (6 mo or 24 mo) was pooled together. 
Western blotting analysis was performed with approximately 1 μg of protein per lane with three 
replicates per age. Ten percent polyacrylamide gels were used for protein electrophoresis at 150 
V for 1 hour until proteins were separated. They were subsequently transferred to polyvinylidene 
fluoride membranes (Bio-Rad) to be run at 100 V for 75 minutes in the transfer apparatus (Bio-
Rad). The membranes were washed in Buffer A (25 mM Tris-HCl, 150 mM NaCl, and 0.1% 
Tween-20) and 15% milk overnight at 4°C and then incubated for 2 hours with the following 
antibodies: Vinculin (V9131) at 1:10,000 (Sigma Aldrich) and GAPDH (MAB374) at 1:2500 
(Millipore). After three 10-minute washes with Buffer A, appropriate secondary HRP-tagged 
antibodies (Bio-Rad) were used during a 30 min incubation. After washing, immunoblots were 
visualized using ECL reagent (Thermo Fisher). Vinculin expression from Western blots were 
quantified from comparing three technical replicates of six pooled biological replicates at each 
age and normalizing to GAPDH intensity. 
 
Drosophila microsurgeries 
Preparation of the Drosophila heart for ventral imaging and atomic force microscopy 
(AFM) was performed as previously described (50). Adult female flies are first anesthetized with 
FlyNap (Carolina Biological) or with brief exposure to 5 – 10 psi CO2 (<1 min) and then 
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immobilized in 35-mm Petri dishes. The beating heart was ventrally exposed via microsurgery. 
Incisions are made to remove the head, thorax, and ventral abdominal cuticle. Flies are then 
submerged in oxygenated hemolymph at 25oC. All organs and debris above the heart are excised 
with careful micropipette aspiration. Direct perturbation of the heart can result in a 
hypercontractile state resembling tetanus and activation of stretch-activated channels. Therefore, 
all precautions were taken to not mechanically perturb the heart. All experiments are performed 
within 1 h of microsurgery although hearts were still beating and could maintain rhythmic 
contraction for up to 8 h if supplied with well-oxygenated hemolymph. Microsurgery did not 
influence fractional shortening or heart shortening velocities, an index of relative force production 
(Figure S3.7).  
 
AFM-based nanoindentation  
All indentation was performed with an MFP-3D Bio Atomic Force Microscope (Asylum 
Research) mounted in a Ti-U fluorescent inverted microscope (Nikon Instruments) with 2 μm-
radius borosilicate glass beads mounted on 120 pN/nm silicon nitride cantilevers (Novascan 
Technologies). All probes were calibrated for precise spring constant using the thermal noise 
method. All force curve analyses were performed by automated software custom-written in 
MATLAB (MathWorks) to calculate elastic modulus (in Pascals) of a local region of the 
myocardium within the heart tube as described previously (24). Microsurgery-prepped fly hearts 
were mounted on the AFM stage in a Fluid Cell Lite coverslip holder with 1 ml of oxygenated 
hemolymph. Immediately before indentation, normal rhythmic heart contraction is visually 
confirmed to ensure that tissue was not perturbed by the surgical procedure. The heart is then 
arrested by incubation in hemolymph containing 10 mM EGTA, resulting in chelation of free 
calcium, cessation of beating, relaxation of the heart tube, and opening of the ostia or inflow 
tracts. One-µm2 area “force maps” were obtained with a 4 × 4 grid of indentations and an 
indentation velocity of 1 µm/s. Three “force maps” were obtained per animal, at 0, 15, and 30 µm 
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from the ventral midline. Zero µm is proximal to the intercalated discs whereas 15 and 30 are 
considered ventral to the costameres or cortex.  
Pharmacologically treated hearts were first indented in hemolymph containing EGTA at 
the ventral midline, proximal to the intercalated discs or cell-cell junctions, as well as 30 μm 
distally. Each heart was washed with fresh hemolymph and contractile recovery confirmed. 
Hearts were then incubated in hemolymph containing either 100 μM blebbistatin (Cayman 
Pharmaceuticals) or 100 μM cytochalasin D (Sigma). Indentation was repeated after 60 min. In 
the case of cytochalasin D–treated hearts, EGTA is added to induce a low-Ca2+ state. Contraction 
recovery through UV-inhibition of blebbistatin was confirmed 2 h after initial incubation. Hearts 
were capable of shortening under cytochalasin D treatment for up to 60 min. 
 
Gene expression analysis 
RNA was extracted from whole, beating heart tubes cleared of all non-muscle tissue 
debris using Zymo Research Quick-RNA Microprep Kit. RNA concentration and purity was 
quantified via spectrophotometry. Reverse transcriptase to synthesize first strand cDNA was 
performed from equal quantities of RNA per sample. For quantitative PCR, each reaction was run 
with 1 μl template cDNA, 2.5 μl forward primer, 2.5 μl reverse primer, 6.5 μl DEPC water, and 
12.5 μl SYBR-green intercalating dye for a final reaction volume of 25 μl. One biological replicate 
was considered to be 10 pooled hearts. Each gene was analyzed for at least three biological 
replicates per genotype and age and absolute quantity was calculated by comparison to a 
standard curve. Values are reported as absolute quantity or normalized geriatric/juvenile quantity 
or transgenic/control quantity. The primers were used for Drosophila are listed in Table S3.13. 
 
Drosophila melanogaster RNAi lines 
UAS-transgene fly lines were obtained from the Bloomington Drosophila Stock Center 
(BDSC), Vienna Drosophila RNAi Center (VDRC), or the Fly Stocks of the National Institutes of 
Genetics (NIG): UAS-Vinc gain-of-function line (BDSC stock No. 21870, 17482), UAS-Vinc RNAi 
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(VDRC stock No. 34568), and UAS-MHC RNAi (NIG stock No. 17927R-1). The cardiac tissue–
specific tinHE-Gal4 (tinman heart-enhancer) driver and FM6;Sco/CyO balancer lines were 
generous gifts from Georg Vogler (Sanford-Burnham Medical Research Institute, La Jolla, CA). 
For both RNAi silencing or overexpression/gain-of-function, UAS-transgenic males were crossed 
with virgin female tinHE-Gal4 flies and maintained at 25˚C throughout all life stages. Newly 
eclosed female progeny were isolated into separate vials with identical culture conditions. Food 
was changed every fourth day. All experiments were performed on these females at their 
appropriate age.  
 
Immunofluorescent labeling of the fly heart 
Briefly, ventrally-exposed beating hearts were treated with 10 mM EGTA, then with 3.7% 
paraformaldehyde in hemolymph, and then permeabalized in 0.1% Triton X in PBS (PBST). 
Samples were blocked with 1% ovalbumin in PBST before being incubated in primary antibody 
overnight at 4°C. Samples were then washed and blocked with ovalbumin for 60 min. Heart tubes 
were submersed in secondary antibodies in PBST, washed with PBST and then PBS before 
mounting on 25-mm coverslips with Fluoromount. Fluorescent microscopy was performed on a 
Ti-U fluorescent inverted microscope with CARV2 confocal controller and CoolSnap HQ CCD 
camera.  
 
Fly heart preparation for transmission electron microscopy imaging 
Dissections were performed as described previously (30). Preparation of the heart for 
transmission electron microscopy (TEM) began with microsurgery, as with AFM and 
immunofluorescence. Proper heart contraction was visually confirmed at 60X. Hearts were then 
relaxed with 0.01 M EGTA in artificial hemolymph and washed 3x with PBS. The samples were 
then fixed overnight at 4ºC or on ice in 2 ml of primary fixative (3% formaldehyde, 3% 
glutaraldehyde in 0.1 M cacodylate buffer, pH 7.4). Samples could be stored in primary fixative for 
several weeks.  Once fixed, a wash step was performed 6X for 5 min each with 2 ml 0.1 M KPO4 
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buffer (pH 7.2) on ice. A secondary fix was performed on ice in the dark for 2 h using 2 ml of fresh 
secondary fixative solution (1% OsO4, 100 mM phosphate buffer, and 10 mM MgCl2, pH 6.0).  
Samples were washed 3X for 5 min each with 2 ml H2O. All subsequent steps before 
polymerization were performed at room temperature. After secondary fixation, samples were 
block stained with aqueous 2% uranyl acetate at room temperature, left overnight in the dark, and 
then washed 3X for 5 min each with 2 ml H2O. An acetone dehydration series were then 
performed at 30 min each: 25%, 50%, 75%, 95%, and 3X 100% anhydrous acetone. 
Samples were embedded in fresh Epon plastic mix (16.2 ml EM bed-812 Epon 812 
substitute), 10.0 ml dodecenyl succinic anhydride, 8.9 ml NMA, 0.5-0.7 ml 2,4,6-
Tn(dimethylamino)phenol. Samples were treated with 1:1 Epon mix and 100% anhydrous 
acetone, then 3:1 Epon mix and 100% anhydrous acetone, for 30 min each. Finally, they were 
submerged in 100% Epon mix at room temperature. Samples were oriented and embedded in 
Epon-filled BEEM capsules and polymerized at 60°C for 1 day. Thin sections (40-70 nm) were 
sliced from the embedded samples using a Diatome diamond knife and mounted on grids coated 
with formvar. Each slice was then stained with 2% uranyl acetate for 30 min and Sato’s lead stain 
for 1 min. To make Sato’s lead stain, add 1 g lead nitrate, 1 g lead citrate, 1 g lead acetate, and 2 
g sodium citrate were added to 82 ml distilled H2O and mixed; then, 19 ml of 4% NaOH was 
added. The solution was mixed, filtered through #1 filter paper, and stored in the dark at 4°C. 
Finally, images were obtained at 120 kV on a FEI Tecnai 12 Transmission Electron Microscope.  
 
TEM imaging and analysis 
Measurement of average distance between adjacent thick filaments and interfilament 
spacing was performed with a custom-written MATLAB script (Figure S3.14). For this procedure, 
the original image is first imported into ImageJ in order to remove background to minimize grain 
noise. In order to locate thick and thin filaments, the grey-scale image was inverted such that 
filaments appeared bright on a dark background. A mask was created from the thick filaments by 
thresholding images above a given brightness and within a specified particle range that excludes 
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thin filaments and large, non-filamentous objects. Centroids for each isolated thick filaments were 
recorded and average thick-thick filament distance was calculated by measuring the average 
distance to all adjacent thick filaments for each thick filament. The isolated thick filament image 
was then used as a mask to isolate thin filaments in the original image. A similar algorithm was 
used to isolate thin filaments: thresholding by brightness and object or particle size and then 
calculating centroids. Each thin filament was then associated with its most proximal thick filament. 
For each thick filament, the average distance to all its associated thin filaments was computed 
using a strategy outlined in Figure S3.14. F-test was performed on 480 and 670 thick filaments 
from control and VincHE flies, respectively. 
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Figure S3.1. Software Tool for Rapid Annotation of Proteins (STRAP) analysis of gene 
ontology and biological function for simian and murine proteomes. Proteins were identified 
using mass spectrometry and quantified based on normalized spectral counts (tables S3-S4). (A 
and B) Proteins from simian and murine left ventricles based on gene ontology. (C) Conserved 
murine and simian proteins clustered by ontology (n = 602). (D and E) Proteins from simian and 
murine left ventricles based on biological function. (F) Conserved proteins clustered by biological 
function. Data expressed in parentheses reflect the number of proteins detected for the indicated 
ontological term and its percentage of the total number of proteins detected. GO and biological 
function were assigned by STRAP software allowing multiple ontological terms to be mapped to 
an individual protein. 
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Figure S3.2. Partial interaction map of upstream vinculin regulators. IPA is shown for 
potential interventional or therapeutic proteins and drugs that act on vinculin. Specific vinculin 
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interactions are in bolded blue. 
 
Figure S3.3. Biometric comparison of adult and aged rats. Body weight (BW), heart weight 
(HW), ratio of HW/BW, cardiac output (CO), ratio of CO/BW, and heart rate were all assessed for 
adult and aged rats. Data are individual animals and mean (n = 6 per time point). P-values 
determined using non-parametric t-tests. 
 
  
112 
 
Figure S3.4. Analysis of vinculin localization in rat and fly myocytes. (A) Magnified image of 
24 mo rat tissue labeled for actin, vinculin, connexin 43 (Cnx43), and nuclei. (B) Vinculin channel 
of the merged image in (A). (C) Magnified image the of vinculin channel in (A) with a line plot 
indicating periodic increases in intensity along the length of the green box (open and closed 
arrowheads indicate local peak and minimum intensities, respectively). (D) Cnx43 was used as a 
mask to discriminate vinculin at the ID versus costameres (top). Pixels were separated by 
colocalization analysis algorithm in FIJI, which is based on the Pearson’s colocalization 
coefficient analysis (middle). Total vinculin was separated into Cnx43-localizing (Cnx43+) and all 
else (Cnx43–). Integrated density was computed from each image for each animal and 
normalized to DAPI (bottom). (E) Vinculin and β1-integrin co-localization in Drosophila heart. The 
line plot indicates intensity over the long axis of the blue box (open and closed arrowheads 
indicate local peak and minimum intensities, respectively). Periodicity indicates striations from 
costameric labeling by vinculin and β1. Scale bars in (A to C), 10 μm.
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Figure S3.5. Vinculin structure and homology across monkey, rat, and fly. (A) Cartoon 
structure of vinculin’s head, hinge, and tail domain, with annotations for protein binding to each 
section. (B) Schematic of vinculin activation. (C) Sequence alignment for vinculin for the indicated 
species. Head and tail domains are indicated with arrowheads pointing out the hinge domain. 
Matched and missing amino acids are indicated by gray asterisks and dashes, respectively. 
Mismatched amino acids with close charge or polarity are indicated with gray dots.
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Figure S3.6. Indentation of isolated adult and aged rat cardiomyocytes and intact fly 
hearts.  (A) Bright field image of an AFM cantilever on top of an adult rat 6 month LV myocyte 
plated on type I collagen. (B) AFM cantilever positioned over the cell-cell junction of two rat 
myocytes for indentation of the region containing the intercalated disc. There was poor adhesion 
after 24 h in culture when measurements were made. (C) Stiffness measurements of isolated 
adult and aged rat cardiomyocytes at the indicated positions within the cells. Data are means ± 
SD (n = 10 per age and location). Data were not statistically significant versus each other, as 
assessed by t-tests. (D) Drosophila cardiac stiffness as a function of drug treatment at the midline 
(0 μm) and 30 μm distal to the midline in 5-wk yw flies. Absolute stiffness is plotted with respect to 
the indicated treatment. Data are means ± SD (n = 10 per treatment and location) *P < 0.05, **P 
< 0.01 versus EGTA at the respective distance, one-way repeated measures ANOVA. 
 
 
 
Figure S3.7. Effects of heart tube preparation on its function. Fat or fibrous tissue deposits 
were removed from the top of the Drosophila heart to ensure contact only with muscle. Fractional 
shortening and wall velocities were measured before and after the extensive cleaning performed 
on intact hearts. Data are means ± SD (n = 10). N.S., no statistical difference determined by 
paired t-tests.
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Figure S3.8. Characterization of diastolic diameter, cardiac stiffness, and vinculin 
expression in the white-Canton S Drosophila genotype. Age-associated decline in diastolic 
diameter (A) and cortical stiffening (B) for white-Canton S (wCS) flies of indicated age. Data are 
means ± SEM (n > 15 per age). *P < 0.05, **P < 0.01, one-way ANOVA. (C) Vinculin expression 
as a function of age in three different Drosophila genotypes. Data are means normalized to 1-wk 
wCS ± SEM (n = 3 biological replicates with 10 pooled hearts). P-values determined using one-
way ANOVA. (D and E) Shortening velocity and lengthening velocity were not significantly 
reduced in unloaded conditions. Data are means ± SEM (n > 20). Hill’s fit is shown for shortening 
velocity. Log-fit is shown for lengthening velocity for illustrative purposes.  *P < 0.05 and ***P < 
0.001, where asterisks to the left and right indicate P-values from two-way ANOVA for difference 
in velocity between viscosity and age, respectively (e.g. ***/* indicates P < 0.001 for reduction in 
velocities as a function of load, and P < 0.05 for difference in velocity profile between wCS 1- and 
5-wk.
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Figure S3.9. Fitting shortening velocities with Hill’s muscle model. (A and B) Least-squares 
fit to Hill’s muscle for shortening velocity (A) and relative power output (B) as a function of relative 
viscosity for 1- and 5-wk wild-type flies and 1-wk cardiac-specific mutant flies (VincHE, VincKD, 
MhcKD, and MhcKD+VincHE). Relative power output was normalized to 1-wk w1118 (left panels) 
and 1-wk Control (right panels). 
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Figure S3.10. Generation of the UAS-Mhc RNAi;UAS-Vinc line. The illustration outlines the 
series of crosses that were performed in order to create a line that was homozygous for both 
UAS-MHC RNAi (on chromosome II) and UAS-Vinc (on the autosomal/X chromosome). 
FM6/Y;Sco/CyO (X;II) was used as a balancer (FM6 on X and Sco or CyO on II). Progeny from 
each cross that were selected for breeding are shown in bold. 
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Figure S3.11. Quantification of genetic perturbations in Drosophila hearts.  (A) 
Overexpression of Vinculin in 1-wk VincHE and MhcKD+VincHE as well as knockdown in 1-wk 
VincKD flies. (B) Myosin heavy chain (MHC) knockdown in MhcKD and MhcKD+VincHE by heart-
specific qPCR. Data are means ± SD (n = 3 biological replicates with 10 pooled hearts). Data are 
absolute quantities of transcript normalized to control (1-wk female progeny of tinHE-Gal4 × 
w1118). *P < 0.05 compared to control, one-way ANOVA. 
 
 
Figure S3.12. Change in VincHE stiffness with cytoskeletal perturbation. Average stiffness is 
shown per drug treatment at the midline (0 μm) and 30 μm distal to the midline in VincHE flies. 
Average stiffness ± SD (n = 10) is plotted with respect to the indicated blebbistatin or cytochalasin 
D treatment for 30-60 min. *P < 0.05 versus EGTA-treatment at respective location, one-way 
ANOVA. 
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Figure S3.13. Transgenic fly heart rate, period, and rate variance. (A) Heart rate in beats per 
minute (bpm). (B) Heart period, the time taken for systole and diastole, in s. (C) The normalized 
heart period variance, an index of rhythmicity (greater variance indicates impaired rhythmicity). 
Data are means ± SEM (n > 29), for all Drosophila transgenic genotypes in Fig. 6. Indices did not 
differ between VincHE and control (P > 0.05, comparing each metric as a function of load using 
two-way ANOVA). Log-fits shown for illustrative purposes.  
 
 
Figure S3.14. Analysis of interfilament spacing in TEM images from the Drosophila heart. 
Custom-written particle-tracking algorithms were used to process TEM images of the cardiac 
myofilaments in cross-section. (A) Thick-thick interfilament spacing (R) was reported as the 
average distance between the centroid of each thick filament and the centroid its nearest thick 
filament neighbors. (B) Thick-thin interfilament spacing (r) was reported as the average distance 
between each thick filament centroid and the centroids of its nearest thin filament neighbors. (C) 
Micrographs were processed to subtract background noise, isolate thick and thin filaments based 
on size, and then have centroids calculated and highlighted.
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Table S3.1. Peptides in adult and aged rhesus monkey left ventricles. Peptides, including 
those that were modified, were detected by mass spectrometry in adult and aged samples of left 
ventricles of Macaca mulatta. Data include each peptide’s spectral count, the protein ID to which 
the peptide was mapped, and a description of that protein. Peptide charge, observed and 
calculated mass (and its difference), and the probability that the predicted peptide is correct are 
also listed. Data represent total peptides detected over all samples (n = 9). Protein annotations 
were made with Ingenuity Pathway Analysis (IPA). Data and materials availability: Proteomic data 
are available via the PRoteomics IDEntifications (PRIDE) database at accession numbers 
PXD001839 (rat) and PXD001842 (simian). 
Table S3.2. Peptides detected in adult and aged rat left ventricles. Peptides, including those 
that were modified, were detected as described in the Extended Methods for adult and aged 
samples of left ventricles of Rattus norvegicus and are listed here. Data include each peptide’s 
spectral count, the protein ID to which the peptide was mapped, and a description of that protein. 
Peptide charge, observed and calculated mass (and its difference), and the probability that the 
predicted peptide is correct are also listed. Data represent total peptides detected over all 
samples (n = 12). Protein annotations were made with IPA. Data and materials availability: 
Proteomic data are available via the PRoteomics IDEntifications (PRIDE) database at accession 
numbers PXD001839 (rat) and PXD001842 (simian). 
Table S3.3. Proteomic analysis for adult and aged rhesus monkey left ventricles. Total 
spectral counts were assessed for adult (n = 4) and aged (n = 5) left ventricle samples. Protein 
group IDs and descriptions of M. mulatta were obtained by Software Tool for Rapid Annotation of 
Proteins (STRAP) and provided alongside peptide probability assessments. Aged/adult ratio of 
spectral counts is shown and was used in subsequent IPA. #Proteins only expressed in the aged 
population. Table analysis available online at https://stm.sciencemag.org/7/292/292ra99 
Table S3.4. Proteomic analysis for adult and aged rat left ventricles. Total spectral counts 
were assessed as described in the Extended Methods for adult (n = 6) and aged (n = 6) samples 
of left ventricle. Protein group IDs and descriptions of R. norvegicus were obtained by STRAP 
and fit to data and probability assessments provided. Aged/adult ratio of spectral counts is shown 
and used in subsequent IPA. #Proteins expressed only in the aged population. Data and materials 
availability: Proteomic data are available via the PRoteomics IDEntifications (PRIDE) database at 
accession numbers PXD001839 (rat) and PXD001842 (simian). Table analysis also available 
online at https://stm.sciencemag.org/7/292/292ra99  
Table S3.5. STRAP annotation of the cellular compartments of the proteins detected in 
both rat and monkey proteomes. Analysis of 602 proteins conserved in the left ventricles 
across all species and ages, and the cellular compartments that map to those proteins. Note that 
multiple ontologies, as obtained by STRAP, exist per protein. Proteins may have additional, 
undiscovered ontological functions. Data and materials availability: Proteomic data are available 
via the PRoteomics IDEntifications (PRIDE) database at accession numbers PXD001839 (rat) 
and PXD001842 (simian). Strap annotation in table form available online at 
https://stm.sciencemag.org/7/292/292ra99 
Table S3.6. STRAP annotation of biological functions for rat and monkey. Analysis of 602 
proteins conserved in the left ventricles across all species and ages and the biological function 
ontologies, obtained by STRAP, that map to those proteins. Note that multiple ontologies exist 
per protein. Strap annotation available in table form at https://stm.sciencemag.org/7/292/292ra99  
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Table S3.7. IPA of bio-function expression for rat. Most well-represented IPA Bio-functions (P 
< 0.05) from comparative analysis of adult and aged rat left ventricles for intercalated disc, 
sarcomeric, and costameric genes. Significance computed by IPA is listed as –log(p-value) or a 
value of ≥1.3. Cardiovascular-related functions are indicated in bold. Vinculin is shown in italics 
and underlined. Table analysis available online at https://stm.sciencemag.org/7/292/292ra99 
Table S3.8. IPA of tox-function expression for rat. Most well-represented IPA Tox-functions (P 
< 0.05) from comparative analysis of adult and aged rat left ventricles for intercalated disc, 
sarcomeric, and costameric genes. Significance computed by IPA is listed as –log(p-value) or a 
value of ≥ 1.3. Cardiovascular-related functions are indicated in bold. Vinculin is shown in italics 
and underlined. . Table analysis available online at https://stm.sciencemag.org/7/292/292ra99 
Table S3.9. IPA and OMIM annotation of age-upregulated proteins associated with cardiac 
function. Proteins that were upregulated with age, including vinculin, are annotated. Annotations 
(for instance, cytogenetic location in Homo sapiens, or associated cardiomyopathies) were 
obtained from Online Mendelian Inheritance in Man (OMIM). The table included here only shows 
proteins with normalized count > 1 and whose mutation is associated with cardiomyopathy in 
humans based on OMIM classification. A complete set of proteins can be found in Supplementary 
Excel file “Table S9.” # denotes proteins expressed only in the aged population. 
 
Table S3.10. IPA of upstream regulators of age-related proteins identified in rat and simian.  
Database of upstream regulators (chemical, kinases, enzymes, transporters, transcriptional 
regulators, miRNAs) and their associated proteins identified in the aging proteomic analysis of 
monkeys and rats. Note that upstream regulators and associated proteins or pharmacological 
agents that affect expression are limited to annotations in the databases listed. Database tables 
available online at at https://stm.sciencemag.org/7/292/292ra99  
 
Protein group description 
(Species: Homo sapiens) Gene symbol 
Normalized count 
(aged/adult) 
Nexilin  NEXN # 
BAG family molecular chaperone regulator 3  BAG3 3.33 
d-Sarcoglycan  SGCD 2 
Dystrophin  DMD 1.5 
Desmoplakin  DSP 1.38 
Telethonin  TCAP 1.33 
α-Actinin-2  ACTN2 1.32 
Troponin C, cardiac  TNNC1 1.32 
Vinculin  VCL 1.32 
Tropomyosin α-1 chain  TPM1 1.31 
Myosin-7  MYH7 1.29 
Myosin light chain MYL3 1.26 
Laminin α-4  LAMA4 1.25 
Titin  TTN 1.22 
Caveolin-3  CAV3 1.2 
Cysteine and glycine-rich protein 3  CSRP3 1.2 
LIM domain-binding protein 3  LDB3 1.2 
Myosin binding protein C, cardiac MYBPC3 1.18 
Troponin T, cardiac  TNNT2 1.15 
Troponin I, cardiac  TNNI3 1.14 
αβ crystallin  CRYAB 1.13 
Myosin regulatory light chain 2  MYL2 1.1 
Myozenin-2  MYOZ2 1.05 
Succinate dehydrogenase flavoprotein subunit  SDHA 1.01 	
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Table S3.12. Fitting shortening velocities with Hill’s muscle model. Coefficients for the Hill’s 
muscle model equation for each genotype or age. Fit was applied to the average value of 
shortening velocity over all loads within each group. 
Coeff yw 1wk yw 5wk w 1wk w 5wk   
a 20.34567095 
8.9868996
77 
21.899865
5 
11.845778
96   
b 1.51E-02 
0.0059025
68 
0.0229840
16 
0.0602608
49   
c 5.55E+05 
673879.59
51 
389417.84
79 
47560.841
51   
v0 (µm/s) 411.40 442.60 408.70 241.95   
Hill Muscle 
Equation 
(v+b)(F+a) = 
b(c+a)         
  v0 = bc/a         
            
Coeff Control VincHE VincKD MhcKD 
MhcKD+Vinc
HE 
a 16.7506 22.9292 17.5898 9.224 19.1638 
b 1.17E-02 1.21E-02 9.30E-03 5.10E-03 8.50E-03 
c 5.85E+05 1.01E+06 7.38E+05 5.15E+05 1.04E+06 
v0 (µm/s) 408.45 535.42 390.40 284.47 460.93 
residual for fit           
Hill Muscle 
Equation 
(v+b)(F+a) = 
b(c+a)         
  v0 = bc/a         
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Table S3.13. Quantitative-PCR primers. Drosophila primers used for qPCR measurements of 
heart tube. Primers were designed by NCBI Primer Blast against sequences found on FlyBase. 
Note that the FN1 gene is used to generate a standard curve based on a human fibronectin 
plasmid. 
Gene	
Name	
Annota
tion	Symbol	 Forward	Seq	(5’-3’)	 Rev	Seq	(5’-3’)	
FN1	 N/A	 AGG	CTT	GAA	CCA	ACC	TAC	GGA	
GCC	TAA	GCA	CTG	
GCA	CAA	CAG	
Vinc	 CG3299	
AGTGGCTAATCTCGTGA
AGGTG	
CGTCGGAGCTGTTGAT
CGTA	
Mhc	 CG17927	
TCTGCGTTGCCATCAATC
CT	
TTCTCAGTCTTTCCGGC
ACC	
E-
cad/Shotgun	
CG372
2	
TGGACGGCACCTCAGCC
AATA	
GCGAATTGTCGCTGGC
AATAA	
aCat	 CG17947	
CTGCATTGATGGCGGGA
TGCAG	
TGCCTTCTTAGGTCGC
GAGTC	
Vav	 CG7893	
GTCGCCAGTCACAGCAA
CAAC	
TGGCACAAATTCGAGC
AG	
aCat-
rel	
CG298
7	
AAGTTCGTGTTGTTCAC
CATG	
ACAACAACTCCGACGC
CTACT	
Slow	 CG7447	
TGATTTATTCGCGCGTG
TTTC	
TGACCCAGCCAGTGTT
CAGAG	
Innex
in3	
CG144
8	
AAGATCCGCATGATCAC
CGAT	
AGTATGCGAACGAGTA
CCCGT	
B1	
int/mys	
CG156
0	
AAACACTGCGAGTGCGA
CAAC	
ACATGTATCGTTGGAC
TCCTG	
Rols	 CG32096	
TAATCGCCACCACGAGG
ATCA	
ATCAATGTGTTCCAGA
TTGCC	
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Preface to Chapter 4 
Chapter 4 is a manuscript in progress that identifies systemic mechanisms which cardiac-
restricted over-expression of Vinculin confer on flies, but which could be conserved across model 
organisms that maintain Vinculin expression with age. Despite previously observed conservation 
of this cellular mechanism, this chapter focuses solely on the increased cardiac contractility 
observed in Drosophila melanogaster when Vinculin is upregulated in the heart (VincHE), which 
was established in chapter 3. Changes in cellular energetics and metabolism are first investigated 
in the heart. Then systemic effects of increased heart contractility and perfusion are investigated 
first through healthspan analysis using functional activity assays and secondly through metabolic 
profiling of whole flies.  
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Abstract 
Despite their limited regenerative capacity, cardiomyocytes may maintain their function 
through compensatory mechanisms as we age, e.g. Vinculin reinforcement of the intercalated 
discs and costameres in aged organisms. This molecular mechanism, which is conserved from 
flies to non-human primates, helps sustain the sarcomere lattice structure and maintain 
cardiomyocyte function. Cardiac-specific Vinculin over-expression in Drosophila melanogaster 
can extend lifespan up to 150%, but systemic connections between changes in the cytoskeletal 
structure and mechanisms that extend lifespan are not apparent. We found that by prolonging 
heart function, the local and systemic energy requirements are dramatically altered; increased 
heart contractility resulted in sustained O2 consumption with age but without localized metabolic 
changes in cardiomyocytes. However, systemic changes from increased cardiac function 
improved physical activity levels as well as energy metabolism in Drosophila. This work is the first 
to identify systemic metabolic improvements from a cytoskeletal perturbation in cardiomyocytes 
that result in extended organismal lifespan, suggesting that age-related cardiac cytoskeletal 
remodeling confers systemic benefits through altering energy metabolism. 
 
  
136 
Introduction 
Aging is a complex process associated with the progressive decline of physiological 
function and is a significant risk factor for cardiovascular disease (CVD); as human lifespan 
increases, CVD risk also increases (1). With age, the heart undergoes extensive changes 
involving decreased elasticity and contractile compliance due to both intra- and extracellular 
changes (2-4). These changes, typically referred to as “remodeling”, reinforce organ structure 
under increasing systolic pressure and afterload associated with aging (5, 6). With age they can 
result into left ventricular wall thickening resulting impaired myocardial performance (7, 8). 
However on a cellular level, compensatory mechanisms involving the sarcomere, cytoskeleton, 
and sarcolemma must aid the cardiomyocytes in managing the increased stress and strain 
associated with aging. We have identified one such mechanism where Vinculin-mediated 
cytoskeletal reinforcement of the intercalated disc (ID) and costamere improves force production 
and myofibril geometry (9). Vinculin is a critical ID linker protein involved in sensing and 
translating sarcomeric contraction into cell shortening. In aged patients with heart failure, vinculin 
undergoes extensive remodeling (10, 11) that is reversed when the heart is unloaded (12, 13); 
these data demonstrate the importance of Vinculin in the cell’s ability to sense and respond to 
pressure and volume overload properly, especially in aged myocytes. Using a multi-model 
approach, we identified that cardiac Vinculin upregulation with age is a conserved mechanism 
across non-human primate, rat, and fly models independent of cardiovascular disease. Further 
interrogation in Drosophila melanogaster, the fruit fly, using cardiac specific overexpression of 
Vinculin (VincHE) revealed increased Vinculin recruitment to both the ID and costamere, which 
led to an improvement in contractility via longitudinal increases in force production, lateral 
increases in myofibrillar anchoring, and improved lattice geometry. Under significant load, 
Vinculin upregulation preserved contractility (9), suggesting Vinculin upregulation is a conserved 
mechanism to counterbalance age-associated stress. In addition to these tissue specific 
enhancements, a significant increase in organismal lifespan was observed in these flies, 
suggesting systemic effects resulting from increased contractility. 
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Despite these observations, the exact mechanism connecting cytoskeletal structure 
perturbations and longevity are unclear. Both Drosophila and C. elegans models have been used 
in recent years to screen for genes associated with regulating lifespan (14, 15). However, these 
early screens focus on genome wide differences rather than tissue specific changes that could 
regulate systemic affects; changes to integral organs such as the heart, implicated in the delivery 
of exogenous factors, nutrients, and O2 have yet to clearly describe the mechanisms behind these 
correlations. The implication that maintaining or enhancing the cytoskeleton and/or sarcomeres 
can extend lifespan is not only restricted to Vinculin but also documented in Drosophila for 
heterozygous b1-integrin and Integrin Linked Kinase mutants (16). These studies suggest a more 
general paradigm that cardiac cytoskeleton changes can have significant systemic effects.  
Of the systemic changes that could be influenced by cardiac output, metabolism is one 
function that directly impacts lifespan. Early work in Drosophila noted a link between temperature-
induced decrease in metabolism and a significant increase in lifespan (17). In addition, metabolic 
profiling of long-lived Drosophila established clear differences in metabolite composition at all 
ages of longevity selected flies compared to age matched controls (18); this mirrors similar data 
in C. elegans (19) and mice (20). Diet restriction studies in Drosophila (21) and mice (20) provide 
another link between organismal metabolism and longevity, suggesting not only that diet 
restriction causes increased lifespan, but that it was diet restriction slowing the changes to the 
metabolome of flies with age that conferred these systemic benefits. However, these findings 
largely focus on identifying metabolomic biomarkers of aging and longevity as opposed to how 
local organ changes in specific organs, e.g. improved cardiac function from a more robust 
sarcomere, could ultimately skew organismal metabolism. Since the heart requires a continuous 
supply of energy to function and stores a minimal amount locally, any changes in contractility and 
demand for energy, either local or systemic, will cause significant changes in energy homeostasis 
and metabolism. Improving heart physiology could alter systemic delivery of nutrients thus having 
a significant impact on healthspan and activity levels in advanced age. The recent development 
of assays to measure fly behavior and relative activity (22, 23) has allowed us to address the idea 
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of healthspan with age. These functional assays allow assessment of flies given a certain genetic 
modification, diet, or environmental factors to determine any functional benefits with aging. It is 
important to note that not all modifications that improve lifespan correlate with increased 
functional capacity with age (24), and not all modification that’s result in functional benefits 
improve lifespan (25). We hypothesize that the increased contractile capacity in the hearts of the 
VincHE flies increases metabolic efficiency and respiration to increase organismal fitness with 
age, thereby also improving longevity.  
We have found that a cardiac specific increase in Vinculin expression and resultant 
contractility helps sustain cardiac respiration with age, without changing localized metabolite 
levels. The increases in function and respiration with age compared to controls significantly alter 
the metabolome of the VincHE flies with age and increase their healthspan. This work for the first 
time establishes a link between cardiomyocyte cytoskeletal remodeling and systemic metabolism 
and function. 
 
Results 
Increased Vinculin expression improves contractility and sustains cardiac respriration 
with age without affecting localized metabolism 
When Drosophila melanogaster are genetically modified to overexpress Vinculin in their 
hearts via cardiac-specific tinHE-Gal4 driver (tinman heart enhancer) in conjunction with UAS-
inducible Vinculin [Vinculin heart-enhanced (VincHE)], those hearts experience a basal increase 
in myocardial shortening velocities, increased velocities under heavy load (Figure 4.1A), and a 
less severe load dependent decline in fractional shortening (Figure 4.1B) by increasing the 
crystallinity of the sarcomere lattice (9). Since this has been postulated to change the contractile 
efficiency (26), we determined whether VincHE flies had altered myocyte bioenergetics. Oxygen 
consumption rate [OCR] scaled with number of hearts assayed, though we obtained sufficient 
signal with a single heart, allowing us to measure fly-to-fly variation (Figure S4.1). VincHE and 
control hearts were also allowed to either freely contract or secured to prevent active contraction 
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to assess metabolic differences as a result of active contraction. VincHE hearts sustained OCR 
with age, both for active contraction and basal OCR, e.g. non-contracting hearts predominantly 
respiring via mitochondria without the added ATP demand due to contraction. However, control 
flies lacking this over-expression experienced declines in both metrics with age, which by 7 
weeks of age were nearly identical (Figure 4.1C). These data suggest that preserved myofibril 
lattice order (9) may not only sustain cardiac O2 respiration with age but also reduce background 
mitochondrial respiration. These data are consistent with the observation that 
pharmachologically-mediated improvements in mitochondrial respiration lead to improved cardiac 
function in mice with heart failure (27). 
 
Figure 4.1. Increased Contraction in VincHE Hearts Leads to Sustained Oxygen 
Consumption with Age. (A) Heart wall shortening (contraction) velocities were assessed with 
and without viscous loading for VincHE, green, and controls, black. (B) Fractional shortening 
were measured under 1 and 20 relative viscous load for each genotype indicated. (C) Maximal 
respiration, oxygen consumption rate (OCR), in pMole/min due to contraction of VincHE and 
control hearts were measured by Seahorse XF24 extracellular flux analyzer at the given ages. 
Basal measurements, diagonal slashes, were reported as OCR of non-contractile heart tubes, 
OCR not due to contraction, overlaid with the OCR of heart tubes actively contracting until the 
addition of rotenone and antimycin effectively killing mitochondrial activity in all cells. Data 
represented as mean ± SEM. 12<n<20 for all samples. *p< 0.05. 
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Sustained cardiac respiration with age likely has a local effect on cardiac metabolism, 
hence we performed an in situ cardiac stress test with hemolymph containing [U-13C6]glucose to 
track glucose metabolism. Hearts incubated in hemolymph with [U-13C6]glucose tracer and 10% 
w/v Ficoll to create viscous load for 2 hours adequately enriched downstream metabolites (Figure 
S4.2) while not exceeding a timeframe that would result in arrested contraction in adult and aged 
flies under viscous load (Figure S4.3). However, when measured by gas chromatography/mass 
spectrometry (GC/MS)-based profiling, metabolite abundances revealed no significant differences 
in metabolite levels between genotype or with age (Figure 4.2A); minimal [U-13C6]glucose labeling 
was detected and no significant differences could be measured in any labeling (1-M0) from TCA 
cycle intermediates (Figure 4.2B). The lack of cardiac metabolic changes suggests that the 
increase in energy expenditure, caused by Vinculin-mediated increase in cardiac contractility and 
respiration with age, must be due in part to some inter-organ communication and systemic 
changes.   
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Figure 4.2. Heart Specific [U13C]glucose Targeted Metabolic Profiling Identifies No 
Significant Differences Between Genotypes or With Age. (A) Gas Chromatography Coupled 
to Mass Spectrometry (GC/MS) measurements were made of 4 pooled biological replicates of 
VincHE and controls at 1, 5, and 7 weeks [only for VincHE] for metabolites in 4 categories: amino 
acids, TCA cycle intermediates, sugars, and other after incubating in [U13C]glucose tracer. Each 
metabolite detected was normalized to its maximal abundance detected across all samples and 
ages and displayed as a heat-map of relative expression. No significant differences between 
genotype or age could be detected. (B) Relative labeling of any carbons (1 being 100% labeled) 
shown for the 4 TCA cycle intermediates for given genotypes and ages. Data not significant. n=4 
of 30 pooled hearts for each biological replicate. 
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Increased organismal fitness and systemic metabolic efficiency observed in VincHE flies 
Age-related behavioral declines are hallmarks of organismal aging (25, 28, 29). Given 
prolonged cardiac function and respiration (Figure 4.1) (9) but lack metabolic changes in the 
VincHE fly hearts (Figure 4.2), it is not clear how these changes will affect organismal aging. 
Thus, we next assessed fly physical activity via a rapid iterative negative geotaxis (RING) assay, 
which utilizes the natural climbing response in flies and which declines with age in Drosophila (22, 
23). When tracked over their lifespan and as a function of genotype, VincHE flies exhibited 
increased climbing ability between the ages of 3-8 weeks compared to controls (Figure 4.3A) until 
the median lifespan was surpassed (Figure 4.3B). RING assay and lifespan analyses of our 
laboratory controls and controls created using tinman-Gal4 virgins crossed with w1118 males from 
another lab confirmed the fidelity of our functional and lifespan assays Figure S4.4). Since forced 
iterations of climbing using the RING assay would require significant increase in energy demand, 
these data show that the VincHE flies possess an increased organismal fitness over the majority 
of their increased lifespan when compared to controls. This suggests that cardiac overexpression 
of Vinculin not only confers local cardiac benefits but also that it increases activity in aged 
organisms. These improvements occur despite a lack of observable metabolic changes in hearts 
with increased Vinculin expression. 
 
Figure 4.3. VincHE Increased Climbing Ability with Age Correlates with Significant 
Increases in Lifespan. (A) Rapid Iterative Negative Geotaxis (RING) Assay described in detail in 
the methods was performed weekly over the entire lifespan of each genotype and the climbing 
distance over an interval of 5 seconds was recorded for each fly. n=250 at the start of the 
experiment. Data represent mean ± SEM. All negative geotaxis data were analyzed with 2-way-
ANOVA with pot hoc Bonferroni test. *** p< 0.001. (B) Survival curves for VincHE and controls in 
the RING assay show median survival indicated by the dashed black line for each genotype. 
***p<0.0001 
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We next employed untargeted (GC/MS)-based profiling of metabolites in whole flies to 
determine what if any affect increased organismal fitness at advanced age from improved cardiac 
performance could have on systemic metabolism. Of 280 unique metabolites we identified 61 
distinct metabolites. Principal component analysis (PCA) revealed differential clustering of 
metabolite expression as a function of both genotype and age (Figure 4.4A), signifying significant 
systemic metabolite differences as a result of Vinculin overexpression in the heart. Further 
metabolite ontological clustering into amino acids, carboxylic acids, fatty acids, nucleosides, 
other, sugar alcohols, sugars, and TCA cycle intermediates showed significant accumulation of 
most identified metabolites in aged VincHE flies compared to controls (Figure 4.4B). Specific 
clusters including six-carbon sugars had preferential accumulation even in moderately aged 
VincHE flies (Figure S4.5A-D), which corresponds to data suggesting glucose accumulation in 
longevity selected flies (18). More complex 18-carbon sugars, e.g. melezitose, are known to 
reduce osmotic stress in insects and prolong lifespan in Drosophila (30), and we also noted a 
significant accumulation of it in aged VincHE flies (Figure S4.5E). Amino acid balance is thought 
to play an important role in diet restriction-mediated extension in lifespan in flies (31) and in TOR 
pathway activation (32); we found the amino acid metabolite cluster to be significantly increased 
with age in VincHE flies (Figure 4.4B). Homoserine, an intermediate of methionine, threonine, and 
isoleucine, exhibited significant accumulation in VincHE at 11 weeks (Figure S4.6A), which could 
reduce downstream methionine availability; methionine restriction extends lifespan in mouse, rat, 
and fly (33-35). Conversely, additional lysine has been implicated in increased Drosophila 
longevity (18), and as with longevity selected flies, VincHE flies exhibit increased levels of lysine 
with age (Figure S4.6B). Accumulation of tricarboxylic acids (TCA) metabolites was also 
observed in aged VincHE flies (Figure S4.7), which corresponds to evidence that accumulation of 
TCA cycle intermediates supports lifespan extension in C. elegans (36). These data show a 
strong correlation between accumulation or efficiency of sugar utilization, amino acids, and TCA 
cycle components and increased lifespan and healthspan. This suggests, for the first time, that 
Vinculin-mediated lifespan extension could occur not just solely from heart-specific improvements 
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in performance but also from systemic metabolic benefits resulting from maintaining cardiac 
output with age.  
 
Figure 4.4. Whole Fly GC/MS Metabolic Profiling Revels Significant Differences in 
Metabolite Accumulation Between All Genotypes and Ages. (A) Principal component analysis 
of biological replicates scaling expression values across genotype and age is plotted for given 
genotypes and ages. (B) Heat-map visualization of changes in the 61 metabolites detected in 
whole fly GC/MS normalized to maximal intensity detected across samples and scaled on an 
expression scale of 1-12 for each genotype and age specified. Metabolites were sorted by 
ontology and color coded to the left with colors and associated ontology specified at the bottom. 
n=4. 
 
Discussion 
The results of this study demonstrate that fly heart-specific Vinculin over-expression 
increases contractility and results in sustained cardiac respiration with age without any local 
changes to metabolites. However, these cardiac benefits, even in aged VincHE cohorts, result in 
a significant increase in organismal fitness with age and extreme changes to the metabolome of 
VincHE flies versus aged matched controls. Specifically, GC/MS revealed significant 
accumulation of most metabolites in VincHE flies with age, suggesting more efficient use. These 
findings are the first to document a systemic metabolic response resulting from cardiac-restricted 
cytoskeletal remodeling, and despite this specificity, our perturbation led to similar organismal 
metabolite accumulation changes observed in other longevity selected organisms.  
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Organismal Fitness Decline Slowed with Increased Cardiac Expression of Vinculin 
Maintaining cardiac function with age resulted in not just lifespan extension but also an 
improvement in healthspan, e.g. measures of fitness with age including movement and skeletal 
muscle. Not only does heart function decline with age in Drosophila (37, 38) and higher 
organisms (39, 40) but skeletal muscle also undergoes significant decreases in mass and 
function with age, i.e. Sarcopenia (41, 42). We employed a climbing assay utilizing flies’ inherent 
negative geotaxis response to quantify the fitness of VincHE flies with age, and found significant 
increases in climbing ability over most their increased lifespan compared to controls. While such 
assays assess a multitude of behaviors such as locomotor function, climbing ability, and escape 
reflex, they offer significant information on age-dependent decline in locomotion (22, 43), which 
can elucidate changes in organismal health with age. Our data show that not only did cardiac-
restricted Vinculin over-expression result in increased climbing ability, but it also correlated with 
an increase in lifespan. Compared to our cytoskeletal perturbation, other studies only see 
improvement in functional capacity (24) or aging (25), but not both, suggesting that further 
interrogation of VincHE organismal fitness may be in order to clarify additional benefits these flies 
have, e.g. in other skeletal muscles with high metabolic demand such as the flight muscles. One 
such example would be to assess continuous exercise/taxing of flies’ fitness, such as the 
treadwheel (44), rather than startle induced climbing. While the difference may be subtle, 
assessing voluntary vs. involuntary responses could help further distinguish the specific health 
benefits of improved cardiac function with age experience in VincHE flies. 
 
Cardiac specific Vinculin Upregulation Correlates with Metabolite Accumulation Similar 
to Metabolic profiling of Long-lived Organisms 
The link between cardiac transcriptional changes and systemic metabolic homeostasis 
has been made in recent years (45); upregulation of Vinculin in the heart improves the 
mechanical function of individual cardiomyocytes as well as the whole organ eliciting a different 
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reason for systemic changes in metabolism: an increase in cardiac output and perfusion of 
peripheral tissues. We have previously demonstrated that VincHE hearts experience an increase 
in power production and increased crystallinity of myofibrils anchored at their Z-discs. We 
hypothesized this was a result of increased Vinculin reinforcement at the ID and costamere, 
respectively. This increase in speed of contraction and proposed increase in probability of actin-
myosin cross-bridge formation (actively cycling motors) (9, 46) could significantly impact cardiac 
respiration. Seahorse analysis, which assess cellular bioenergetics and O2 flux, showed 
increased OCR due to active contraction in VincHE hearts and sustained OCR with age. In 
addition, the cardiac viscos load assay showed the increased ability of these hearts to move load, 
which demonstrated that the VincHE hearts have increased contractile velocity with elevated 
afterload (9). If tissue perfusion is a measure of heart rate and stroke volume with stroke volume 
being dependent on preload, afterload, and contractility (47), VincHE hearts should have 
increased and sustained perfusion with age as suggested by OCR measurements.  
While targeted [U13C6]glucose experiments employed to detect localized changes in 
cardiac metabolism provided little evidence of measurable changes, untargeted whole fly GC/MS 
revealed significant accumulation of metabolites in all ontological clusters with age in VincHE 
flies. Specifically increased hexose levels found in VincHE flies mirrors metabolic profiling on 
longevity selected flies (18) and these data with the increase in fitness observed provide a strong 
correlation between sugar accumulation or efficiency of sugar utilization and increased lifespan 
and healthspan in Drosophila. Another sugar, melezitose, known to reduce osmotic stress in 
insects by reducing water potential (30), was highlighted in this study as significantly accumulated 
in VincHE flies and has been linked life extension in insects (48), but has little translational 
relevance, unfortunately. 
One common link between metabolism and lifespan across models is diet restriction (49-
51), but the specific mechanisms behind this have yet to be comprehensively understood, e.g. 
caloric restriction versus restriction of specific components such as proteins (24, 31). It has been 
widely noted that the restriction of diet in general, and of amino acids in particular to modulate 
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lifespan (31, 51). VincHE flies exhibited significant accumulation of amino acids, and specifically 
in Homoserine and Lysine. Homoserine is a precursor for methionine and it is well documented 
that methionine restriction extends lifespan in several model organisms (33-35). Methionine 
metabolism affects the downstream synthesis of polyamines, cysteine and glutathione, the 
methylation of DNA, lipids, hormones, and enzyme substrates, so its accumulation in VincHE flies 
could have significant impact on any of these downstream pathways. However, the impact on 
humans remains less well studied. If methionine restriction confers such drastic benefits from flies 
to rats, could it benefit humans in the same manner? Foods high in methionine are protein rich; 
those low in methionine would also be low in protein, mostly plant based. Simply limiting intake of 
proteins may not be practical to general health. More recent work has elicited the specific 
pathway within the methionine metabolism cycle that confers the benefits of methionine 
restriction: the transsulfation pathway that produces hydrogen sulfide (H2S) gas (52). Further 
examination of this pathway and its relation to cardiovascular improvements is needed to identify 
if accumulation of homoserine in VincHE flies would mean less utilization of methionine 
downstream and overall decreased methionine metabolism in these flies. Future studies using 
Methionine-2-13C added to Drosophila food in combination with food consumption tracking could 
further clarify the means for Homoserine accumulation, i.e. how methionine is being utilized 
downstream. In addition, methionine restriction studies could be performed on the controls used 
in this study to see if some rescue of lifespan could be obtained to mimic VincHE flies.  
While the heart specific targeted [U13C6]glucose profiling did not indicate specific trands 
in substrate utilization, future work incorporating this targeted tracing in whole flies is necessary to 
identify the specific pathways that are metabolizing glucose in these flies. Labeling of specific 
carbons in TCA cycle intermediates, for example, can differentiate which pathway was prioritized 
to incorporate glucose metabolism. This can give significant information for future studies, and for 
tissue specific metabolism. For example, the heart uses fatty acids for ATP production under 
normal circumstances, but in times of stress, will switch to fast glucose metabolism for ATP 
production (53). The ability to distinguish between these pathways will provide specific 
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mechanisms by which genetic perturbations affect energy metabolism and homeostasis. In 
addition to metabolic analyses, whole fly oxygen consumption could be assessed as previously 
measured in Drosophila (54) in order to give indications of oxidative phosphorylation and flux 
through the TCA cycle, since ATP production from glucose in much less oxygen consuming than 
from fatty acids. These measurements may provide significant insight into how a better 
functioning heart can affect whole organism energy homeostasis and fitness. 
Our whole fly metabolic profiling suggest that both age, consistent with other aging 
profiles for Drosophila (55, 56), and cardiac-specific genetic perturbation affects systemic 
metabolism which also exhibits similarity with at least one other cardiac perturbation study on 
organismal metabolism (45, 57). It is known why some of these metabolic changes may have 
such a significant impact on organismal lifespan, but we show a strong correlation between 
vinculin-mediated improvements in systemic metabolic efficiency and organismal fitness for 
additional pathways, which improv healthspan as well as lifespan. These data not only suggest 
additional targets but also imply a new paradigm may exist in cytoskeletal mediated changes in 
metabolism. 
 
Materials and Methods  
Drosophila Lines, Husbandry, and Culture Conditions 
Fly line UAS-Vinculin (#21870) was obtained from the Bloomington Drosophila Stock 
Center at Indiana University. Cardiac-specific perturbation of gene expression was achieved via 
the Gal4-UAS system as described previously (58). Briefly, UAS-transgenic males were crossed 
with virgin female tinHE-Gal4 flies using the GAL4-UAS system as previously described (59, 60). 
Female progeny of tinHE-Gal4 and w1118 served as control. Proper insertion of both constructs 
was validated using heart-specific gene expression analysis previously (9). Flies were raised on 
standard agar-containing food at 25oC. Food was changed every third day.  
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Drosophila Microsurgeries 
Preparation of the Drosophila heart for tissue collection and Seahorse measurements 
was performed as previously described (61), and did not affect heart function as previously 
shown (9). Adult female flies were briefly exposed to 5 pounds per square inch CO2 (< 1 min), 
then anesthetized with Fly Nap (Carolina Biological) for 5 minutes, and secured dorsal side down 
onto a 35 mm petri dish. The beating heart was exposed by incisions to remove heart, thorax, 
and the ventral abdominal cuticle. Flies were then submerged in an artificial oxygenated 
hemolymph at 25oC (62). Internal organs and debris above the beating heart were all carefully 
aspirated away with a micropipette so as to not perturb the heart, which could result in a 
hypercontractile state. The beating heart can be sustained for hours with regular oxygenation and 
hemolymph changes, but all experiments were performed within 1 hour of microsurgery. 
 
Rapid Iterative Negative Geotaxis (RING) Assay 
Climbing ability was assessed as previously described (22, 23). Briefly, 200 flies per 
genotype were placed into vials of 25 flies each on standard agar containing food. Each week, 
the day prior to measurement, the flies were briefly anesthetized with CO2 and placed into a fresh 
vial. Vials sat for 24+ hours post transfer to allow flies to recover from CO2. The day of the 
experiment, flies were carefully transferred into new 10 cm flat bottom homopolymer 
polypropylene digestion tubes [Environmental Express] without the use of CO2 to ensure no 
effects of anesthesia agent on performance. 4 tubes at a time were placed side by side into the 
RING apparatus similar to ones used previous (23). Flies were allowed to acclimate to their new 
environment for 20 minutes. After flies had acclimated 5 sets of negative geotaxis were recorded 
where all flies were tapped down to the bottom of their tubes and allowed to climb to the top. 
Videos of each set were taken for 10 seconds to ensure full capture. Videos were subsequently 
uploaded to computer, and still images were acquired 5 seconds after each tap and 
measurements were obtained and recorded. 1 minute was allowed in between each negative 
geotaxis and video capture to allow flies to recover. Mean height climbed between 0 – 9 cm was 
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calculated for each genotype and Two-way analysis of variance (ANOVA) with a Bonferroni post-
test was performed to assess significance at each time-point over their entire lifespan. Flies were 
transferred into new food vials for continued testing throughout their lifespan. Tubes used for 
climbing measurements were thrown out after each use. Lifespan and deaths were also recorded 
every 2 days when food was changed. 
 
[U-13C]glucose Traced in situ Stress Test with Gas Chromatograph- Mass Spectrometry 
Metabolic Profiling 
30 hearts per biological replicate were prepped via microsurgery detailed above. 10mM 
[U13C]glucose hemolymph with 10% Ficoll was prepared to mimic cardiac stress via viscous load. 
30 hearts were bathed in 5 mL of hemolymph solution for 2 hours to provide adequate 
[U13C]glucose tracing but avoiding any arresting of contraction (Figure S4.3). After 2 hours, hearts 
were washed in hemolymph with no addition of sugars and hearts were extracted into 300ul 8:1 
MeOH/H2O in 2 mL Eppendorf tubes on dry ice. Tubes were stored at -80o until metabolite 
extraction.  
Metabolites were extracted as described previously (63). Briefly, 4 metal balls per tube 
were added, the tubes were put into the Retch Mill and milled for 2 minutes with 25 shakes/s. 
100ul of diH2O was added to each tube. Tubes were placed back into Retch Mill for an additional 
2 minutes with 25 shakes/sec. 250 ul of -20°C chloroform was added and tubes were shaken 
again for 20 minutes at 4o C with 2000 rpm on an Eppendorf Thermomixer. Tubes were then 
centrifuged for 5 minutes at 20,000 g at 4o C. Upper polar phase of mixture was collected and 
evaporated under vacuum at -4o C. 
Metabolite derivatization was performed using a Gerstel MPS. Metabolites extracted from 
hearts were derivatized using MTBSTFA, metabolites from whole flies using TMS. Dried polar 
metabolites were dissolved in 15 μl of 2% (w/v) methoxyamine hydrochloride (Thermo Scientific) 
in pyridine and incubated for 60 min at 45 °C. An equal volume of 2,2,2-trifluoro-N-methyl-N-
trimethylsilyl-acetamide (MSTFA) or N-tertbutyldimethylsilyl-N-methyltrifluoroacetamide 
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(MTBSTFA) with 1% tert-butyldimethylchlorosilane (TBDMS) (Regis Technologies) was added 
and incubated further for 30 min at 45 °C. Derivatized samples were analyzed by GC-MS using a 
DB-35MS column (30 m x 0.25 mm i.d. x 0.25 µm, Agilent J&W Scientific) installed in an Agilent 
7890A gas chromatograph (GC) interfaced with an Agilent 5977 mass spectrometer (MS). For 
MTBSTFA derivatized samples, the GC oven was held at 100°C for 1 min, increased to 255°C at 
3.5°C min-1, increased to 320°C at 15°C min-1 and held at 320°C for 3 min. For TMS 
measurements, the GC oven was held at 80°C for 6 min, increased to 300 °C at 6°C min-1, 
increased to 325 °C at 10°C min-1, and held at 325 °C for 4 min. Metabolite levels and mass 
isotopomer distributions were determined by integrating metabolite ion fragments and corrected 
for natural abundance using targeted in-house library and in-house algorithms. 
 
Seahorse Oxygen Consumption Assay 
The Seahorse XF24 extracellular flux analyzer allows real-time, non-invasive 
measurements of O2 flux using the fluorescent probes attached to disposable assay cartridges. 
These measurements were used to correlated O2 consumption rate (OCR) to cardiac function by 
looking at maximal and minimal OCR. Rigorously cleaned Drosophila hearts attached to a 
trimmed cuticle were placed at 1/well into an 24well islet plates [Seahorse Bioscience] using 
tweezers. 400 µl of hemolymph described above with 5mM Phenol red was added to each well. 
Screens were placed on top over each recessed well to protect underlying heart tubes from 
coming into contact with probes or being disturbed. All hearts were checked for contractility 
before the start of the assay. Mitochondrial function and OCR was assayed using the ability of the 
XF24 to inject a series of compounds into well throughout the assay. Briefly, hearts were 
measured for basal respiration without injection of any pharmachalogical compounds then 
permeabalized with 3nM perfringolysin O (commercially, XF PMP (XF Plasma Membrane 
Permeabalizer)) as described previously (64) with addition of 7.5 µg/ml of Oligomycin. Maximal 
respiration was calculated as the difference between the maximal respiration detected after 400 
nM FCCP addition and the minimal detected [nonmitochondrial respiration] after addition of 1 µM 
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rotenone and 4 µM antimycin A treatment [max-min]. 16 loops of mixing and measurement were 
performed after the addition of rotenone and antimycin to allow all mitochondrial respiration to 
cease in the hearts. All data are mean ± standard error of the mean (SEM) of the individual OCR 
measurements from each heart assayed over multiple plates as indicated. 
 
Gas chromatography-Mass spectrometry (GC-MS) sample preparation and analysis  
Polar Metabolites from 5 whole flies per biological replicate were extracted using 
methanol/water/chloroform as described above. Dried polar metabolites were prepped and 
analyzed as described above. Metabolite levels and mass isotopomer distributions were 
determined by integrating metabolite ion fragments and corrected for natural abundance using 
non-targeted MetaboliteDetector software, TMS derivatization, and in-house algorithms. n=4 per 
genotype and age. Data variation was determined by Principal Component Analysis (PCA).   
 
Longevity Assay 
Females were collected for 2 days after which they were briefly anaesthetized by CO2 
and separated into groups of 25 flies in each vial. The flies were kept at 25o. Dead flies were 
counted every 2 days after transfer onto new standard agar-containing food. Each experiment 
consisted of 200-250 flies. Data were analyzed using Prism 5.0a (Graphpad Software, Inc.).  
 
Statistical Methods 
All data were checked for Gaussian distribution prior to analysis using D’agnostino-
Pearson omnibus normality test. Two-way analysis of variance (ANOVA) was used when 
comparing 2 or more groups at more than one condition such as negative geotaxis assay 
followed by a Bonferroni multiple comparisons post hoc test of significances. Significances are 
displayed on the graph with Bonferroni post-hoc test results denoted over specific point 
comparisons. One-way ANOVA with Dunn’s post-test was performed on whole fly metabolite 
abundance values across all genotypes and ages. Lifespan analyses were performed using a log-
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rank analysis (Mantel-Cox test). In all cases p < 0.05 were taken as significant. All statistical 
analyses were performed using Prism 5.0a (Graphpad Software, Inc). Specific analyses used are 
indicated in figure legends. All in situ experiments were performed with biological replicates of 15-
30 flies unless otherwise indicated, and are displayed with average and standard error of the 
mean (SEM). Metabolomic experiments represent < 4 biological replicates of 30 pooled fly hearts 
as indicated in the legends. 
 
Supplemental Materials 
 
Figure S4.1. Oxygen Consumption Rate Scales with Number of Hearts per Well in XF24 
Extracellular Flux Analyzer. Optimal hearts required for sufficient OCR signal in the XF24 
extracellular flux analyzer were measured by testing two genotypes, denoted Gen1 and Gen2, 
with both 1 or 3 hearts per well over course of the assay. Graph shows Gen1 3x, 3 hearts/well as 
being about 3 times the signal of Gen1 1x, 1 heart/well from relative OCR at all time-points. 
Graph shows Gen2 3x also recorded 3 times the signal of Gen2 1x. A , B, C, and D denotes 
dosing of various pharmacological agents testing mitochondrial function. A time-point denotes 
addition of Oligomycin. B and C time-points both denote addition of FCCP. D time-point denotes 
addition of Rotenone and Antimycin. n= 5 per genotype and condition. 
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Figure S4.2. Experimental Design of C13 Labeled Glucose Targeted Mass Spectrometry of 
Heart Samples from VincHE and Control Hearts. VincHE and control hearts are exposed via 
microsurgery then bathed in hemolymph with a relative viscosity of 5 hr and [U13C]glucose 
swapped in for the normal glucose concentration in order to test [U13C]glucose uptake in 
metabolic pathways under cardiac stress induced by increased viscosity. [U13C] will then be 
incorporated into different metabolites downstream and label various carbons within each: M0, 
M1, M2, M3, etc, which can be determined by spectral patterns. 
 
 
Figure S4.3. Viscous Loading Assay has Minimal Effects on Contraction of Fly Hearts for 
up to 2 hours. (A) 1 week old w1118 wildtype hearts with the poorest contractile capacity were 
measured for contraction as indicated by fractional shortening (FS) > 5% beating against a 
relative viscous load of 1 hr and 5 hr. (B) 5 week old w1118 wildtype hearts with the poorest 
contractile capacity were measured for contraction as indicated by fractional shortening (FS) > 
5% beating against a relative viscous load of 1 hr and 5 hr. n=25 for each condition and age. 
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Figure S4.4. Controls Crossed from tinman-Gal4 x w1118[Engler Lab] Tin1118 and from 
tinman-Gal4 x w1118[Bodmer Lab] Tin1118-Bodmer Exhibit Similar Climbing Ability at All 
Ages and Similar Lifespan. (A) Rapid Iterative Negative Geotaxis (RING) Assay described in 
detail in the methods was performed weekly over the entire lifespan of each genotype and the 
climbing distance over an interval of 5 seconds was recorded for each fly. n=200 at the start of 
the experiment. Data represent mean ± SEM. All negative geotaxis data were analyzed with 2-
way-ANOVA with pot hoc Bonferroni test. (B) Survival curves for controls: tinman-Gal4 x 
w1118[Engler Lab] and from tinman-Gal4 x w1118[Bodmer Lab] in the RING assay show median 
survival indicated by the dashed black line for each genotype. 
 
Figure S4.5. Sugar Metabolites Accumulate with Age in VincHE Flies. (A) Sucrose 
abundance plotted for each genotype at given ages. (B) Glucose abundance plotted for each 
genotype at given ages. (C) Galactose abundance plotted for each genotype at given ages. (D) 
Mannose abundance plotted for each genotype at given ages. (E) Melezitose abundance plotted 
for each genotype at given ages. n=4 for each condition. Statistical significance calculated by 2-
way ANOVA with post-hoc Dunn’s test. * p<0.05 
  
156 
 
 
Figure S4.6. Amino Acid Metabolite Accumulation with Age in VincHE Flies. (A) Homoserine 
abundance plotted for each genotype at given ages. (B) Lysine abundance plotted for each 
genotype at given ages. n=4 for each condition. Statistical significance calculated by 2-way 
ANOVA with post-hoc Dunn’s test. * p<0.05 
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Figure S4.7. TCA Cycle Intermediate Metabolite Accumulation with Age in VincHE Flies. 
Abundance plotted for TCA cycle intermediates: Pyruvate, Lactate, Citrate, Succinate, Fumarate, 
and Malate, for each genotype at given ages. Statistical significance calculated by 2-way ANOVA 
with post-hoc Dunn’s test. * p<0.05 
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CHAPTER 5 
Conclusions 
In the United States, cardiovascular disease (CVD) is the #1 killer of both men and 
women. While CVD affects some in their middle ages, the risk of CVD significantly increases 
beginning at age 45 for men, and 55 for women (1). Furthermore, a report from the American 
Heart Association from 2016 stated that nearly 70% of individuals between the ages of 60-79 and 
85% of those over 80 have some form of CVD (1). While these data suggest that cardiac disease 
is nearly a consequence of living longer, these individuals still require medication, hospitalization, 
and care which can be a burden on our society. Thus, it is imperative that we study the molecular 
hallmarks of cardiac aging to promote healthier aging either therapeutically or with smarter 
engineering of cardiac tissue. Much effort has focused on maladaptive remodeling of the heart in 
recent years, but far too little has been devoted to understanding what mechanisms in 
cardiomyocytes precede pathology, and help compensate for age-related increases in stress and 
load. 
Common models to study CVD, e.g. mice and rats, are slow to age, expensive, and 
commonly do not recapitulate human CVD until significantly stressed via techniques such as 
transaortic constriction (2, 3). This need for a rapidly aging, genetically tractable, and genetically 
homologous model has led to the use of the fruit fly, Drosophila melanogaster, for studying age-
related cardiovascular disease. Drosophila has for many years been used to study genetics and 
development, but recent focus has been cardiovascular research with an emphasis on aging and 
disease. The fruit fly is uniquely suited for studying cardiovascular aging and disease due to its 
relatively short lifespan ~7 weeks, conservation of cardiac disease genes (4), and the breadth of 
transgenic systems including thousands of existing RNAi lines and genetic mutants (5-8). Unlike 
rat and mouse models which have a resting heart-rate of 600-800 beats per minute (bpm), 
Drosophila’s 60-120 bpm mimics that of humans, and combined with its small size allows for 
much easier in situ measurement of common cardiac parameters. The development and 
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progression of methods for visualizing Drosophila heart tube contraction (9-13) has propelled the 
study of cardiac mechanics.  
Using the tools offered by the Drosophila model to study cardiac aging in a simpler heart 
structure with the necessary physiological relevance (14), this dissertation project offers evidence 
for two mechanisms that could be targeted to promote healthier aging of the heart. Specifically, 
we have showed that the previously under-researched cardiac basement membrane (BM) which 
has been shown to undergo age-related thickening in rats (15) and remodel as a result of left 
ventricular unloading (16), can be decreased moderately in flies correlating with improved heart 
function with age. Additionally, upregulation of cytoskeletal components such as Vinculin have 
been documented with age (17, 18), and our data provides evidence that this upregulation 
precedes pathology to reinforce the sarcomere laterally and longitudinally within cardiomyocytes. 
This final chapter of the dissertation will briefly summarize the key discoveries of this work and 
suggest future studies to evolve the use of the Drosophila model as a springboard to understand 
the molecular underpinnings of cardiovascular remodeling and disease. 
 
Summary of Results 
Downregulation of Basement Membrane in the Drosophila Heart Preserves Contractile 
Function and Improves Lifespan 
 At the beginning on this dissertation project in 2012, few studies had examined the 
impact that BM extracellular matrix has on cardiac remodeling with age. Most studies focused on 
age-related increases in fibrillar interstitial ECM such a Collagen I, Collagen III, and Fibronectin 
that thicken and stiffen myocardium, impairing diastolic function (17, 19-22). However, these 
studies neglect how BM protein remodeling may affect the cardiomyocyte’s ability to sense 
stiffness changes in the microenvironment. We have showed that BM proteins experience an 
increase with age in non-diseased Rhesus macaque and rat myocardium which mirrors previous 
studies that note thickened basement membranes in aged rat hearts (15). One common lab 
wildtype of Drosophila melanogaster, w1118, also experienced a basal increase in BM thickness 
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and upregulation of Collagen IV [Viking and Pericardin] and Laminin [LamininA] when compared 
to another wildtype yw which undergoes age-related cytoskeletal remodeling and sustains cardiac 
function with age even under significant load. We chose to use the w1118 model as a recapitulation 
of age-related mammalian BM thickening. Through cardiac-restricted RNAi, we downregulated 
LamininA (LanAKD), Viking (VkgKD), and Pericardin (PrcKD) in Drosophila separately ~30-40% 
to decrease BM thickness and observe resultant phenotype. LanAKD, VkgKD, and PrcKD flies 
experienced a basal increase in heart tube diameters which allowed increased contractile 
distance and increased fractional shortening. The LanAKD flies experienced the greatest effect 
as a result of Laminin knockdown decreasing several other BM components most likely 
amplifying the phenotype. LanAKD experienced a significant increase in relaxation velocities at 1 
week even under significant load, and experienced preservation of both contractile and relaxation 
velocities with age. All KD genotypes experienced significant extension of median and maximal 
lifespan compared to controls, with LanAKD surviving 40% longer than controls.  
 These data have shown that an important link exists between BM regulation changes as 
a result of age or genetic perturbation and mechanical function. Our data specifically suggest that 
downregulating BM with age to prevent thickening could have beneficial effects, but significant 
work in mammalian models is necessary to confirm the translatability of these conclusions. The 
increased complexity of cellular organization within the microenvironment in higher organisms 
may complicate the simple prospect of downregulating BM in the heart to improve function. 
However, at least a few studies in mammals have noted the impact that the BM and sarcolemma, 
specifically dystrophin, has on cardiomyocyte mechanotransduction. Dystrophin studies exploring 
the cardiac phenotype of patients with Duchenne Muscular Dystrophy have noted the mechanical 
importance of functional dystrophin in sensing mechanical stress within the heart and note 
dystrophin deficiency leads to severe cardiomyopathy (23-25). When subjected to mechanical 
stretch, hearts from mdx deficient mice experience an increase in left ventricular compliance as a 
result of a disturbed dystrophin-glycoprotein complex which perturbed cell-extracellular matrix 
contacts causing a slippage of myocytes during LV distention (26). Results from hearts with B-
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sarcoglycan-null and Laminin-a(2) mutation from mice mirrored the mdx mouse model of 
cardiomyopathy suggesting that the whole organ dilation experienced by DMD patients is a 
specific effect of their disrupted cell matrix contacts. Dystrophin loss of function studies in 
Drosophila have also demonstrated heart tube dilation (27) which corroborates the slight dilation 
experienced by our BM KD flies, but these studies aim to recapitulate DMD severity and do not 
examine KD effects. Significant work on BM expression, organization, and remodeling are 
necessary across all models and in humans in order to identify if these proteins, which link the 
fibrillar interstitial ECM to cardiomyocytes, could regulate physiological vs. pathological responses 
with age. In this published chapter (28) we have shown that these proteins can regulate 
contractile function, but more cross-model studies with and without pathology are needed to 
make further conclusions and necessitate mouse or rat models. 
 One last interesting result of our BM KD studies was the affect BM expression can have 
on rhythmic contraction. Increased arrhythmia index (AI), or heart period variance, has been 
described for w1118 flies with age compared to yw (12), and since we observed differences in BM 
thickness between these genotypes and as a result of KD, we hypothesized that the differences 
in layer coupling between KD genotypes could give rise to genotype-specific contractile 
irregularities. Thus, we examined how decreasing BM production could affect heart rhythm. KD 
flies experienced a load-dependent increase in heart period compared to controls at 1 week, but 
at 5 weeks, flies experienced a significant increase in heart period at all loads (Figure 5.1A). 
Heart period variance also showed a load-dependent increase but only for LanAKD and VkgKD; 
PrcKD flies did not exhibit these changes (Figure 5.1B). Additionally, m-mode images for both the 
LanAKD and VkgKD flies showed a significant percentage of heartbeats with an incomplete 
diastole (ID) before a new systole (Figure 5.1C), i.e. a fibrillar event. At both 1 and 5 weeks, 
LanAKD and VkgKD flies but not PrcKD flies had a load-dependent increase in the percentage of 
incomplete diastoles compared to controls (Figure 5.1D). These data suggest that while KD flies 
have increased fractional shortening, preserved shortening and lengthening velocities with age 
and increased organismal lifespan as we noted in chapter 2, KD of Laminin A and Viking, 
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localized mainly between the ventral muscle and cardiomyocytes, exacerbate the electrical 
decoupling of the cardiomyocytes increasing their contractile irregularity unlike Pericardin which is 
localized largely on top of and around the heart tube. Thus, future studies need to examine how 
decreasing BM expression in the heart could be attained without compromising conduction. In 
vitro studies using differentiated and contracting cardiomyocytes given shRNA to Laminin or 
Collagen IV and imaged for Calcium handling could give indication to issues in conductance as a 
result of decreased expression of BM components.  
 
Figure 5.1. Reduced BM ECM Production Cause Contractile Irregularity. (A) Heart Period 
(defined as the beginning of one contraction to the beginning of the next contraction) was 
measured for indicated genotypes and ages as a function of load. (B) Heart Period Variance or 
Arrhythmia Index defined as standard deviation of heart period normalized to the median value 
for each fly was measured for indicated genotypes and age as a function of load. (C) Example m-
mode with incomplete diastole (ID) commonly found VkgKD and LanAKD flies indicates 
incomplete relaxation before new contraction highlighted in orange. (D) Quantification of 
percentage of incomplete diastoles normalized to total diastoles sampled in the 20 second 
videos. *p<0.05, **p<0.01, ***p<0.001. 
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Vinculin Network-mediated Cytoskeletal Regulation of Contractile Function, Metabolism, 
and Healthspan with Age 
In chapters 3, we examined how the conserved upregulation of Vinculin with age impacts 
cardiac function by creating a Drosophila model that over-expresses Vinculin in the heart 
(VincHE). We used this model to interrogate why cardiomyocytes upregulate and remodel 
Vinculin with age. Increased Vinculin expression resulted in increased recruitment of Vinculin to 
both the costamere and the intercalated disc (ID). Atomic force microscopy showed increased 
stiffening of the ID’s and costameres in VincHE flies. Viscous loading assays used to mimic 
cardiovascular stress in situ demonstrated that the hearts in VincHE flies experienced increased 
wall velocities, fractional shortening, and power output even at significant load. Transmission 
electron microscopy (TEM) of the myofilaments within the VincHE hearts determined that these 
flies had increased myofibril crystallinity which increases the efficiency of actin cross bridge 
cycling. These studies corroborated a Vinculin KO mouse model which observed the opposite 
effect where myofilament spacing increased (29). We also examined what impact overexpressing 
Vinculin in a fly model with compromised cardiomyocyte cytoskeleton via Myosin Heavy Chain 
knockdown (MhcKD). Briefly, the MhcKD hearts exhibited significant decreases in ID stiffness, 
wall velocities, and lifespan, but by combining MhcKD + VincHE we were able to rescue function 
and return ID stiffness, velocities, and lifespan to near control levels suggesting that Vinculin 
reinforcement of the ID and costamere can rescue a compromised cytoskeleton. In this published 
chapter (30) we showed the importance of Vinculin to cardiac function and suggested future work 
to examine the organismal benefits which could confer the significant increase in lifespan 
observed. 
In Chapter 4 we examined how the increase in cardiac function in VincHE flies affects 
organismal metabolism and fitness. We observed sustained cellular bioenergetics in VincHE 
hearts in advanced age via Seahorse oxygen consumption measurements. However, we were 
unable to use targeted metabolomics to determine localized changes in metabolic flux within 
these hearts. Whole fly gas chromatography mass spectrometry (GC/MS) provided significant 
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evidence for accumulation of metabolites in VincHE flies with age compared to age matched 
controls. The specific metabolite profiles correlated with several longevity selection studies across 
other animal models (31-34). Using the rapid iterative negative geotaxis (RING) assay we 
determined that VincHE flies exhibited increased fitness even with advanced age suggesting that 
the cardiac benefits conferred both an increase in lifespan and healthspan which does not always 
occur (35, 36). Future worked using targeted GC/MS on VincHE whole fly samples is necessary 
to observe the metabolic flux of glucose and determine which pathways are being preferentially 
metabolized in these flies. These studies could be used to circumvent Vinculin upregulation or 
used in tandem to maximize the health benefits that these flies exhibit. Furthermore, Seahorse 
OCR studies on hearts pharmacologically stressed via epinephrine or similar compounds could 
be used to exacerbate respiratory requirements in VincHE hearts to see how OCR 
measurements under maximal respiration compare with controls. In chapter 4, we have identified 
that Vinculin-mediated increase in cardiac output also increases helathspan by increasing 
metabolic efficiency as determined by increase accumulation of metabolites in advanced age. 
Future studies are necessary to identify the specific metabolic pathways involved, and our work is 
ongoing. 
  
 174 
References 
1. Mozaffarian, D., E. J. Benjamin, A. S. Go, D. K. Arnett, M. J. Blaha, M. Cushman, S. R. 
Das, S. de Ferranti, J. P. Després, H. J. Fullerton, V. J. Howard, M. D. Huffman, C. R. 
Isasi, M. C. Jiménez, S. E. Judd, B. M. Kissela, J. H. Lichtman, L. D. Lisabeth, S. Liu, R. 
H. Mackey, D. J. Magid, D. K. McGuire, E. R. Mohler, C. S. Moy, P. Muntner, M. E. 
Mussolino, K. Nasir, R. W. Neumar, G. Nichol, L. Palaniappan, D. K. Pandey, M. J. 
Reeves, C. J. Rodriguez, W. Rosamond, P. D. Sorlie, J. Stein, A. Towfighi, T. N. Turan, 
S. S. Virani, D. Woo, R. W. Yeh, M. B. Turner, and A. H. A. S. C. a. S. S. Subcommittee. 
2016. Heart Disease and Stroke Statistics-2016 Update: A Report From the American 
Heart Association. Circulation 133:e38-e360. 
2. Zemljic-Harpf, A. E., S. Ponrartana, R. T. Avalos, M. C. Jordan, K. P. Roos, N. D. Dalton, 
V. Q. Phan, E. D. Adamson, and R. S. Ross. 2004. Heterozygous inactivation of the 
vinculin gene predisposes to stress-induced cardiomyopathy. Am J Pathol 165:1033-
1044. 
3. Manso, A. M., R. Li, S. J. Monkley, N. M. Cruz, S. Ong, D. H. Lao, Y. E. Koshman, Y. Gu, 
K. L. Peterson, J. Chen, E. D. Abel, A. M. Samarel, D. R. Critchley, and R. S. Ross. 
2013. Talin1 has unique expression versus talin 2 in the heart and modifies the 
hypertrophic response to pressure overload. J Biol Chem 288:4252-4264. 
4. Cammarato, A., C. H. Ahrens, N. N. Alayari, E. Qeli, J. Rucker, M. C. Reedy, C. M. 
Zmasek, M. Gucek, R. N. Cole, J. E. Van Eyk, R. Bodmer, B. O'Rourke, S. I. Bernstein, 
and D. B. Foster. 2011. A mighty small heart: the cardiac proteome of adult Drosophila 
melanogaster. PLoS One 6:e18497. 
5. Dietzl, G., D. Chen, F. Schnorrer, K. C. Su, Y. Barinova, M. Fellner, B. Gasser, K. Kinsey, 
S. Oppel, S. Scheiblauer, A. Couto, V. Marra, K. Keleman, and B. J. Dickson. 2007. A 
genome-wide transgenic RNAi library for conditional gene inactivation in Drosophila. 
Nature 448:151-156. 
6. Staudt, N., A. Molitor, K. Somogyi, J. Mata, S. Curado, K. Eulenberg, M. Meise, T. 
Siegmund, T. Häder, A. Hilfiker, G. Brönner, A. Ephrussi, P. Rørth, S. M. Cohen, S. 
Fellert, H. R. Chung, O. Piepenburg, U. Schäfer, H. Jäckle, and G. Vorbrüggen. 2005. 
Gain-of-function screen for genes that affect Drosophila muscle pattern formation. PLoS 
Genet 1:e55. 
7. Duffy, J. B. 2002. GAL4 system in Drosophila: a fly geneticist's Swiss army knife. 
Genesis 34:1-15. 
8. Klueg, K. M., D. Alvarado, M. A. Muskavitch, and J. B. Duffy. 2002. Creation of a 
GAL4/UAS-coupled inducible gene expression system for use in Drosophila cultured cell 
lines. Genesis 34:119-122. 
 175 
9. Ocorr, K., N. L. Reeves, R. J. Wessells, M. Fink, H. S. Chen, T. Akasaka, S. Yasuda, J. 
M. Metzger, W. Giles, J. W. Posakony, and R. Bodmer. 2007. KCNQ potassium channel 
mutations cause cardiac arrhythmias in Drosophila that mimic the effects of aging. Proc 
Natl Acad Sci U S A 104:3943-3948. 
10. Ocorr, K. A., T. Crawley, G. Gibson, and R. Bodmer. 2007. Genetic variation for cardiac 
dysfunction in Drosophila. PLoS One 2:e601. 
11. Wolf, M. J., H. Amrein, J. A. Izatt, M. A. Choma, M. C. Reedy, and H. A. Rockman. 2006. 
Drosophila as a model for the identification of genes causing adult human heart disease. 
Proc Natl Acad Sci U S A 103:1394-1399. 
12. Fink, M., C. Callol-Massot, A. Chu, P. Ruiz-Lozano, J. C. Izpisua Belmonte, W. Giles, R. 
Bodmer, and K. Ocorr. 2009. A new method for detection and quantification of heartbeat 
parameters in Drosophila, zebrafish, and embryonic mouse hearts. Biotechniques 
46:101-113. 
13. Cammarato, A., S. Ocorr, and K. Ocorr. 2014. Enhanced assessment of contractile 
dynamics in Drosophila hearts. Biotechniques 58:77-80. 
14. Choma, M. A., M. J. Suter, B. J. Vakoc, B. E. Bouma, and G. J. Tearney. 2011. 
Physiological homology between Drosophila melanogaster and vertebrate cardiovascular 
systems. Dis Model Mech 4:411-420. 
15. de Castro Brás, L. E., H. Toba, C. F. Baicu, M. R. Zile, S. T. Weintraub, M. L. Lindsey, 
and A. D. Bradshaw. 2014. Age and SPARC change the extracellular matrix composition 
of the left ventricle. Biomed Res Int 2014:810562. 
16. Birks, E. J. 2013. Molecular changes after left ventricular assist device support for heart 
failure. Circ Res 113:777-791. 
17. Heling, A., R. Zimmermann, S. Kostin, Y. Maeno, S. Hein, B. Devaux, E. Bauer, W. P. 
Klövekorn, M. Schlepper, W. Schaper, and J. Schaper. 2000. Increased expression of 
cytoskeletal, linkage, and extracellular proteins in failing human myocardium. Circ Res 
86:846-853. 
18. Hein, S., S. Kostin, A. Heling, Y. Maeno, and J. Schaper. 2000. The role of the 
cytoskeleton in heart failure. Cardiovasc Res 45:273-278. 
19. Burgess, M. L., J. C. McCrea, and H. L. Hedrick. 2001. Age-associated changes in 
cardiac matrix and integrins. Mech Ageing Dev 122:1739-1756. 
 176 
20. Bonda, T. A., B. Szynaka, M. Sokołowska, M. Dziemidowicz, M. M. Winnicka, L. 
Chyczewski, and K. A. Kamiński. 2015. Remodeling of the intercalated disc related to 
aging in the mouse heart. J Cardiol. 
21. Polyakova, V., I. Loeffler, S. Hein, S. Miyagawa, I. Piotrowska, S. Dammer, J. Risteli, J. 
Schaper, and S. Kostin. 2011. Fibrosis in endstage human heart failure: severe changes 
in collagen metabolism and MMP/TIMP profiles. Int J Cardiol 151:18-33. 
22. Huet, E., E. Gabison, B. Vallee, N. Mougenot, G. Linguet, B. Riou, C. Jarosz, S. Menashi, 
and S. Besse. 2015. Deletion of extracellular matrix metalloproteinase inducer/CD147 
induces altered cardiac extracellular matrix remodeling in aging mice. J Physiol 
Pharmacol 66:355-366. 
23. Danialou, G., A. S. Comtois, R. Dudley, G. Karpati, G. Vincent, C. Des Rosiers, and B. J. 
Petrof. 2001. Dystrophin-deficient cardiomyocytes are abnormally vulnerable to 
mechanical stress-induced contractile failure and injury. FASEB J 15:1655-1657. 
24. Kamogawa, Y., S. Biro, M. Maeda, M. Setoguchi, T. Hirakawa, H. Yoshida, and C. Tei. 
2001. Dystrophin-deficient myocardium is vulnerable to pressure overload in vivo. 
Cardiovasc Res 50:509-515. 
25. Petrof, B. J., J. B. Shrager, H. H. Stedman, A. M. Kelly, and H. L. Sweeney. 1993. 
Dystrophin protects the sarcolemma from stresses developed during muscle contraction. 
Proc Natl Acad Sci U S A 90:3710-3714. 
26. Barnabei, M. S., and J. M. Metzger. 2012. Ex vivo stretch reveals altered mechanical 
properties of isolated dystrophin-deficient hearts. PLoS One 7:e32880. 
27. Taghli-Lamallem, O., T. Akasaka, G. Hogg, U. Nudel, D. Yaffe, J. S. Chamberlain, K. 
Ocorr, and R. Bodmer. 2008. Dystrophin deficiency in Drosophila reduces lifespan and 
causes a dilated cardiomyopathy phenotype. Aging Cell 7:237-249. 
28. Sessions, A. O., G. Kaushik, S. Parker, K. Raedschelders, R. Bodmer, J. E. Van Eyk, 
and A. J. Engler. 2016. Extracellular matrix downregulation in the Drosophila heart 
preserves contractile function and improves lifespan. Matrix Biol. 
29. Tangney, J. R., J. S. Chuang, M. S. Janssen, A. Krishnamurthy, P. Liao, M. Hoshijima, X. 
Wu, G. A. Meininger, M. Muthuchamy, A. Zemljic-Harpf, R. S. Ross, L. R. Frank, A. D. 
McCulloch, and J. H. Omens. 2013. Novel role for vinculin in ventricular myocyte 
mechanics and dysfunction. Biophys J 104:1623-1633. 
30. Kaushik, G., A. Spenlehauer, A. O. Sessions, A. S. Trujillo, A. Fuhrmann, Z. Fu, V. 
Venkatraman, D. Pohl, J. Tuler, M. Wang, E. G. Lakatta, K. Ocorr, R. Bodmer, S. I. 
 177 
Bernstein, J. E. Van Eyk, A. Cammarato, and A. J. Engler. 2015. Vinculin network-
mediated cytoskeletal remodeling regulates contractile function in the aging heart. Sci 
Transl Med 7:292ra299. 
31. Le Couteur, D. G., S. Solon-Biet, V. C. Cogger, S. J. Mitchell, A. Senior, R. de Cabo, D. 
Raubenheimer, and S. J. Simpson. 2016. The impact of low-protein high-carbohydrate 
diets on aging and lifespan. Cell Mol Life Sci 73:1237-1252. 
32. Hansen, T. O., P. Sarup, V. Loeschcke, and S. I. Rattan. 2012. Age-related and sex-
specific differences in proteasome activity in individual Drosophila flies from wild type, 
longevity-selected and stress resistant strains. Biogerontology 13:429-438. 
33. Fuchs, S., J. G. Bundy, S. K. Davies, J. M. Viney, J. S. Swire, and A. M. Leroi. 2010. A 
metabolic signature of long life in Caenorhabditis elegans. BMC Biol 8:14. 
34. Kircher, H. W., and B. Al-Azawi. 1985. Longevity of seven species of cactophilic 
Drosophila and D. melanogaster on carbohydrates. Journal of Insect Physiology 31:165-
169. 
35. Mair, W., M. D. Piper, and L. Partridge. 2005. Calories do not explain extension of life 
span by dietary restriction in Drosophila. PLoS Biol 3:e223. 
36. Piazza, N., B. Gosangi, S. Devilla, R. Arking, and R. Wessells. 2009. Exercise-training in 
young Drosophila melanogaster reduces age-related decline in mobility and cardiac 
performance. PLoS One 4:e5886. 
37. Lieber, S. C., H. Qiu, L. Chen, Y. T. Shen, C. Hong, W. C. Hunter, N. Aubry, S. F. Vatner, 
and D. E. Vatner. 2008. Cardiac dysfunction in aging conscious rats: altered cardiac 
cytoskeletal proteins as a potential mechanism. Am J Physiol Heart Circ Physiol 
295:H860-866. 
 
